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 True anophthalmia is the most severe congenital eye malformation. With 
absence of the eye, optic nerve, chiasm and optic tracts. Identifying the genes that 
cause genetic true anophthalmia should improve our understanding of the critical 
processes required for development of the eye. Recessive loss-of-function 
mutations in SMOC1 have been identified as the cause of Ophthalmo-acromelic 
syndrome (OAS), a multisystem disorder which has true anophthalmia as a 
prominent feature with characteristic limb and facial malformations. In order to 
establish the function of SMOC1 in development I used the zebrafish as a model 
organism to support a link between SMOC-1 and BMP signalling. 
  
 As a first step I characterised the genomic structure of zebrafish smoc1 
gene. I was able to correct an error in the zebrafish genome (Zv8) that annotated 
zsmoc1 as two fragmented and rearranged orthologous loci.  However, using RT-
PCR I could show that there is in fact a single intact zsmoc1 transcript. In addition, I 
was able to identify an un-annotated 5’ coding exon using 5' RACE which showed 
that the full open reading frame includes a signalling peptide. RT-PCR was also 
used to identify several novel zsmoc1 splice isoforms. 
 
 To explore the link between zsmoc1 and bmp signalling I used injection of 
antisense morpholino oligonucleotide and capped mRNA to examine the effects of 




the bmp signalling pathway. The resulting embryos were analysed using 
morphometric analysis (Kishimoto scale), a quantitative assay of 
dorsalisation/ventralisation and live imaging of reporter transgenic fish.  I 
developed a quantitative RT-PCR assay for expression of dorsal (otx2 and runx3) 
and ventral (eve1 and gata2) marker genes. I established a reliable system for live 
imaging of zebrafish development between 8 hpf and 24 hpf. By combining this 
system with fluorescent transgenic reporters marking the eye field (rx3:gfp 
reporter) and BMP-signaling (BRE:gfp reporter) I was able to accurately quantitate 
the effect of smoc1 depletion on eye size and SMAD1/5/8 signalling in the eye. 
These results support the predictions from the Drosophila homologue Pent that 
zsmoc1 functions as an antagonist of bmp signalling. 
 
 Finally, I describe my attempt to produce a zebrafish model for OAS using 
genome editing technology. I designed, produced and validated transcription 
activator like effectors nucleases (TALENs) targeted to the zsmoc1 open reading 
frame using the Voytas Goldengate method. I designed and optimised a novel 
strategy to demonstrate targeted cutting activity for in vitro validation. Following 
injections of the in vitro validated TALEN into zebrafish embryos I used Ion 
Torrent sequencing to assess the in vivo activity of the engineered TALEN pairs. 








Lay Summery  
True anophthalmia is the most severe congenital eye malformation with absence 
of the eye, optic nerve, chiasm and optic tracts. Identifying the genes that cause 
genetic true anophthalmia should improve our understanding of the critical 
processes required for development of the eye. Recessive loss-of-function 
mutations in SMOC1 have been identified as the cause of Ophthalmo-acromelic 
syndrome (OAS), a multisystem disorder which has true anophthalmia as a 
prominent feature with characteristic limb and facial malformations. In order to 
establish the function of SMOC1 in development I used the zebrafish as a model 
organism to support a link between SMOC1 and BMP signalling. 
                                        
As I first step characterised the genomic structure of zebrafish smoc1 gene. I was 
able to correct an error in the zebrafish genome (Zv8) that annotated two 
fragmented and rearranged orthologous loci.  However, using RT-PCR I could show 
that there is in fact a single intact smoc1 transcription unit. In addition I was able 
to identify an un-annotated 5’ coding exon using 5'  RACE which showed that the 
full open reading frame includes a signalling peptide. RT-PCR was also used to 
identify several novel zsmoc1 splice isoform. 
  
To explore the link between zsmoc1 and BMP signalling I used injection of 
antisense morpholino oligonucleotide and capped mRNA to examine the effects of 




in the BMP signalling pathway. The resulting embryos were analysed using 
morphometric analysis (Kishimoto scale), a quantitative assay of 
dorsalisation/ventralisation and live imaging of reporter transgenic fish.  I 
developed the qualtitative RT-PCR assay for expression of dorsal (otx2 and runx) 
and ventral (Eve1 and gata2) marker genes. I established a reliable system for live 
imaging of zebrafish development between 8 hpf and 36 hpf. By combining this 
system with fluorescent transgenic reporters marking the eye field (rx3) and BMP-
signaling (BRE reporter) I was able to accurately quantitate the effect of smoc1 
depletion on eye size and SMAD1/5/8 signalling in the eye. These results support 
the predictions from the drosophila orthology that zsmoc1 functions as an 
antagonist of BMP signalling. 
  
Finally I describe my attempt to produce a zebrafish model for OAS using genome 
editing technology. I designed, produced and validated transcription activator like 
effectors nucleases(TALENs) targeted to the zsmoc1 open reading frame using the 
Voytas Goldengate method. I designed and optimised a novel strategy to 
demonstrate targeted cutting activity in vitro validation. Following injections of the 
in vitro validated TALEN into zebrafish embryos I used ion torrent sequencing to 
assess the in vivo activity of the engineered TALEN pairs. Unfortunately these 
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SMOC2 : Secreted modular calcium-binding protein 2 (gene) 
SMOC-1 : Secreted modular calcium-binding protein 1 (protein) 
SMOC-2 : Secreted modular calcium-binding protein 2 (protein) 
BMP : bone morphogenetic protein 
Dpp :  Decapentaplegic  
MAD : Mothers against Decapentaplegic  
smad : Mothers against Decapentaplegic homologue 
p-smad : phosphorylated smad 
FGF : fibroblast growth factor 
TGF : transforming growth factor beta 
Shh : Sonic hedghog 
tm : melting temperature 
MO : morpholino oligonucleotide 
TAL effector : transcription activator-like effector 




ZFN : Zinc finger nuclease 
CRISPR : clustered regularly interspaced short palindromic repeats 
  
Practical 
Hpf : hour post fertilisation 
Dpf : days post fertilisation 
O/N : overnight 
ISH : in situ hybridisation 
SDS- PAGE : Sodium  Dodecyl Sulphate-Polyacrylamide Gel Electrophores 
WB : Western blotting 
SB : southern blot 
PCR : polymerases chain reaction 
RT-PCR : reverse transcription- PCR 
RACE : Rapid Application of cDNA Ends 
q-PCR : quantified - PCR or real time PCR 
BLAT : Basic local alignment tool 
NCBI : National Centre for Biotechnology Information 
OMIM : Online Mendelian Inheritance in Man 
UCSC : University of California Santa Cruz  






















1.1.1 Clinical features 
 
 Ophthalmo-acromelic syndrome (OAS or Waardenburg anophthalmia) is 
caused by mutations in SPARC related modular calcium binding 1 (SMOC1) and is 
characterised by a spectrum of eye phenotypes, with eye malformations ranging 
from microphthalmia to true anophthalmia (Tekin et al. 2000). However a 
significant proportion of the known cases (92%) have bilateral anophthalmia (Fig 
1.1.1 A; Tekin 2002; Tekin et al. 2000; Cogulu et al. 2000; Kara et al. 2002; 
Garavelli et al. 2006). True anophthalmia is the most severe eye malformation, 
describing complete absence of the eye (no globe, optic tract, chiasm or tract), and 
is taken to indicate a catastrophic failure of early eye development (Fitzpatrick & 
van Heyningen 2005). Other gene mutations which cause anophthalmia in humans 
have been found in PAX6 (Glaser et al. 1994), SOX2 (Fantes et al. 2003), OTX2 
(Ragge et al. 2005), STRA6 (Pasutto et al. 2007) and BMP4 (Bakrania et al. 2008), 







 The other defining feature of OAS is a distinctive pattern of limb 
malformations with the lower limbs showing the most severe defects
oligodactyly  is observed in 
cases exhibiting  some 
ray (Tekin et al. 2000
The upper limb malformations
(57%; Fig. 1.1.1 C)
Fig 1.1.1 Ophthalmocharacterised by bilateral eye and limb malformation
 A patient showing the typical features of OAS  (A) anmetacarpals in the hands and (D) oligodactyly (2006). Smoc1tm1a/tm1a the eye (E)  and oligosyndactyly in the lower limbs (F). This data is summarised in (G) Rainger et al. (2011)  
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with OAS include mental retardation (37%) and craniofacial abnormalities (37%; 
Fig. 1.1.1 G; Rainger et al. 2011).   
 
1.1.2 The identification of mutations in SMOC1, the principal genetic cause of OAS 
 
  Three separate research groups have identified homozygous mutations of 
SMOC1 as the cause of OAS (Rainger et al. 2011; Abouzeid et al. 2011; Okada et al. 
2011).  
  Our group identified eight separate mutations in eight families. Six of these 
are loss of function mutations as they are either nonsense or frameshift mutations 
(Rainger et al. 2011). The last two missense mutations are predicted to be loss of 
function, as they completely phenocopy the nonsense mutations. Additionally, the 
amino acid residues that are changed in the missense mutations are evolutionarily 
well conserved; the Arg278 residue is conserved to Xenopus laevis and the Thr283 
residue is conserved to Drosophila melanogaster (Rainger et al. 2011). Of the six 
families where a SMOC1 mutation has not been identified, two mutations map to 
the 14q24 locus and are likely to be as yet unidentified SMOC1 regulatory 
mutations. This suggests that SMOC1 mutations account for ~70% of OAS cases 
(Rainger et al. 2011). Independent research from two other research groups has 
identified four different mutations in SMOC1, all of which are predicted to be loss 
of function mutations (either nonsense or splice site mutations; Okada et al. 2011; 





1.1.3 The structure of SMOC-1 
 
 SMOC-1 is a member of the BM40 family of proteins and along with its close 
homologue, SMOC-2, it is made up of six domains: one signal peptide and one 
Follistatin-like domain, two Thyroglobulin-like domains, a unique SMOC domain 
and two EF hand domains (Fig 1.1.2). (Vannahme et al. 2002; Vannahme et al. 
2003). The protein also contains a signal peptide sequence. The signal peptide 
sequence is a short string of 5-30 hydrophobic amino acids followed by a signal 
peptidase cleavage site. The cleavage of signal peptides targets the protein to the 
secretory pathway. As the SMOC proteins lack the long strings of hydrophobic 
amino acids that would be necessary for a transmembrane protein this structure 
would predict that the protein is secreted and not a transmembrane protein. This 
result is borne out by experimental data with Smoc-1 and Smoc-2 which are both 
secreted into the media in cell culture. Whole mount immunohistochemistry of 
both the testes and the ovaries has shown that SMOC-1 is localised to the basement 








Fig 1.1.2 A  side by side comparison of the structure of theSMOC subfamily of BM40 proteins and related Drosophila Pentagone. 
 Both SMOC-1 and 2 are based on the human amino acid sequence (UniProt: Q9H4F8 and 




 Once the signal peptide has been cleaved off, the mature SMOC peptide 
starts with a Kazal like domain followed by two thyroglobulin-like domains. These 
related domains in other proteins have been shown to inhibit protein degradation 
by blocking peptidase activity. Notably, the second thyroglobulin domain appears 
to be critical for SMOC-1 as this domain harbors the only two missense mutations 
identified (Rainger et al. 2011).  
 The thyroglobulin domains flank 65 conserved amino acids, which have 
been called the SMOC domain. However there is no compelling evidence of a 
specific function attached to the SMOC domain, and it is possible that it is made up 
of several smaller structural motifs each with a distinctive function (Vannahme et 
al. 2002; Vannahme et al. 2003).  
 The final functional groups are a pair of EF hand domains containing glyco-
saminoglycan-binding motifs. These motifs allow SMOC proteins to bind to heparin 
and heparin sulphate and it has been shown that in cell culture SMOC-1’s adhesion 
to the cell membrane is dependent on the presence of heparin sulphate proteins 
(e.g. the glypicans). If the glycosaminoglycan-binding motifs are mutated then the 











1.1.4 The mode of action of Smoc-1 in animal models 
 
 
 While Smoc-1 is not a well studied protein, the developmental data from 
animal models supports the human genetic assignment of this as the causative 
gene in OAS. 
 Two separate papers detailing the phenotypes of gene trap mice have been 
published, and both have remarkably similar features (Smoc1tm1a/tm1a (Rainger et 
al. 2011) and Smoc1Tp/Tp (Okada et al. 2011)). A compelling case can be made that 
they phenocopy OAS in humans. As in OAS cases both show more severe defects in 
the lower limbs than upper limbs. The hind limbs displayed both oligodactyly and 
syndactyly, while the forelimbs displayed no phenotype. The Smoc1tm1a/tm1a mice 
had a significant percentage of embryos that showed a cleft palate phenotype 
(27.3%), which is also observed in OAS (Rainger et al. 2011). This is consistent 
with the presence of expression patterns observed in both in situ hybridisations of 
E9.5 and E10.5 mouse embryos which show distinctive expression patterns in both 
the first branchial arch and the limb buds (Rainger et al. 2011; Fig 1.1.3 a & b).  
 The most surprising aspect of the mouse phenotype is that the eye defects 
are comparatively mild when compared to the true anophthalmia displayed in OAS 
patients. The Smoc1tm1a/tm1a mice show a mild coloboma phenotype while 
Smoc1Tp/Tp mice show mild microphthalmia and mild defects in closure of  the optic 
fissure. It is thought this might be due to leaky expression from the gene trap 
(Smoc1tm1a/tm1a had residual expression of 10% of the Smoc1 transcript). However, 
 
a complete null has now been generated, and the ocular phenotype remained mild. 
(Rainger personal correspondence 2012)
  
______________________________________________________________________________________________
that smoc-1 is not a significant player in the development of the mouse eye. It is 
expressed at much low
buds. Rainger et. al failed to detect 
hybridisation. Yet the 
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er levels in the eye than either the branchial arch or limb 
Smoc-1 transcripts in the
Smoc1tm1a/tm1a LacZ reporter was active in the eye.  
Fig 1.1.3 The known expression patterns of lopment.  
(A and B) OPT models of whole mount in situ at both E9.5 and E10.5 respectively. expression is seen in thearches (BA), the fronto(FN), the forelimbs  (FL) and the somites (S). (B).has expanded to the forward and hind limbs expression is confined medially in both to the dorsal and ventral axes.(C, D, E  and F if a) situ of zebrafish showing that expression is initially localised within the anterior of the RPEhpf) (C and D). clearly compliant to the ventral retina flanking the optic fissure smoc1 expression can also be seen in the branchial arches. Figures taken from and (Abouzeid et al. 2011)
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consistent with the observation that Smoc-1 down regulation causes a mild eye 
phenotype (Rainger et al. 2011).  
 
 The only other significant functional work published in vertebrates is in 
Xenopus. Unilateral xsmoc1 depletion  with  morpholino oligonucleotides leads  
Xenopus embryos to develop unilateral anophthalmia on the side of the injection 
(Thomas et al. 2009). However by 2011 Abouzeid et al. 2011 had demonstrated that 
smoc1 is expressed in the zebrafish eye by 16 hpf and reported that smoc1 depletion 
results in a coloboma phenotype suggesting that the zebrafish could be a good model 
organism for the study of OAS. 
 Outside of vertebrates some compelling work has been done in Drosophila. 
Mutations in the Drosophila smoc1 orthologue Pentagone result in the loss of 
lateral identity, exemplified by the absence of the fifth longitudinal vein 
(Vuilleumier et al. 2010). While the structure is not homologous to the vertebrate 
limb, it does have obvious similarities to the oligodactyly observed in both humans 
and mice (Vuilleumier et al. 2010). The imaginal wing discs are a well-established 
model system for bmp signalling. It is possible to dynamically monitor the dpp (the 
Drosophila homologue of BMP) gradient in real time and is relatively easy to 
manipulate the other components of the BMP signalling pathway.  In fact, the 
pentagone expressed in the imaginal wing discs allowed Vuilleumier et al. to 
investigate its effect on the dpp gradient. This led them to propose a molecular 










responsive silencer elements. This was later confirmed 
this; not only was 
imaginal disc away from the midline where dpp levels were greatest but in flies 
 
Fig 1.1.4  The Vuilleumier model of  
(A) Under the Vuilleumier modelthe region of dpp activity Pentagone inturn inhibits dpp activity by blocking the endocytosis of dpp. the effect of dpp and pentagone levels in the cenral band of dpp expressionloop which fine-tunes the Dpp gradient.embryos) the dpp is endocytosed near source. Resulting in a narrower but more intense band of activity.  If pentagone is upregulated (if pentis blocked. Resulting in a broader but less intense band of Figures derived with  information 
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 was initially identified as the gene regulated by BMP 
genetically
pentagone expression confined to the lateral edges of the 
Pentagone action in Drosophila
 dpp represses pentagone expression. This excludes pentagone from which leads to the establisment of a pentagone countergradient to dpp. (B)Drosophila imaginal wing discs restricts pentagone expression to the lateral wingdisk, forming a  If pentagone is reduced (as in the case of the pent mutant 
agone is expressed with the dpp promoter) dpp activity. 
taken from Vuilleumier et al. 2010 
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where dpp was ectopically expressed throughout the wing disc pentagon 
expression was eliminated. They went on to show that pentagone itself altered dpp 
signalling. In Pent mutants the region of dpp signalling was contracted though the 
intensity of mad phosphorylation (and thus dpp signalling) was significantly 
increased. Conversely, where Pentagon was ectopically expressed the gradient is 
broader but mad? phosphorylation was significantly reduced. They went on to 
show that pent mutants could be rescued by down regulating endocytosis. This 
lead them to propose a model where pentagone acted not as a simple BMP 
antagonist but as a gradient expander. In this capacity it acts in a feedback loop 
with dpp. Hamaratoglu et al. went on to expand upon this work and showed that 
this feedback loop was critical in controlling the shape of the Drosophila wing as it 






1.2 Eye development 
 
1.2.1 Vertebrate eye development 
 
 
Vertebrate eye development can be broadly divided into five separate 
stages. 
 
1. Specification of the eye field (Fig. 1.2.1 A). 
2. Formation of the optic vesicle (OV) (Fig. 1.2.1 B). 
3. Lens(L) induction (Fig. 1.2.1 C) 
4. Organization of the neural retina and retinal pigment epithelium (Fig. 1.2.1 
D-E)  
5. Fusion of the optic fissure (Fig. 1.2.1 E-F; reviewed in Fitzpatrick & van 
Heyningen 2005; Adler & Canto-Soler 2007; Chow & Lang 2001).  
 
 It should be noted that lens induction, fusion of optic fissure and the early stages 






PRE: presumptive retinal ectoderm
MS: mesenchyme; SE:
LP: lens placode; pre
epithelium; NR: neural retina;
stalk; OF: optic fissure;  
fertilisation; GD: gestation day.
42 
  
Figdevelopment of a generic vertebrate eye  
(A) endoderm (in the anterior neural plateThe transcription factors known to be involved are shown.envaginates towards the SE. (C) makes contact with the surface ectoderm (SE)differentiatpresumptive retinal epithelium (RPretina (NR) and optic s(OS). the SE to form the lens placode (LP). This is followed by the invagination of the optic vesicle.OF begins to form in the ventral eyecupcup matures the lens vesicle (LV) separates from thbefore becoming the solid lens(L). The lens induces the SE to differentiate into the C. The gap between the NR and RPE closes and the NR fully differentiatesMeanwhile the optic stalk forms the passage for the optic nerveoptic f Figure based on information taken from Soler 20071995Ohuchi et al. 1999et al. 1997 and van Heyningen 2005
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 For over 50 years it has been 
known that eye field formation is 
dependent on neural induction. 
Nieuwkoop demonstrated this by 
explanting frog neural-ectoderm which 
differentiated into optic tissue if the cells 
of the explant were first disassociated 
(Nieuwkoop 1963).  This differentiation 
occurred even in the absence of 
mesodermal tissue, showing that the 
development is cell autonomous 
(Nieuwkoop 1963; Chow & Lang 2001). It has since been established that the 
vertebrate eye is derived from the pre-lens placode. After the neural tube has 
closed the anterior neural plate is potentiated for eye development by the 
expression of noggin and otx2 (Zuber et al. 2003; Chuang & Raymond 2002). The 
presumptive retinal ectoderm (PRE) is derived from this region of the anterior 
neural plate (Donner et al. 2006;Streit 2007; Lachke & Maas 2010; Varga et al. 
1999). Surrounded by the pre-telencephalon and pre-diencephalon (Fernández-
Garre et al. 2002; Inoue et al. 2000), the PRE is defined by the positive regulation of 
Fgf signalling and simultaneous inhibition by Bmp and Wnt signalling (Fig. 1.2.1 
A; Lachke & Maas 2010; Macdonald et al. 1995). This leads to the up-regulation of 
multiple transcription factors, most notably Lhx2 Rx, Six3, Pax6, Hesx1 and Six6 
(Lachke & Maas 2010; Zuber et al. 2003). 
Fig. 1.2.2 the sequence of development for the vertebrate eye.  





 The correct establishment of the eye field requires that these transcription 
factors act simultaneously and cooperatively. Knocking out any one of these genes 
results in significant eye defects (Zhang et al. 2000; Mathers et al. 1997; Roy et al. 
2013; Dattani et al. 1998; Wallis et al. 1999). Yet, no transcription factor fully 
controls the expression of any of the others. Rx is the earliest marker of the eye 
field yet does not initiate Pax6, Six3, or Otx2 expression within the neural plate. 
This was demonstrated by Zhang et al. (2000) with knockout mice. The presence of 
Rx is required to up regulate the expression of each of these genes during the 
specification of the eye field (Zhang et al. 2000). Conversely Pax6 null mice still 
initiate Rx, Six3, and Otx2 expression (Chow & Lang 2001).  
 
 While these results appear contradictory they can be explained by either 
common external signals and/or via cross regulation.  The role of Wnt, Fgf and 
Bmp signalling during eye development is already well-established (Lachke & 
Maas 2010) and it appears that cross regulation is also a factor.  This was 
established by the injection of various "cocktails" of different combinations of eye 
field transcription factors (Rx,  Six3, Pax6, tll and Optx2) into a one cell Xenopus 
embryo, the resulting overexpression leads to the formation of ectopic eyes in 88% 
of Xenopus embryos (Zuber et al. 2003). This demonstrates that these transcription 
factors are sufficient to drive eye field specification. Zuber et al. went on to show 
that removing any one gene from the mRNA cocktail reduced but did not eliminate 
the formation of ectopic eyes (between 24% for a mRNA cocktail minus Pax6 and 





 Within the PRE the cell fate is restricted along the midline of the PRE until it 
is separated into two distinct eye fields by Shh signalling (Chiang et al. 1996; 
Macdonald et al. 1995). When these separate eye fields have been established the 
optic vesicle (OV) begins to form by bilaterally envaginating towards the surface 
ectoderm (SE). Once the OV has made contact with the SE both tissues begin to 
differentiate.  The OV induces the formation of the lens placode (LP). Then the LP 
in turn induces the OV to differentiate into the presumptive retinal pigment 
epithelium (RPE), neural retina (NR) and the optic stalk (OS). After the lens 
placode has been induced it begins to invaginate forming the lens vesicle (LV). 
Simultaneously OV also invaginates surrounding the (LV) and coincidentally the 
NR, RPE and OS form.  
As the optic cup changes morphology the optic fissure is formed.  The RPE 
and NR begin to fuse approximately in the middle of the longitudinal axis of the 
developing eye. This fusion proceeds simultaneously proximally and distally, 
creating a single unified layer of neural ectoderm. Once the fusion front reaches 
the OS, it closes forming the optic nerve (ON). By the time the lens has induced the 
formation of the cornea (C) the optic fissure has closed and the optic globe is 
complete (reviewed in Adler & Canto-Soler 2007; and Fitzpatrick & van Heyningen 
2005). 
 This is the generic model of vertebrate eye development and it should be 
noted that there is interspecies variation in the development of the eye. For 
example in teleost fish (i.e. zebrafish and medaka) a pair of OV aren't formed by 
the invagination of the diencephalon. Instead the eye field is formed inside the 
 
telencephalon: it divides to 
into the eyes (Woo & Fraser 1995)
differences. For example
migration and not envagination 
Lens in zebrafish delaminates from the OV rather than invaginating inwards with 
the RPE (Glass & Dahm 2004)
Dahm 2004). However, the broad 
The function of the main eye differentiation genes is conserved and the relative 
time points are conserved between species







form two independent eye fields,
. This leads to several other 
, the RPE and NR are organised by individual cell 
(Rembold et al. 2006; Brown et al. 2010)
. Therefore the LV never forms in zebrafish 
sequence of events remains largely the same
 (Fig. 1.2.1), 
 (Adler & Canto-Soler 2007
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Fig 1.2.3 Schematic of the expression of signalling proteins in dorsoventral patterning of the vertebrate eye. 
The figure depicts the regions with highest levels of expression as assessed by situ hybridisation  
OS: optic stalk; R: retina;  
RPE: retinal pigment epithelium; L: lens
D: dorsal; V: ventral; A: anterior; P: posterior. Figure based on information taken from  Adler & Canto-Soler 2007
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 As the eye is formed it is simultaneously patterned along several axes. The 
eye varies both structurally and molecularly in the dorsoventral, anterior posterior 
and naso-temporal axes. To achieve this several interacting signalling pathways 
are utilised (Table 1.2.1) most notably Wnt signalling, Mapk signalling and Bmp 
signalling (Adler & Canto-Soler 2007).  
 An example of this is Bmp signalling in the patterning of the dorsoventral 
axis. The retina varies morphologically along the dorsoventral axis in a number of 
ways.  There are differential rates of retina expansion, with dorsal tissue 
expanding faster than ventral tissue (Koshiba-Takeuchi et al. 2000), leading to the 
formation of the optic fissure which is located in the ventral tissue (Koshiba-
Takeuchi et al. 2000). Bmp ligands are expressed in a spatially restricted manner 
(Fig. 1.2.3). Bmp4 for example is expressed dorsally and promotes dorsal 
Stage of eye development Transcription factors Signalling Pathways 
1.Formation of OV  Rx; Pax6; Six3; Lhx2;Six6; ET; tll; Hes1;Otx2; Sox2 FGFs; Wnts; BMPs 2. L induction   Rx; Pax6; tll Cyclops; SHH; RA 
3.Patterning of the NR and RPE  Pax6; Rx; Lhx2; Chx10;Otx2; Mitf; Pax2; Foxg1; BF2/Foxd2 
SHH; FGFs; Activin; BMP;RA 
4. Fusion of the OF Pax6; Lhx2; Hes1 RA 
5. Dorsoventral patterning of the NR Pax6; Foxg1;Foxd2; SOHo1; GH6;Pax2; Vax; Tbx5;Xbr1 
Nodal; FGFs; SHH; BMPs; RA ; Ventroptin; Follistatin; Chordin;  Noggin; DAN 
Table 1.2.1 The transcription factors and signalling pathways known to be involved in the development of a vertebrate eye. 
The table illustrates which transcription factors and signalling cascades are known to be functional in eye development. Genes and signalling pathways in which mutations cause anophthalmia or microphthalmia have been highlighted in bold. Genes only known to cause microphthalmia are underlined.  




differentiation. In Xenopus the up-regulation of bmp4 expression leads to an 
expansion of the expression of dorsal marker genes (for example pax6).   There is a 
corresponding down-regulation of ventral expressed genes (for example pax2 the 
vax2; Sasagawa et al. 2002). Bmp antagonists like Noggin and Chordin-like1 
(ventropin) promotes ventral identity by blocking bmp signalling (Sakuta et al. 
2001). Up-regulation of the proteins leads to an expansion of ventral marker genes 
(for example pax2 and vax2).  
 Of course, Bmp signalling is not the only pathway to specify dorsal identity. 
Wnt signalling also promotes the dorsal retina. While both Shh and RA signalling 
have been shown to promote ventral identity(Sakuta et al. 2001; Marsh-Armstrong 
et al. 1994). 
 Eye development is thus dependent on a complex cascade of molecular 
events. The process is finely balanced, with many processes occurring 
simultaneously and with a considerable amount of crosstalk. The failure of any one 
part will impact in the whole process of eye development,which would then lead to 











1.2.2 Known genetic causes of anophthalmia and microphthalmia 
 
 
 The majority of genes known to cause anophthalmia and microphthalmia 
can be split into two categories encoding either proteins acting on signalling 
pathways or transcription factors (Adler & Canto-Soler 2007; Williamson & 
FitzPatrick 2014). This is unsurprising, given that anophthalmia and 
microphthalmia are developmental disorders. Anophthalmia, as the most severe 
eye malformation may be reasonably hypothesised to result from mutations in 
genes acting at the very earliest stages of eye development thus leading to optic 
vesicle aplasia with consequent complete failure in the initiation of eye 
development (S  Olitsky and L Nelson 2006). Most of the causative genes are 
expressed during the early stages of eye development. (Table 1.2.1). However, in 
many cases the absence of the eye is the consequence of regression, after some 
initial development in the optic cup. This appears particularly likely in the cases 
that are not true anophthalmia as the presence of optic nerve, chiasm and optic 
tracks suggests regression (Fitzpatrick & van Heyningen 2005). This has been 
observed in mouse models of anophthalmia. For example bmp7 knockout mice 
were shown to initially undergo normal lens and retinal development before 
degradation. In total 60% of the bmp7 null mice went on to develop anophthalmia 
(Dudley et al. 1995). Furthermore, the known causative genes discussed above are 





 Biallelic mutations in PAX6 were the first identified genetic cause of 
anophthalmia, but such compound heterozygous cases are rare (Glaser et al. 
1994). Heterozygous PAX6  loss-of-function mutations are more common and are 
associated with eye abnormalities; typically aniridia and Peter's anomaly 
(Hingorani et al. 2012). PAX6 is a transcription factor that plays a central role 
throughout eye development. It is expressed at every stage of eye formation 
(Macdonald & Wilson 1997) and has been shown to be essential to many different 
processes in eye development (Table 1.2.1). This central role has led to PAX6 
acquiring the label of "the master regulator of eye development" (Halder et al. 
1995; Baker 2001). 
 While PAX6 may be a master regulator there is considerable evidence that it 
functions downstream of RX (or RAX).  RX is the earliest known marker of the optic 
vesicle and it is continually expressed in both the OV and NR throughout eye 
development (Bailey et al. 2004). RX compound heterozygotes have been 
associated with severe ocular malformations (either anophthalmia or 
microphthalmia; Chassaing et al. 2014; Voronina et al. 2004).  
 The strongest evidence that RX acts upstream of PAX6 comes from mice. 
Homozygous nulls fail to express Pax6 (Zhang et al. 2000).  Additionally, in 
Xenopus, Rx morphants cannot form OV, leading them to display true 
anophthalmia. This can be rescued with the injection of both otx2 and Pax6 mRNA  
(Mathers et al. 1997).  
 The most commonly mutated genes in bilateral anophthalmia and severe 
microphthalmia are SOX2 and OTX2 which together account for at least 60% of 




has a central role in establishing the brain field (Adler & Canto-Soler 2007), from 
which the OV initially forms. Unsurprisingly patients with OTX2 mutations often 
have neurological defects along with ocular malformations (Ragge et al. 2005). 
Unusually for a gene known to cause anophthalmia OTX2 is excluded from the OV, 
which envaginates from the diencephalon (Adler & Canto-Soler 2007). Later in eye 
development it begins to express in the OS before becoming restricted to the RPE 
(Martinez-Morales et al. 2001). OTX2 is thought to be critical to neural retina 
development. This is supported by the phenotype of OTX2 heterozygotes. Patients 
who do not have anophthalmia invariably display retinal defects (Fitzpatrick & van 
Heyningen 2005). It has been proposed that the whole spectrum of ocular defects 
found in OTX2 mutants are caused by the failure in RPE formation, and that the 
severity of the defects depends on how early RPE development fails (Fitzpatrick & 
van Heyningen 2005). This is the case in mice, where the Otx2-/- genotype is 
embryonic lethal due to a failure of gastrulation (Acampora et al. 1995). As in 
humans, the severity of the ocular malformations that Otx2 heterozygotes display 
is extremely variable. Otx2+/- mice display ocular phenotypes, which range from 
completely normal (Acampora et al. 1995) to displaying anophthalmia (Matsuo et 
al. 1995) depending on the genetic background. Martinez-Morales et al. 
demonstrated that Otx proteins have a critical role to play in RPE formation by 
crossing Otx2+/- and Otx1-/- mice. This led to the almost complete ablation of the 
RPE, which has the knock-on effect of disrupting NR differentiation (Martinez-









BMP4  Ligand  Monoallelic  STRA6 RA synthesis Biallelic  
BMP7 Ligand  Monoallelic  ALDH1A3 RA synthesis Biallelic  
GDF6 Ligand  Monoallelic  RARB RA synthesis Monoallelic and Biallelic  




 SOX2 is a central component of the eye development network in humans. 
The loss of a single allele is the most common cause of anophthalmia in humans 
(Williamson & FitzPatrick 2014). Work on SOX2 in model organisms has shown 
that it is involved in multiple processes during eye formation (table 1.2.1). For 
example SOX2 acts as a binding partner for multiple eye development genes. The 
Sox2-Pax6 complex has been shown to be vital for the correct expression of 
crystallin during the lens development of chickens (Kamachi et al. 2001) and Sox2-
Otx2 heterodimers have been shown to regulate Rx expression (Danno et al. 2008).  
 
 The second category of vertebrate eye genes are those involved in signalling 
pathways. Currently two pathways that have been implicated as causes of 
anophthalmia in humans. They are the BMP signalling pathway and retinoic acid 
(RA) signalling pathway (Table 1.2.2; Williamson & FitzPatrick 2014).  
 Of the two, the BMP signalling was the first to be implicated in human 
anophthalmia/microphthalmia(Williamson & FitzPatrick 2014). Currently there 
Table 1.2.2 The signalling pathways genes linked to anophthalmia/microphthalmia phenotype  





are four genes that have both been linked to anophthalmia/microphthalmia and 
are components of the BMP signalling pathway.  
 The first to be discovered was BMP4 (Bakrania et al. 2008). There have 
been at least six cases of patients with mono allelic BMP4 mutations displaying 
anophthalmia / microphthalmia that have been published(Bakrania et al. 2008; 
Reis et al. 2011; Zhang et al. 2009). However, there may be other causative genes 
or confounding environmental effects in this instance as there are two cases where 
large deletions that include multiple genes, along with BMP4 have led to milder eye 
phenotypes (e.g. Rieger anomaly, micro-cornea, nystagmus and glaucoma; Reis et 
al. 2011). It is clear that Bmp4 does have a functional role in vertebrate eye 
development. The expression pattern of Bmp4 is conserved from mice to humans 
(Reis et al. 2011) and the Bmp4 null mice failed to develop the lens placode (Furuta 
& Hogan 1998; Williamson & FitzPatrick 2014). This appears to be an entirely 
separate process from OV specification as the expression of Pax6 remains 
unaffected (Furuta & Hogan 1998). Of particular note in relation to the symptoms 
of OAS is that BMP4 heterozygotes also display digit abnormalities, with two 
unrelated cases exhibiting postaxial polysyndactyly (Williamson & FitzPatrick 
2014). 
 BMP7 is another BMP ligand linked to eye development. Three unrelated 
cases have been reported of BMP7 heterozygotes that display anophthalmia/ 
microphthalmia (Wyatt et al. 2010). If BMP7 mutations are indeed a cause of 
anophthalmia/ microphthalmia then either the genetic background or an 
environmental variable must also play a role because all the causative mutations 




phenotype(Wyatt et al. 2010). However, this is in line with the results obtained for 
bmp7 knockout mice, which displayed a high variability in phenotype severity 
depending on the genetic background of the mice used (Dudley et al. 1995; 
Wawersik et al. 1999). In C3H/He mice 91% of the homozygous nulls developed 
anophthalmia (Wawersik et al. 1999). Whilst only 50-60% of 129/Sv mice  
developed anophthalmia(Dudley et al. 1995; Wawersik et al. 1999) and  20% of C2 
mice displayed no eye defects at all. 
 Finally the BMP ligands GDF3 and GDF6 have both been linked to 
anophthalmia/ microphthalmia (MIM: 601147; Asai-Coakwell et al. 2007;  MIM: 
606522; Ye et al. 2010). Yet there is still uncertainty as to whether these mutations 
are causative (Williamson & FitzPatrick 2014). This is because the variants have 
only been identified in less than 2% of cases of anophthalmia/microphthalmia and 
every variant currently reported is a heterozygous non-synonymous mutation 
(Williamson & FitzPatrick 2014) with these variants either inherited from an 
unaffected parent, or the mode of inheritance was never established (Williamson & 
FitzPatrick 2014). While GDF6 has been shown to be required for the correct 
development of the eye in multiple model organisms, it appears to be involved 
later in eye development. GDF6 mouse knockouts exhibit abnormal neural retina 
and display altered electroretinograms (Asai-Coakwell et al. 2013). In addition 
GDF6 zebrafish morphants display ventralised neural retina (French et al. 2009; 
Gosse & Baier 2009) and Xenopus morphants showed a reduction in neuronal 





 More recently the retinoic acid (RA) signalling  pathway has been linked to 
cause anophthalmia/microphthalmia (Williamson & FitzPatrick 2014). Inhibiting 
the RA pathway with diethylaminobenzaldehyde (DEAB) in zebrafish induces a 
range of eye phenotypes (i.e. ranging from dorsalised retina to microphthalmia) 
depending on the time points it is administered and the dosage used (Le et al. 
2012; Marsh-Armstrong et al. 1994). To date causative mutations have been 
identified in three genes that are components of the RA synthesis pathway; STRA6,  
ALDH1A3 and RARB (Williamson & FitzPatrick 2014). The RA signalling cascade is 
unique among the developmental signalling pathways in that the signal is not 
carried by a protein but a simple organic molecule, retinoic acid. Retinoic acid is a 
derivative of vitamin A (retinol) which,if  secreted,can act as a Ligand.  
Alternatively it can be activated within the cell that synthesised it. In this case RA 
is used for intracellular signalling (Duester 2008). Retinol is usually transported in 
the body bound to a carrier protein called RBP4 (Duester 2008). 
  STRA6 promotes the absorption of retinol-RBP4 (Kawaguchi et al. 2007). 
This increases the available supply of retinol for conversion into RA and thus acts 
as an agonist of RA signalling (Rhinn & Dollé 2012). RA signalling is known to be 
utilised throughout eye development (Table 1.2.1) and indeed in multiple 
developmental processes. This is shown by the fact that biallelic STRA6 mutations 
cause pulmonary hyperplasia/diaphragmatic hernia/eventranation, anophthalmia 
/microphthalmia and cardiac defect (PDAC) syndrome (Chitayat et al. 2007). PDAC 
is a very distinctive syndromic cause of anophthalmia and is most often embryonic 






 Once the retinol has been absorbed it must be converted into RA. This 
reaction occurs in two stages. The retinol is first converted into retinaldehyde 
which is then converted into RA.  ALDH1A3 is an enzyme that catalyses the 
conversion of retinaldehyde into RA (Hsu et al. 1994). Patients with homozygous 
ALDH1A3 mutations display bilateral eye abnormalities, both anophthalmia and 
microphthalmia (Fares-Taie et al. 2013). To date 11 unrelated incidences of 
anophthalmia/microphthalmia families have been identified with biallelic 
ALDH1A3 mutations(Williamson & FitzPatrick 2014). 
 
 Once retinoic acid is synthesised it facilitates the activation of target genes 
by binding target sequences. This process is accomplished by retinoic acid 
receptor (RAR) proteins. Once the retinoic acid binds to them, they are able to bind 
the target sites and up regulate target genes (Rhinn & Dollé 2012). RARB is a tissue 
specific member of the RAR family of proteins. Only four families have been 
identified with RARB mutations, which have been observed to be both monoallelic 
and biallelic (Srour et al. 2013).  
 
 There are several other plausible candidate genes which may account for a 
small percentage of anophthalmia/microphthalmia (Williamson & FitzPatrick 
2014), However they remain less well studied,  account for a small percentage of 
cases and/or are associated with less severe eye defects (Ranging from 
microphthalmia to coloboma; Williamson & FitzPatrick 2014). It is likely that 




 One recent example is MAB21L2. Mutations in MAB21L2 only account for a 
tiny fraction of anophthalmia cases (five families have been identified; Rainger et 
al. 2014). What is noteworthy is that the majority of them seem to be residue 
specific (Rainger et al. 2014). Four out of the five mutations identified are 
monoallelic and have occurred independently within 2 residues of each other 
(three in Arg51 and one in Glu49). The one remaining mutation occurs in Arg247, 
and despite being biallelic the phenotype is substantially less severe. The siblings 
have bilateral coloboma (Rainger et al. 2014). Little is known about the function of 
MAB21L2; the wild type protein has been shown to bind to RNA in vitro and this 
binding is lost in the mutant alleles (Rainger et al. 2014). It is reasonable to 
speculate that it is this loss of binding of target RNAs that leads to anophthalmia 
but further work is needed to confirm this.  
  
 While none of the genes discussed have been shown to be causative genes 













1.2.2 Potential causes of anophthalmia 
  
 There are broadly three classes of anophthalmia. Primary anophthalmia, 
where the eye fails to develop at all. This is due to the failure of the establishment 
of the eye field andoccurs extremely early in development (Fitzpatrick & van 
Heyningen 2005). If SMOC1 controls the shape of signalling gradients (e.g. BMP, 
SHH or RA) then it could affect the size of the domains and even presence of early 
eyefield master regulators (e.g. PAX6, SOX2 and OTX2) which would lead to an 
absence of any other eye tissues, as is the case in Xenopus rx morphants (Mathers 
et al. 1997). 
 The second possibility would be regressive anophthalmia, where the eye 
field begins to develop though at some point eye development fails. In this 
scenario, an arrest in eye development may result in eye degeneration, casuing 
true anophthalmia. This is the most common mechanism of eyelessness in blind, 
cave dwelling vertebrate (fish?), though the molecular details vary between 
species. For example the eyes of blind cave Astyanaxs undergo broadly normal eye 
development up to 24 hpf , only for the lens to become apoptotic (Hinaux et al. 
2011). Without the signals from the lens the RPE begins to degrade resulting in 
anophthalmic fish. In this example the degradation is lens dependent. If a lens is 
transplanted into the embryo from a sighted species of Astyanaxs into a blind 
Astyanaxs,  then the fish will go on to develop healthy eyes and when you 
transplant the lens of a blind Astyanaxs embryo into a sighted Astyanaxs that 




precise molecular mechanism is unknown, it is thought to be mediated by an 
upregulation of hedgehog signalling during gastrulation (Yamamoto et al. 2004). 
 The final possibility is Secondary anophthalmia where eye development 
arrests at an early stage of development resulting in small rudimentary eyes that 
only become apparent upon detailed analysis. This has also been observed in blind 
cave-dwelling animals. For example in Poecilia mexicana eye development is 
arrested immediately after eye formation resulting a significant reduction in eye 
size (Yamamoto et al. 2004). 
 
 Of the three competing explanations of the anophthalmia phenotype of OAS 
patients we can safely discount secondary anophthalmia as OAS patients often 
display true anophthalmia and secondary anophthalmia would leave residual optic 
tissue(Fitzpatrick & van Heyningen 2005). Of the remaining options regression 
seems more likely as it is far more common in nature. Every known blind cave 
vertebrate undergoes some level of eye development even though the eyes are 
nonfunctional. This would seem like a very evolutionarily inefficient system. Why 
would it be beneficial for an organism to spend the energy forming eyes that are 
never used? The answer is thought to be that in vertebrates the formation of the 
eyefield is inextricably linked to the formation of the telencephalon (Woo  &  
Fraser 1995; Woo  et al. 1995) and any primary anophthalmia in  a vertebrate 
would also be associated with severe defects in brain development (Rétaux & 
Casane 2013). The counter argument to this is that OAS is associated with learning 
difficulties, but the penetrance is far lower than you would expect if the 




1.3. Main Aims 
   While it has become clear that mutations in SMOC1 are the principal cause of OAS 
the molecular function of SMOC1 is still poorly understood. The overall aim of my 
thesis is to help elucidate the function of SMOC1, and through doing this 
understand how disrupting these processes leads to the clinical features of OAS. To 
do this I hoped to address two central questions. 
 
 1.3.1 How do defects in SMOC1 function cause the features of OAS?   
To answer this question I aim to establish a zebrafish model of OAS. Principally 
because the ex-vivo development of zebrafish allowed me to observe the effects of 
SMOC1 depletion on the formation of the eye in real-time.  
 1.3.2 Establish if smoc-1 is functionally homologous to Drosophila pentagone  
At the outset of the thesis, the best models for SMOC1 function had implicated it as 
a simple antagonist of BMP signalling. However just prior to the beginning of the 
project, work on the Drosophila orthologue of SMOC1 (pentagone) proposed a 
more complicated model. Pentagone was proposed to act by controlling the shape 
of (dpp/BMP) signalling gradient, and whether or not it acts to antagonise or 
agonise the (dpp/BMP) signalling pathway depends on the context of the 
perturbation. This model was further validated by the work of Hamaratoglu et al. 
2011.  
The second aim of my thesis is to confirm whether or not this model is conserved 




  Chapter 2  
Chapter 2 will focus on establishing that zebrafish are a valid model organism for 
studying SMOC1. I will first demonstrate that zebrafish do include an intact copy of 
the zsmoc1 gene, and that this gene is expressed during zebrafish development, i.e. 
within the first 24 hours of zebrafish development. I will confirm the presence of 
any alternative splicing, both to identify any biologically relevant alternative 
transcripts but also aid in the targeting of endonucleases to produce true knockout 
zebrafish lines. 
 
Once I identified DNA sequences it will be analysed so we can predict functional 
significance of different zsmoc-1 domains. While this information is of biological 
significance it can also be used to target endonucleases more effectively. In 
summary I aim to: 
 
2.1 Define the correct gene structure of zsmoc1 
I aimed to determine whether the apparently rearranged gene structure of zsmoc1 
in the current version of the genome assembly was correct. 
 
2.2 Establish if any alternative splicing is present in zsmoc1. 
Alternative splicing is widespread, with many eukaryotic genes being alternatively 




targeting of TALENs and morpholino reagents for efficient depletion of zsmoc1 
throughout development. 
 
2. 3 Analyse the structure of the zsmoc-1 protein product bioinformatically. 
 




Chapter 3 describes the use of  morpholino oligonucleotides targeting zsmoc1 to: 
 
3. 1 Determine if zsmoc1 morphants are truly dorsalised. 
 
Pilot work undertaken in my masters project showed that zebrafish appeared to 
display a characteristic dorsalised phenotype of a bmp antagonist which implies an 
early loss of BMP signalling. If zsmoc1 morphants are dorsalised they should show 
an increase in the levels of dorsal marker genes and a corresponding decrease in 
the levels of ventral marker genes. 
To establish this, a novel qPCR quantitative assay of embryo dorsalisation 
/ventralisation will be developed. The assay will be developed using  qPCR to 
establish the relative expression level of marker genes between 12 and 16 hpf.  
Once validated using morpholinos which directly alter bmp signalling, the assay 





3. 2 Characterise zsmoc1 morpholinos  
 
Morpholino oligonucleotides are known to have quite severe off target effects. To 
rule this out, I will take two approaches:  First, inhibit the p53 cell death pathway 
with co-injection of zsmoc1 targeting MO in any morpholino work as 
recommended in Huang et al. (2012) as this is a pathway most often connected 
with morpholino toxicity (Bedell et al. 2011). Second, hSMOC1 will be cloned into a 
CS2+ plasmid backbone to enable the production of capped mRNA which can be 
used to try to rescue the zsmoc1 morphant phenotype.  
 
3. 3 Use real-time imaging of fluorescent transgenic reporter fish to 
understand the developmental pathology induced by zsmoc1 morpholinos. 
 
To achieve this an automated macroscope system will be optimised so both the 
establishment of the eyefield and the development of the eye can be monitored in 
real time from between 12 and 24 hpf.  
 
Given the severe eye defects associated with OAS and the fact that zsmoc1 is 
expressed in the developing zebrafish eye, and also as bmp signalling is involved in 
the establishment of the eyefield,  it is plausible that zsmoc1 is involved in 
regulating this gradient. If this is the case then zsmoc1 morphants should display 
eye defects, which should manifest is a reduction in eyefield size or a delay in 




imaging of the rx3:gfp (Rembold et al. 2006) zebrafish line will be used as rx3 is 
the earliest known marker of the zebrafish eye field.  
 
Additionally there is a bmp signaling gradient which is established within the eye 
field at between 16 hpf that establishes the dorsal ventral pattern across the optic 
cup. The signalling gradient is confined from dorsal to ventral. Given that zsmoc1 is 
expressed within ventral optic cup it is a plausible regulator of the dorso-ventral 
bmp gradient. 
If this is the case then the dorsoventral gradient should be disrupted. To test this a 
BRE:gfp (Collery & Link 2011) bmp reporter line will be used to visualise the area 
of bmp activity on  both zsmoc1 morphant and control embryos. 
 
3. 4 Establish if zsmoc1 acts as a Pentagone homologue 
 
Whole mount immunostaining and OPT quantitative image analysis will be used to 
determine if p-smad gradient is established in the same manner as the mad 
gradient in Drosophila (Vuilleumier, R. et al. 2010). Overexpression of smoc1 
mRNA should extend the range of p-smad activation but weaken the signal, while 
injection of zsmoc1MO should result in a contracted gradient but have stronger p-






While the morpholino work is compelling, (Chapter 3) the repetition of the results 
with a genetic inactivation of zsmoc1 is highly desirable as it would conclusively 
rule out off target effects.  
 
In summary I aim to: 
 
4.1 Induce loss of function genomic mutations in zsmoc1 
 




 4.1. 1 Design multiple TALEN pairs that target zsmoc1. 
 
 4.1. 2 Constructing the TALEN construct using Golden Gate  cloning. 
  
 4.1. 3 Confirm that the synthesis was successful and the constructs 
 cleave DNA in vitro.  
 
 4.1.4 Establish whether TALEN pairs induce hereditable mutations 






























 2.1.1 Danio rerio 
 
 
 Danio rerio, more commonly known as zebrafish, have been studied for 
over 70 years. Following the work of Streisinger et al. in the late 70s and early 80s 
zebrafish have become an extremely popular developmental organism. Used 
alongside mice, chicks, Xenopus and Drosophila.  
 
 Zebrafish are carnivorous cyprinids, native to southern India. They 
probably originally evolved to survive on floodplains in shallow pools of water, but 
the prevalence of irrigation used in the cultivation of rice by humans has proved an 
ideal habitat for zebrafish, and where they are endemic. It is a small hardy fish, no 
more than 4 cm long with characteristic blue horizontal stripes from which they 








2.1.2 Danio rerio as a useful model of disease 
 
 Zebrafish have a number of characteristics which make them an attractive 
model organism particularly for developmental biology. Firstly they are small and 
robust fish that can be kept cheaply in large numbers. While their gestation time is 
similar to mice, between 3-4 months they are prolific breeders with a single 
mating pair producing between 100 and 300 embryos every 7-14 days (Spence et 
al. 2008). This enables high throughput experiments and large screens (e.g. 
induced mutagenesis or small molecule/chemical biology). The embryos develop 
rapidly; zebrafish embryos start feeding after only five days and most of the 
organogenesis is completed after only 36 hours (Kimmel et al. 1995).   
 They develop ex vivo and the embryos are translucent, making them ideal 
for imaging embryonic development. These characteristics allow fluorescent 
reporter transgenic animals (e.g. GFP tagged proteins) to be used to visualise 
zebrafish gene expression in real-time (Gosse & Baier 2009; Collery & Link 2011; 
Molina et al. 2007) and resolve individual organs or even single cells (Fig. 3.2.14;  
Asai-Coakwell et al. 2009). 
 While zebrafish are not as closely related to humans as other model 
organisms (e.g. mice), they do have orthologues to the majority of human genes 
(71.2%). However only half of these genes are direct one-to-one homologues due 
to genome duplication (Howe et al. 2013). Whilst care should be taken when 
extrapolating results from zebrafish to human diseases they have already provided 




first large scale screens of zebrafish and identified several mutations that proved 
to be analogous to human disease (Driever et al. 1996; Haffter et al. 1996). For 
example the zebrafish mutant sauternes was mapped to ALAS2. Once the 
phenotype was characterised it went on to be the first animal model for congenital 
sideroblastic anaemia (Brownlie et al. 1998). The mutant gridlock has been used as 
a model for aortic coarctation, which has led to the identification of compounds 
that suppress the developmental pathology leading to coarctation (Peterson et al. 
2004). 
  Even in cases where the precise phenotype is not conserved, model 
organisms can provide insights into human biology. Biological networks are more 
strongly conserved; interactions identified in one model species strongly predict 
interaction in another species, even if the phenotype is different (McGary et al. 
2010). Bmp signalling is a classic example of this. In zebrafish defects in the bmp 
signalling  pathway during gastrulation trigger a distinctive spectrum of 
phenotypes characterised in Kishimoto et al. (1997; Fig. 3.1.3). These phenotypes 
were induced by varying levels of bmp activity. Using them it was possible to 
rapidly screen zebrafish embryos for mutation in bmp interactors. The vast 
majority of interactors have conserved roles up to mammals despite having 
different phenotypes. For example R-smads (Transcription factor; Fujii et al. 1999; 
Dick et al. 1999), BAMBI (repressor) (Tsang et al. 2000;Grotewold et al. 2001) and 
Chordin(repressor) (Branam et al. 2010) have all been shown to have conserved 
functions in multiple model organisms (reviewed in Ramel & Hill 2012).  Of course 




appeared to play a relatively minor role e.g. the zebrafish homeobox gene  Dharma 
is an antagonist of bmp2b (Koos & Ho 1999). 
 Given their advantages in imaging, zebrafish embryos are used extensively 
in developmental biology. For example Zebrafish mutational screens identified 
numerous phenotypes (Driever et al. 1996; Da Costa et al. 2014; Moens et al. 2008; 
; Wang et al. 2007). A good example of this was the use of this system to identify 
one eyed pinhead, a member of the nodal pathway and a significant player in early 
development (Gritsman et al. 1999).  
 Zebrafish are increasingly used to validate that mutations identified in 
humans are causative. For example if a missense variant fails to rescue a 
developmental effect induced by loss of function of the orthologous gene in fish 
embryos when wildtype mRNA can it is considered a null (Manzini et al. 2012; 
Sivasubbu et al. 2013).  This approach has even been used in large scale assays to 
quantify the relative functional activity of multiple variants of the same gene by 
comparing the degree to which they rescue the Morpholino knockdown of their 
zebrafish orthologue (Kabashi et al. 2011). Zebrafish are also valuable model 
organisms for drug discovery. For example Yeh et al. conducted a small molecule 
screen which identified several novel inhibitors of angiogenesis, which have 
potential as anti-cancer drugs. They went on to implicate two previously ignored 
pathways (both the COX-2-dependent signalling and beta-catinin signalling ) as 







2.1.3 Zebrafish Genomics 
 
 The zygotes of zebrafish tolerate microinjection and the levels of gene 
products within the early embryo can thus be easily modified via the use of 
morpholino oligonucleotides (MO). MO are short modified oligonucleotides 
resistant to degradation.  In zebrafish studies they are commonly designed to be 
complementary to mRNA. If targeted correctly they can impede either mRNA 
translation or splicing (Nasevicius & Ekker 2000; Morcos 2007;  Bedell et al. 2011). 
Over-expression of a desired gene can be achieved by injecting a plasmid with 
zebrafish promoters but since  DNA transcription only begins at the blastula stage 
of zebrafish (4hpf; Skromne & Prince 2008) this generally produces mosaic 
expression patterns (Kabashi et al. 2011; Monte Westerfield 2000). A more 
common strategy is to inject artificially synthesized mRNA directly into a single 
cell embryo which often leads to more even and ubiquitous expression 
(Finckbeiner et al. 2011; Skromne & Prince 2008). 
 
 Gene targeting/knockout technology in zebrafish has lagged behind mice as 
zebrafish appear to lack a homologous recombination pathway. Thus targeted 
mutations must be directly induced at the target site via technologies such as zinc 
finger nucleases (ZFNs; Ekker 2008), transcription activator-like effector nucleases 
(TALENs; Cade et al. 2012) and clustered regularly interspaced short palindromic 
repeats (CRISPRs; Hruscha et al. 2013).  However, a wide array of mutant lines 
available in specific genes have been identified via TILLING (targeting induced 




mutagenesis (typically chemically induced by ENU) and high throughput 
sequencing is used to identify mutations in individual genes (Stemple 2004; Moens 
et al. 2008). For example Tilling was used to generate mutations in superoxide 
dismutase gene (sod1) which will then be used to generate a better model of motor 
neuron disease (MND) which more closely mimics the features of MND (Da Costa 
et al. 2014).  
 The other obstacle is the current state of the zebrafish genome. The 
sequencing project was started in 2001 and was finished in 2013 (Howe et al. 
2013).  In the most recent  genome build 83% is  comprised of sequence mapped 
by clone by clone sequencing(Howe et al. 2013). This is where 50-60 kb sections of 
a genome are cloned into bacterial artificial chromosomes (BACs) before the whole 
segment is sequenced. Once the full 50-60 kb scaffold is sequenced it is then 
assembled with the other scaffolds (Brown TA. 2002). The remaining 17% of the 
zebrafish genome was assembled by more error prone shotgun sequencing where 
the whole genome is fragmented and sequenced directly(Howe et al. 2013; Staden 
1979; Anderson 1981).  
  Adequate alignment and annotation of the zebrafish genome proved 
challenging as it is a member of the Teleostei infraclass of fish. The common 
ancestor of this class went through the Teleost-specific genome duplication (TSD), 
which comprised a whole genome duplication event specific to Teleost fish (Meyer 
& Schartl 1999;Taylor et al. 2003).  
 Genome duplication presents a problem for genomic sequencing because it 
means the zebrafish genome is highly repetitive. As sequencing reads can only be 
so long (~900bp) they must be aligned together. Any repetition that is both 
 
sufficiently long and similar can be misaligned. Either multiple distinct paralogous 
sequences can be erroneously 
missed because they are mapped to the wrong loci  
 If the repetitive sequence is greater than 1 kb both clone by clone 
sequencing and shotgun sequencing can make these kinds of mistakes. Though 
shotgun sequencing is far more error prone because the whole genome is 
sequenced in one step which
can lead to assembly errors. While with clone by clone sequencing the repetitive 
elements must either be located within the same scaffold (50




Fig 2.1.1 Schematic representation of different outcomes of genomic assembly. If a sequence of repetitive DNA is not correctly aligned it is possible for software to misalignthe sequence in 2 ways. 1




combined into a single loci, or  paralogues can be 
(Fig. 2.1.1;
 means any repetitive elements in the entire genome 
(Brown TA. 2002). 
___________________________________




 Eichler 2001).   









 The zebrafish genome is the most highly repetitive animal genome 
sequenced so far which explains why it has taken 9 years longer to finish the 
zebrafish genome than originally predicted. For comparison the Xenopus tropicalis 
started in 2002 and was finished by 2011 despite having a larger genome (Table 
2.1.1; Hellsten et al. 2010). Even though the genome has been officially finished 
over 4% of the scaffolds have not been mapped to the reference genome. Though 
the Genome Reference Consortium continues to update the zebrafish genome and 
one day these maps will be resolved. 
_______________________________________________________________________________________________________________________________________________ 
Species  start date end date Size Protein coding genes Completion 
Danio Rerio v9.4 2001 2013 1.4 x 109 26,000 94.00% 
Xenopus tropicalis v.4.1 2002 2010 1.7 x 109 21,000 97.60%  
Table2.1.1 Summary of the zebrafish and Xenopus genome projects. (data taken from Howe et al. 2013; Hellsten et al. 2010) 
_______________________________________________________________________________________________________________________________________________ 
 






2.2.1 Clarifying the Genomic organization of zsmoc1  
 
 To further the understanding of smoc1 zebrafish was chosen as a model 
organism for the reasons outlined above. The first challenge involved identifying 
the zebrafish orthologue of smoc1.  Using the human SMOC1 cDNA two zebrafish 
sequences were identified by  BLAT searching of UCSC genome browser Jul 2010  
Zv9 dan Rer 7. However, the genomic sequence annotates zsmoc1 as two adjacent 
fragments arranged in opposing orientations on chromosome 17 (Fig. 2.2.1. A). 
One fragment is located between genomic coordinates 48424231 and 48449106.  
This is transcribed in the reverse orientation and contains exons 2 to 9.  The other 
fragment is located between coordinates 48482432 and 48542881. It is comprised 
of exons 10 to 15, and is transcribed in a forward orientation. Together these 
genes structures account for the full-length of vertebrate smoc1.  
Yet, if this represents the true genomic organisation of zsmoc1 then these 
are probably pseudogenes of no functional relevance. To establish whether the 
zsmoc1 locus in the current version of the zebrafish genome is correct, RT-PCR 
analysis was performed. PCR primers were designed flanking exons 8 and 9 
junction and zebrafish cDNA was used as a template (Fig. 2.2.1. A,B). This 
demonstrated that it was possible to PCR across the exon 8/9 junction, thus 
 
proving that full-length
this genome assembly has been misassembled. 
A further BLAT search identified a zebrafish 
on Zv7 _NA65. This sequence clearly encompasses the intron between exons nine 
and ten, and shows that the intron is approximately 11,000 bp long.
to the new genome map shown in 





Fig. 2.2.1 The genomic organisation of the zebrafish 
(A) Schematic representation of the genome browser showing that zsmoc1 is recorded in two separate genes, which are adjacent but transcribed  in opposing orientations. Grey exons represent exons only found in zebrafish. The structure of expressed zsmoc1shown by black lines. The primers used inred for reverse. (B) RTPCR analysis of the exon 8/9 junctions form 24 hpf zebrafish cDNA showing th
fragments can amplified across the 8/9 junction. 
smoc1 based on NW_001879596.1
76 
 zsmoc1 transcript is present in vivo. The 
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2.2.2  The recorded sequence of zebrafish zsmoc-1 is incomplete 
  
 Once the genomic structure of zsmoc1 was corrected I was able to amplify 
and clone the apparent full-length cDNA.  This was then used to synthesise zsmoc1 
mRNA.  Injection of zsmoc1 mRNA into zebrafish zygotes resulted in no 
overexpression phenotype (data not shown).  This was surprising because in 
Xenopus xsmoc1 overexpression results in severe ventralisation (Thomas et al. 
2009) and raised the possibility  the current zsmoc1 cDNA was missing the 
signalling  peptide sequence, as this did not appear to be conserved between 
zebrafish and mammals.  
Signalling peptides are short stretches of 5-30 aa that have a high hydrophobicity.  
They induce cleavage by signal peptidase which places the protein into the 
secretory pathway (von Heijne & Gavel 1988). To investigate this, the signalling  
peptides of an array of SMOC-1 proteins from several species were compared 
using SignalP v4.1 (Fig. 2.2.2). The first 50 amino acids of SMOC-1 were compared 
between zebrafish, human, mouse, and Xenopus. Drosophila Pentagone, the fly 
homologue of the SMOC proteins was also included in the analysis. SignalP v4.1 
(Petersen et al. 2011) was used to identify  a  20 amino acids region of high 
hydrophobicity in every Smoc-1 protein except for in zebrafish. It also identified 
the target sequence for signal peptidase at the end of this hydrophobic region for 
each protein excluding zsmoc-1. This suggested that either  zsmoc-1 is not 
secreted or that the zebrafish cDNA sequence is missing the signal peptide 











Fig. 2.2.2 A comparison of signal peptide prediction algorithms on SMOC-1 in multiple species. 





 To further investigate this, the exon structure of the proteins was compared 
across species. In all Smoc-1 proteins and in Drosophila Pentagone the signal 
peptide was alternatively spliced onto the protein three amino acids before the 
Kazal domain. Analysis of the zebrafish sequence, revealed a canonical splice 
acceptor sequence (CAG) 3 amino acids before the Kazal domain, strongly 
indicating that there is another SMOC1 variant present in zebrafish where the 
signalling  peptide is spliced onto zsmoc-1. 
 
 
2.2.3 5'RACE identifies the signal peptide open reading frame and 5’ UTR of zsmoc1 
  
  Alignment of the genomic structures of SMOC1 in vertebrates revealed that 
the first intron is always large, ranging from 50,000 to 80,000bp (Sup. Table 2.). 
This makes a computational search for the start codon impractical. Instead the five 
prime UTR of zsmoc1 was identified by 5' RLM RACE. Total RNA was isolated from 
12hpf AB embryos before being processed by 5' RLM RACE. Due to the low 
efficiency of RACE PCR and the relatively low abundance of zsmoc1 in zebrafish, 
the transcript was amplified sequentially with two nested PCRs. An initial outer 
PCR produced no bands, but this is not uncommon for RACE PCRs, as only the most 
abundant transcripts produce bands in the initial stages. The second inner PCR 
produced three bands. The band in each of the two zsmoc1  lanes were both the 




12hpf. There was one unexpected band of a different size in the positive control 
bmp2b secondary amplification. This band was sequenced and shown to be a 
spurious amplification of the seventh exon of rasa3(data not shown).  
 To confirm the identities of the 450bp band, this was excised from both 
lanes on the gel, TA cloned and sequenced (Fig. 2.2.3 C). BLAT Searching this 
sequence against the zebrafish genome (NW_001879596.1 Zv7 _NA65) showed 
that the entire fragment maps close to zsmoc1 on chromosome 17(Sup. Fig. 3) 
between positions 48,480,000 and 48,600,000. 39 bp maps to the current first 
exon of the zsmoc1 gene while the remaining sequence maps to an unannotated 
region. To test whether this fragment coded for the missing signal peptide the 
sequence was translated with the ExPASy translate tool. A 33 residue open reading 
frame was discovered in the same frame as zsmoc1.  SignalIP V4 predicts that this 
open reading frame encodes a signal peptide (Fig. 2.2.3 D) although the Y score is 
just below the threshold for significance(which was taken to be a Matthew Pearson 
correlation of lower than 0.5; chapter 6 6.5.6). However the results are still 
compelling as the predicted  cleavage site is located at the exact residues where it 













Fig. 2.2.3 5'RACE identified a novel 5' UTR exon coding the signal peptide of zsmoc1. 




2.2.4 Identifying transcript variants of zsmoc1 
 
 The RT-PCR using the primers spanning exons 6 to 8 consistently returned 
multiple bands (Fig. 2.2.4 C). This raises the possibility that zsmoc1 has multiple 
isoforms. To test this these PCR product were cloned into pGEM®-T Easy Vector 
using TA cloning. Ninety-six clones were sequenced. From these sequences it 
became apparent that there were seven different zsmoc1 sequences (Fig. 2.2.4) 
(Fig. 2.2.5). Six of the sequences are previously unrecognised zsmoc1 transcripts. 
All alternative splicing was confined to the SMOC domain. The SMOC domain is a 
unique functional domain identified in the original paper that identified SMOC-1 
(Vannahme et al. 2002). It is located between the thyroglobulin domains. The 
region has no known function but is conserved in all vertebrates in both SMOC-1 
and SMOC-2. The number of transcripts are quantified and the relative abundance 
is displayed as percentages (Fig. 2.2.4 B; Fig. 2.2.5 B).  
Alternative isoforms in different genes have a range of known functions 
including changing the stability, localisation and catalytic activity of protein 
(Kelemen et al. 2013; Stamm et al. 2005). In other cases any functional significance 
of an alternative splice form is unknown. This is particularly the case for low 
abundance transcripts in which aberrant splicing may be caused by stochastic 
errors within the splicing machinery(Kelemen et al. 2013; Stamm et al. 2005). To 
decrease the chances of pursuing on non-functional or functionally redundant 
variants, I focused further analysis on the highly abundant zsmoc1 transcripts. 




of the total population of clones at 24hpf and are detailed in Fig. 2.2.4. While the 
remaining isoforms were classified as minor isoforms and are detailed in Fig. 
2.2.5.  
 The isoforms are labeled A to G in order of relative abundance. Isoform A 
was the most abundant transcript in the clonal analysis, so was taken to be the 
canonical zsmoc1 sequence. Each of the identified splice forms maintain the open 
reading frame of zsmoc1. All the identified splice sites also follow the "GU-AG" rule 
of splicing (Fig. 2.2.4. A; Fig. 2.3.5. A). These features support the hypothesis that 
these transcripts are not the spurious products of aberrant splicing (Magen & Ast 
2005; Xing & Lee 2005). 
 Isoform B omits exon 6, which resulted in the omission of 51 base pairs 
(corresponding to 17 amino acids) from the canonical sequence while Isoform C 
has an alternative splice acceptor site on exon 8 (8a), which results in the inclusion 
of an extra 33 bp (11 amino acid residues). 
 The minor smoc1 splice variants are also each located within the SMOC 
domain. Variants E and F both involve an alternative splice donor site within exon 
8(8'') resulting in a loss of 6bp (2aa). Variant E also skips exon six like Variant B.  
Variant F uses the same alternative splice donor site within intron 8 as used in 
Variant C.  Variant D and Variant G are both the product of exon exclusion.  In 
Variant D the transcript lacks exons 6 through 10 resulting in the complete 




Fig. 2.2.4 The structure of the zebrafish 
  (A) A schematic representation of the each exon codes for. The consensus transcript is 4(black and white numbered boxes). All known functional domains are annotated. The exon structure of the three most common variants are shown. All identified alternative splicing was confined to the SMOC domain. Isoform B skips the splice acceptor site exon 6 which results in the omission of 51bp (or 17 aa) within the SMOC domain from the transcript. Isoformalternative splice acceptor site upstream of exon seven resulting in the inclusion of an additional 33bp (11aa) pairs between exons six and 7 within the SMOC domain which has been highlighted in green. (B) The relative abundance of the different analysis. The most abundant transcript was this isoform A (42%) so this was labeled the canonical zebrafish transcript. The next most abundant transcript was isoform B (26%) followed by isoform C (14%). The remaining transpopulation (18%). (C) RTresults in multiple bandsdirectly correspond to the bands amplified from clones of isoforms A, B and C. 
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 To confirm the presence of all the major transcripts RT-PCR analysis was 
performed on RNA from wild type zebrafish embryos. The three bands produced 
were of the predicted sizes for Variants A, B and C, and were the brightest bands of 
RT-PCR conducted using cDNA.  This confirms that the isoforms both exist and  
represent the most abundant isoforms of zsmoc1. (Fig. 2.2.4. C) Other bands are 
observed which may represent the minor alternative splice forms detailed in Fig. 
2.2.5. However, some of these bands probably represent heteroduplex formation 
given the mixed population of amplicons (Thompson  et al. 2002).  It is particularly 
prevalent between the variants that differ only slightly e.g. splice variants A, B and 
C, which differ by regions of either 33 bp or 51 bp. This difference in size leads to 
the formation of secondary structure within heteroduplexes (either a loop in the 
DNA or failing that a Y-shaped DNA structure) causing reduced mobility. The 
presence of heteroduplexes would explain why there are bands with an apparent 
size greater than splice variant C, the largest splice variant identified in our clonal 
analysis.  
 To test this, the PCR was repeated in the products were run out on 
polyacrylamide gels. As a reducing gel any DNA heteroduplexes would be 
denatured. The unexplained bands disappeared, proving they were an artifact 
(data not shown). 










Fig. 2.2.5 The structure of the zebrafish 
 (A) A schematic representation of the consensus transcript and the regions of the protein that each exon codes for. Splicing is confined to the depicted in grey. Isoform D does not include exons 6mature transcript resulting in the complete ablation of the smoc1 domain. Isoform E skips exon 6. It also uses the 8b splice donor site resulting in the loss of the six bp coding for the EG amino acids from the protein structure. sites resulting in the inclusion of the VSFRFFLTLNP cassette but the loss of transcript. Isoform G losses exon 6 and 7 resulting in deletion of 96 base pairs (32aminoThe relative abundance of minor minor splice acceptor transcript will this isoform D (8%). was the least abundant identified transcript ( 
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2.2.5 The temporal expression pattern of zsmoc1 transcript variants 
 
 To address whether the major splice variants were developmentally 
regulated the expression patterns of the major splice variants were measured over 
the course of zebrafish development, by performing both RT-PCR (Fig. 2.2.6 A) 
and qPCR (Fig. 2.2.6 B,C) over the first two day of development (4, 8, 12, 24 and 
48 hours post fertilisation (hpf). One pair of PCR primers was designed that would 
amplify every known zsmoc1 variant in addition to primers that would only 
amplify specific zsmoc1 variants. All samples were normalised to reference gene 
elongation factor alpha (elfa): which has already been shown to be stably 
expressed during early zebrafish development (Tang et al. 2007). The results of 
the qPCR were averaged between two biological replicates. With the notable 
exception of at 8 hpf, the relative expression of zsmoc1 increases over the course of 
development, showing the greatest relative expression levels at the last time point 
measured, 48 hpf (Fig. 2.2.6 B).  All the major splice forms were detected at every 
stage of development tested, with the exception of splice form C which was not 
present at detectable levels of sample at 8 hpf. At all stages of development splice 
form B is most abundant followed by splice form A and then splice form C. There is 
a general trend towards lower expression levels of the variants overtime, possibly 
because of an upregulation of the minor splice variants. However the general 
pattern remains the same. So there is no compelling evidence that the splice forms 




2.2.6 Identification of candidate novel splice sites in human SMOC1 
 
 The identification of novel splice isoforms may be important for the 
interpretations of diagnostic sequencing in human disease.  Pathogenic mutations 
may be missed if they are located in unknown isoforms. We have one family with 
definite OAS that plausibly maps to the SMOC1 locus but in which we have not 
found a pathogenic SMOC1 mutations(personal correspondence Joe Rainger 2012).  
This raises the possibility that the pathogenic mutation could be located in an 
unknown exon.   
It may be difficult to identify splice isoforms in humans, particularly if they 
are often not very abundant, or are expressed only at specific developmental 
stages. It has been estimated that 95% of human genes are alternatively spliced. If 
this is true then between 88,000–132,000 splicing events still remain to be 
captured (Pan et al. 2008).  
I decided to try to identify alternative transcripts in human SMOC1 using 
the data I had generated in the zebrafish for cross species analysis. Using the 
search strategy outlined in Fig. 2.2.7 we investigated our six novel splice variants 
to establish if any were conserved in humans. Zebrafish and mammals are only 
distantly related so the initial searches were performed using protein sequence 











Initial searches yielded no hits against the human databases, possibly due 
to the low representation of ESTs and mRNA transcripts from early stages in 
human development. To address this, we searched again against the mouse 
databases. Of the six splice variants only one was detected in the mouse genome, 
this was an alternative splice acceptor site equivalent to site 8a zebrafish splice 




variant C. Taking advantage of the higher conservation between human and mouse 
genomes it was then possible to directly query the human genomic sequence using 
a nucleotide query. Using this approach, a strong candidate alternative splice 
acceptor site was identified. Located upstream of hSMOC1 exon6 it was almost 
completely conserved at the nucleotide sequence (Fig. 2.2.8. A). Out of a total of 33 
functional base pairs there is only a single synonymous change between mice and 
humans.   
 A multiple alignment shows that there is 68% identity between zsmoc-1 
and hSMOC-1 at a protein level (Fig. 2.2.8. B), with conservation of all the known 
functional domains with the exception of the signal peptide in zebrafish. The 
zebrafish Variant C sequence has two regions which are apparently unique to 
zebrafish marked here as U Z (unique zebrafish). The first was located between the 
Kazal domain and first thyroglobulin domain. This represents a “novel” exon. The 
second is flanked by the first thyroglobulin domain and the SMOC domain. This is 
the sequence attributable to the alternatively spliced exon 6 and is absent is 
zsmoc1 splice variant B. The alternative splice form 8a protein sequence is 
conserved from zebrafish to mice with a 91% identity. If the transcript is indeed 
expressed in humans it would show the same level of conservation (predicted 















Fig. 2.2.8 Multiple sequence alignm (A) A sequence alignment of human and mouse genomic sequence of Showing the canonical exon 6(blue), alternatively spliced exon 6'2 (green) and splice acceptor sequence(red). mouse and  zebrafish. Total zebrafish identity is 69%. The conserved functional domains are annotated (Kazal Domain, Thryroglobulin 1 and 2, SMOC and EF hand domains) there are also regions of sequence that are not conserved in any other known awhich have been labeled UZ (unique zebrafish). The predicted alternative splice sequence in human variant 3 (exon 6') is 91% conserved in zebrafish (exon one amino acid being changed (red box). All alignments were performed in Clustala substitution with a highly similar amino acid, "amino acid. Spaces were introduced to produce the best alignments.
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2.2.7 Functional predictions using zsmoc1 isoforms 
 
 To help ascertain the potential function of the zsmoc1 isoforms a 
bioinformatics approach was used to analyse protein structure in silico. Initially 
the zsmoc1 isoforms A B, and C were analysed using PONDR-VLXT (Li et al. 
1999;Romero et al. 2001; Romero et al. 1997) to see if regions of alternative 
splicing corresponded with intrinsically disordered regions (IDRs) within zsmoc1. 
IDRs are the domains of a protein with no defined three-dimensional 
structure(Dunker et al. 2008; Dyson & Wright 2005). Which means the amino 
acids making up an IDR have complete freedom of movement in vivo. It has already 
been established that there is a bias for alternatively spliced exons to be located in 
the disordered regions in proteins, this is particularly true for symmetrical exons 
(Romero et al. 2006). The largest predicted region of disorder in zsmoc-1 is  in 
isoform B (Fig. 2.2.10 B) and is located between residues 143 and 200 of the 
SMOC domain. This is the region in which all of the alternative splicing events are 
localized (Fig. 2.2.4; Fig. 2.2.5). This is the only statistically significant predicted 
IDR in zsmoc1. The alternative exon 6  in isoforms A and C and splice acceptor site 
8a are both predicted to be highly ordered motifs within this region of disorder 
(Fig. 2.2.10 B and C). This implies that they are functional motifs and do not have 
a purely structural function.    




                                                            
.   Fig. 2.2.10 In silico analysis of the structure of zsmoc-1 for the alternative splice variants.   




 The predictions were made by Motif scan (2013) of a single post-
translational modification in each alternatively spliced region of the major zsmoc-1 
isoforms provide support this hypothesis. Motif scan predicted a N-myristoylation 
























2.3  Discussion 
 
 
2.3.1 The zebrafish genomic locus has been established 
 
 The misleading, fragmented genomic annotation of zsmoc1 hampered my 
efforts to understand this protein. I have demonstrated that zsmoc1 is present as 
one contiguous gene in zebrafish.  The current annotation also misses a 
functionally important 5’ section of the open reading frame. Although the zebrafish 
genome was supposedly completed in 2013(Howe et al. 2013) the zsmoc1 locus is 
still misannotated in the public genome browsers. This could be due to the fact a 
large part of the genomic sequence still relies on shotgun sequencing. Currently 
17% of the current build of the zebrafish genome is aligned from shotgun 
sequencing (Howe et al. 2013). 
 The missing zsmoc1 signal peptide has been found(Fig. 2.2.3). The coding 
sequence of the first exon is almost completely comprised of the open reading 
frame coding for the signalling  peptide in zebrafish and indeed in every vertebrate 
species and in Drosophila Pent (Fig. 2.2.2; Fig. 2.2.3). This arrangement creates a 
problem for automated gene analysis software because signalling  peptides are not 
the most strongly conserved domains. It is the overall hydrophobicity of the amino 
acid sequence rather than the specific amino acid order that targets the signal 




signal peptide in zebrafish is spliced over a large first intron again similar to the 
situation in other vertebrates where the first intron is between 50 -80 kb away 
(Sup. Table 1).  
 The intron-exon boundaries and splice arrangement of the of the first exons 
of the Smocs are remarkably well-conserved across evolution (Fig. 2.2.2; Fig. 
2.2.3).   
 
 
2.3.2 Alternative splicing in zsmoc1 action 
 
 Alternative splicing is essential to understanding the eukaryotic proteome. 
First discovered in the late 70s (Berget et al. 1977; Chow et al. 1977) it rapidly 
became apparent that the vast majority of eukaryotic transcripts are spliced 
(Kelemen et al. 2013). This largely explains some of the discrepancy between gene 
number and protein number in eukaryotes. zsmoc1 is no exception (Fig. 2.2.4; Fig. 
2.2.5). I have identified seven separate splice transcripts of zsmoc1, six of which 
are novel and have not been reported. All identified splicing was confined to 
between exons 6 and 10; between the thyroglobulin domains in the region 
identified as the SMOC domain raising the question of whether the splice variants 
have any different functionality. RUST(regulated unproductive splicing and 
translation) is a mechanism to control the level of mature transcript by 
introducing frame shifts into the coding sequence and trigger nonsense mediated 




events (Lewis et al. 2003). RUST can be convincingly ruled out in zsmoc1 as all 
alternatively spliced variants I have identified are symmetrical (i.e. the spliced 
region has a base pair length which is a multiple of three so will usually preserve 
the reading frame of the transcripts whether the exon spliced or not; Magen & Ast 
2005). This places our alternative transcripts in the other 65%-75% of transcripts 
that have altered transcripts within the coding region.  
 
 There are a wide range of known functional possibilities. Alternative 
splicing has been known to change the stability (Sakurai et al. 2001), localisation  
(Prou et al. 2001) and catalytic activity (Li & Koromilas 2001) of proteins. In silico 
analysis on isoforms A, B and C found splicing was confined to the largest region of 
predicted intrinsic disorder within zsmoc-1 (Fig. 2.2.9). This is in line with 
predictions that alternative splicing is preferentially found within intrinsically 
disordered regions (IDRs) as they are less structurally constrained (Wang et al. 
2005; Romero et al. 2006). A change within an allosteric region of a protein will 
disrupt that structure resulting in loss of function. IDRs have no defined structure 
to disrupt, which means alternatively spliced exons in these regions are much less 
likely to disrupt the overall structure of a protein. IDRs in proteins have several 
known functions, including providing structural flexibility to proteins by allowing 
them to move dynamically and are often also associated with protein binding sites 
where they will only form a defined structured when bound to their ligand. 
(Pancsa & Fuxreiter 2012). Intriguingly, the alternative splice sites in the less 
abundant splice variants A and C result in a dramatic reduction in predicted 




composition implies they are post translational modification sites. Motif scan 
predictions supported this, with post translational modification predicted in both 
splice exons 6 and 8a (Fig. 2.2.9.). This would not be a surprising, as the 
introduction of post translational modification sites is the most common identified 
function of alternative splicing (Kelemen et al. 2013b). 
 There is a danger in over interpreting in silico predictions without 
validation by experimental data. If the relative expression of the splice variants 
had changed with time then we would have shown that the variants were 
developmentally regulated. Yet, the ratios remain consistent (Fig. 2.2.6), so while 
a functional role of the splicing variants cannot be ruled out neither can it be ruled 
out that they are simply co-expressed exons with no differential function. The 
alternatively spliced exons are too short for in situ hybridisation so that at the 
present time it is impossible to establish whether they have different localisations 
during zebrafish development (Fig. 2.2.4; Fig. 2.2.5).  
 Given the difficulty of obtaining direct functional evidence for different 
splice variants most are analysed purely on the basis of their evolutionary 
conservation. If a splice site is conserved then presumably it must be functionally 
relevant otherwise there will be no purifying selection to maintain it. Under this 
analysis splice variant C is likely to be a functional variant as it shows high 








2.3.3 Cross species analysis  as a means of detecting alternative transcripts in humans 
 
 While cataloging the alternative splicing patterns in genes from different 
species is interesting from an evolutionary standpoint, it is also potentially 
medically relevant; the majority of hereditary diseases are thought to be due to 
aberrant splicing (Ward & Cooper 2010). Most documented cases are caused by 
mutations directly to splice donor (GT) or splice acceptor sites (AG) (Krawczak et 
al. 2007). The sequences are essential for the correct splicing, and their mutation 
can lead to a whole range of defects. An exons can be excluded, introns included 
and cryptic splice sites can be activated within genes. These mutations are often 
functionally nulls. In two thirds of cases aberrant splicing results in frame shifts 
which, along with intron inclusion, leads to premature stop codons and NMD 
(Magen & Ast 2005). As is the case for the mutation of SMOC1 identified in 
Abouzeid et al. (2011). The patient had inherited a homozygous splice donor site 
mutation in exon 4 which led to OAS. Two further SMOC1 mutations were 
identified with splice donor site mutations in Okada et al. (2011) which means 
25% of the known cases of OAS are caused by missplicing. As patients with splice 
mutations display the same severity of both anophthalmia and limb abnormalities 
it is assumed that these defects are functionally nulls rather than hypomorphs. 
Even an alteration in the ratios of spliceoforms can profoundly affect the 
phenotype of the disease. Mutations in the splice sites of ATP7A inhibit copper 




conserved bases in the same splice sites lead to the much less severe occipital horn 
syndrome (OHS) (Møller et al. 2000; Das et al. 1995).  
 Unidentified exons can also harbor mutations that lead to pathology.  These 
would then be missed when screening patients. For example in 1998 it was 
discovered that mutations in USH2A lead to the development of syndromic deaf 
blindness, Usher syndrome type IIa (Eudy et al. 1998). In the following six years 
mutations were identified in USH2A in 63% of Usher type IIa patients. That still left 
37% of patients without an identifiable mutation. Wijk et al. identified 51 novel 
exons for USH2A, and went on to identify mutations in five out of 12 patients 
located in these exons (van Wijk et al. 2004). This accounted for ~20% of Usher 
type IIa patients, leaving only ~17% of cases unexplained. Exon skipping can also 
rescue nonsense mutations, which would lead to less severe symptoms. Mutations 
in Dystrophin provide a good example of this.  It is a large protein (427 kd) with a 
correspondingly large genome locus made up of 79 exons. Mutations in Dystrophin 
lead to 2 related syndromes: Duchenne muscular dystrophy (DMD) and Becker 
muscular dystrophy (BMD). Both syndromes are usually caused by indels (80% ). 
Deletions that are out of frame are functionally nulls and lead to DMD, while in 
frame deletions lead to the milder BMD (Muntoni et al. 2003). To help study these 
diseases mutations in Dmd have been induced to produce the mdx mouse which 
mimic the features of the disease, the main one being a 60-70% reduction in type A 
γ-aminobutyric acid (GABAA) receptor clusters. Exon skipping has been artificially 
induced in mdx mouse. These skipped exons restore the reading frame of the Dma 
gene and greatly reduce the DMD phenotype including completely rescuing GABAA 




 The cataloguing of alternative splicing events in the human genome 
remains incomplete with estimates ranging from 40 to 50% of human splice 
variants still to be uncovered. This is because of the drawbacks of EST technology. 
While ESTs provide powerful sequence depth, quality remains low. EST sequences 
are based off single reads and so often include sequencing errors and chimeric 
cDNA. While there is some debate, the splicing patterns of alternatively spliced 
genes are thought to be less well conserved than those of non-spliced 
genes(Modrek & Lee 2003; Kriventseva et al. 2003). Still functionally important 
splice forms should be conserved and these account for the most interesting splice 
sites. The comparison of splice variants from different species has been used to 
perform cross species analysis and successfully identify unannotated splice forms 
within different genomes (Lu et al. 2010; Chen et al. 2006). The availability of 
novel zsmoc1 splice variants allowed the performance of a cross species analysis 
which led to the identification of a potentially novel human SMOC1 splice variant 
(Fig. 2.2.7).  
 Mutations have not been identified in 42% of our patients with OAS. This 
raised the possibility that as in the case of USH2A these mutations were hidden in 
this previously unidentified exons (van Wijk et al. 2004). With this in mind the 
cohort of OAS patients where the causative mutation had not been identified
were screened for mutations by Joe Rainger (Personal correspondence 2013). 








2.3.4 Concluding remarks  
 
 
 In this chapter I have established that zebrafish contains at least one full-
length orthologue of SMOC1. The orthologue is developmentally regulated and it 
has multiple previously unrecognized spliceoforms.  I have also demonstrated that 
cross species analysis can be used to identify potentially novel human exons, 






























3.1.1 Developmental signalling 
 
 The central question of developmental biology is how a single cell with a 
generic identity generates a whole organism comprised of multiple organs, which 
in turn is comprised of different tissues. Tissues themselves are mixtures of 
different cell populations. The development of an animal requires the regulation of 
cell fate, pluripotency, proliferation, apoptosis and migration. How is this 
specificity of cell identity achieved? In Caenorhabditis elegans the specification of 
cell fate is accomplished almost entirely by cell division(Sulston & Horvitz 1977; 
Kimble & Hirsh 1979; Fay 2005), however, this is unusual.  
 In most organisms developmental specification of cell identity is achieved 
via secreted ligands:  secreted molecules (usually proteins) that can be detected by 
receptors most commonly sited on the surface of a cell. There are multiple 
signaling pathways, though the most significant for development are the tgf-beta 
Shh, Mapk and Wnt pathways (Pires-daSilva & Sommer 2003). While each family is 
involved in multiple processes and there is considerable evidence for cross talk.   
This chapter is focused on the BMP signalling pathway(Verheyen 2007), as this is 
the pathway that both the work presented and the existing literature links to 




   3.1.2 The Bmp signalling cascade 
 
 Bone morphogenic proteins (Bmp) are a sub family of the TGF-beta 
superfamily. The major components of the Bmp cascade used during development 
have been conserved from Cnidaria, Drosophila to humans. The elements of this 
signalling cascade are well studied. There are 11 different Bmp ligands in the Bmp 
subfamily. These are split into four different subfamilies which are involved in 
both distinct and overlapping functions (Miyazono et al. 2010). For example, while 
bmp2b is involved in the dorsoventral patterning of the zebrafish embryo during 
gastrulation (Martnez-Barber et al. 1997), it also specifies the dorsal identity of the 
zebrafish retina (Kruse-Bend et al. 2012). While bmp7 (Little & Mullins 2009) and 
gdf6 are exclusively involved in embryonic and retinal patterning (Gosse & Baier 
2009) respectively, some of this is due to the dimeric nature of bmp ligand. Both 
homomeric and heteromeric dimers are expressed, but they are not functionally 
redundant. In zebrafish embryonic development, it is only heteromeric bmp 
dimers that are functional. Both bmp2b/7 and bmp2b/4 have dorsalising activity, 
but homodimers do not, which is demonstrated by the failure of homodimeric 
bmp2b to rescue bmp2b nulls (bmp2b morphants) while heterodimeric bmp 2/7 









Fig. 3.1.1 The canonical in  
A schematic representation of the core elements of the dorsoventral patterning of the zebrafish embryo. Signals initially carried in the form of an extracellular gradient of bmp ligand. The ligand binds to the bmp receptor complex which triggers it to autophosphorylate. Once the co-smad (1/5/8). The activated cothe nuclease where it acts as a transcription factor.The figure also illustrates that proteins can prevent ligand binding to the the formation of activated bmp complex entirely. The pool regulated by the degradation endocytosed ligand receptor complexes.(Data reviewed in Ramel & Hill 2012
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bmp signalling pathway. 
bmp signalling pathway activated during the 
receptor is phosphorylated, it is endocytosed, Whereupon-smad forms a trimeric complex with smad 4 before accumulating in 
  bmp cascade is regulated at several levels. Secreted bmp receptor complex while pseudo receptors can prevent of active components is continually   and Schwank et al. 2011). 
Chapter 3 
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 The various bmp ligands are recognised by bmp receptor complex, which is 
a membrane-bound tetramer. Broadly there are two types of sub receptors, type 1 
and type 2. Bmp  ligands preferentially bind to the type 1 receptors, which then 
recruit the type 2 receptor. The Type 2 receptor activates the complex by 
phosphorylating the receptors GS domain. There are multiple types of each 
receptor (Ehrlich et al. 2011), which allows the formation of a variety of 
combinations of receptor complex, each with unique binding affinities. A good 
example of this is zebrafish dorsoventral patterning. Zebrafish have at least five 
known type 1 receptors (alk3a, alk3b, alk6a, alk6b and alk8; table 3.1) and two 
known type 2 receptors (bmpr2a and bmpr2b;  table 3.1). Little & Mullins  used  
morpholinos  to  knock-down each type 1 bmp receptor. Alk8 MO knockdown 
resulted in a complete ablation of the phospho-smad 1/5/8 (hereafter termed p-
smad) gradient.  In contrast individual alk3a, alk3b, alk6a and alk6b MO 
knockdowns have no phenotype (or very mild dorsalisation), demonstrating that 
they are functionally redundant. However, when alk3a, alk3b, alk6a and alk6b are 
all knocked down simultaneously, the p-smad gradient is ablated (Little & Mullins 
2009). This demonstrates that the functional bmp2r complex  is a heterodimeric 









Pathway BMP ligand Type 2 receptors Type l receptors R-smad Co-smad 
  bmp2b   alk3a smad1   
zebrafish embryo   bmpr2a alk3b     
dorsoventral  bmp4   alk6a smad5 smad4 
patterning   bmpr2b alk6b     
  bmp7a   alk8  smad8   
      
      alk3a smad1   
Zebrafish retina  GDF-6 bmpr2a alk3b     
dorsal ventral      alk6a smad5 smad4 
patterning bmp2b bmpr2b alk6b     
      alk8  smad8   
      
      
Drosophila  wing  Decapentaplegic   Thickveins     
patterning Screw wishful thinking Saxophone MAD Medea 
  Glass Bottom Boat   Punt     
 
______________________________________________________________________________________________________________________________________________ 
 Once the receptor complex is activated it phosphorylates regulatory smads 
(r-smads). There are three r-smads in vertebrates (smad 1/5/8;  Table 3.1.1), and 
they share extremely conserved amino acid sequences (Arnold et al. 2006). There 
is a degree of functional redundancy; for example mouse knockouts of Smad1 nulls, 
Smad5 nulls and Smad1+/-:Smad5+/- double heterozygotes all die at E10.5 while 
displaying identical abnormalities (Arnold et al. 2006). Yet r-smads are not 
entirely redundant. In situ hybridisation shows that smad1 and smad5 have 
distinct expression patterns in gastrulating zebrafish embryos and these 




expression patterns are under different systems of regulation.  smad1 expression is 
up regulated by bmp2b, while smad5 is ubiquitously expressed (Dick et al. 1999). 
Additionally, exogenous smad1 can rescue bmp2b nulls  (swirl mutants) but smad5 
cannot (Dick et al. 1999). 
 Once they are phosphorylated a pair of r-smads will bind to a co-smad 
(smad 4 in vertebrates) forming a trimer (Kruse-Bend et al. 2012). The complex is 
then translocated into the nucleus, where it acts as a transcription factor. It binds 
to target sequences which will then alter the expression of target genes, either up-
regulating or down regulating them depending on the context(Ramel & Hill 2012). 
In gastrulating zebrafish embryos, bmp up regulates id1 (Collery & Link 2011), 
eve1 (Seebald & Szeto 2011; Barro et al. 1995) and gata2 (Maeno et al. 1996; Oren 
et al. 2005; Sykes et al. 1998) expression, whilst simultaneously down regulating 
otx2 (Navaneetha Krishnan Bharathan, 2014) and run3x (Cohen 2009). Whether 
the gene is turned on or switched off by smad binding is dependent on the 
cofactors it binds with (Ramel & Hill 2012; Arora et al. 1995; Dai et al. 2000; Cheng 
et al. 2007).  
 While binding partners for the smads have been identified (e.g. HoxC8, 
Nkx3-2 and id1; Ramel & Hill 2012) their precise function remains 
uncharacterised. Of the known cofactors, Schnurri (Arora et al. 1995) is the most 
well studied, but like the smad complex, its effects appear to be context specific; up 
regulating some genes (e.g. Brinker in Drosophila; Pyrowolakis et al. 2004) while 
down regulating others (e.g. Ubx B in Drosophila; (Dai et al. 2000)) . Cofactors have 
been identified that impart tissue specificity, which accounts for the reuse of bmp 




factor in bone formation (reviewed in Karsenty 2008). Knocking it down inhibits 
bone formation as even the presence of Bmp is essential for osteoblast 
differentiation. Oaz has been shown to mediate late onset bmp signalling with 
neuronal defects in both the brain (Cheng et al. 2007) and nasal cavities (Cheng & 
Reed 2007) reported in knockout mice. However, the knockout mice do not show 




3.1.3 Bmp signalling gradients 
 
 Secreted bmp ligands impart spatial information to the embryo via their 
action as morphogens. The so-called French flag hypothesis (Wolpert 1969) posits 
that p-smad activity is concentration dependent and that cell fate is determined by 
reaching specific thresholds of p-smad activity. There is some evidence that this is 
the case;  as would be predicted, the bmps have been observed forming the stable 
gradients of p-smad activity in sea urchins (Lapraz et al. 2009), Drosophila 
(Akiyama et al. 2008),  Xenopus (Plouhinec & De Robertis 2009) and zebrafish 
(Gosse & Baier 2009). Only in Drosophila has the Dpp gradient been directly 
observed.   GFP tagged-Dpp was used to quantify the gradient in real time, which 
showed that in Drosophila  ligand concentration decreases exponentially as the 
ligand migrates further from the source(Teleman & Cohen 2000). This is the same 
pattern that would be predicted for a classical morphogen (Teleman & Cohen 




has been shown to be dosage dependent, again this is consistent with the action of 
a morphogen.  
 In the dorsoventral patterning of the zebrafish embryo up-regulation of p-
smad signalling has been shown to phenocopy bmp mutants and morphants (von 
der Hardt et al. 2007; Topczewski et al. 2001); morpholino knockdown of chordino 
(an antagonist of BMP signalling) and perturbation of the bmp gradient with 
Knypek morpholino knockdowns both lead to defects in the lateral migration and 
therefore the extension movements of the gastrulating zebrafish embryo. This is 
unexpected and the opposite of what would be predicted if bmp does act as a 
morphogen. Hardt et al. (2007) went on to demonstrate that these defects are 
caused by the disruption of the shape of the bmp gradient in the embryos. The 
laterally migrating cells followed the shape of the gradient, from high to low psmad 
expression. In the chordino mutants, the bmp's were ubiquitously expressed so 
there was no gradient for the lateral cells to follow (von der Hardt et al. 2007). 
 Whether or not bmp is acting as a classical morphogen, successful signalling 
is reliant on the formation of the gradient. This gradient must be dynamically 
controlled and maintained. If a gradient is formed by unregulated passive diffusion 
and degradation of the signal would be susceptible to perturbation (for example 
genetic mutation, temperature and the availability of nutrients ; Eldar et al. 2003). 
Developmental gradients must also scale with the growth of the embryo/organ 
(Barkai & Ben-Zvi 2009). To achieve this, the gradient must be actively controlled 
and indeed decades of research have identified proteins that regulate the activity 




 When Bmp ligand is secreted, it is subject to the antagonism of secreted 
bmp binding proteins such as Chordin and Twisted gastrulation (Table 3.1.2; 
Ramel & Hill 2012). In zebrafish gastrulation these proteins are expressed 
dorsally, forming a gradient  directed towards the ventral side of the embryo. They 
block bmp signalling by binding to bmp dimers and preventing them from 
interacting with bmp receptor proteins (Piccolo et al. 1996; Chang et al. 2001; 
Branam et al. 2010), antagonising the Bmp action more as the bmp gradient 
extends dorsally. Another secreted Bmp antagonist is Tolliod. Tolliod is a protease 
that binds to the inactive bmp chordin complex, cleaving the chordin and releasing 
the bmp and thus upregulates bmp signalling (Pappano et al. 2003). 
 Another form of extracellular control is regulating the shape of the gradient 
by controlling the speed at which the ligand travels. The availability of finely 
quantified gradients means that Drosophila has been the model organism of choice 
for investigating these problems. Work on the Bmp homologue Decapentaplegic 
(Dpp) has demonstrated that proteins exist that regulate Dpp migration. Most 
notably the glypican homologues Dally and Dally-like as they control the shape of 
the gradient are neither classical antagonists nor agonists, and have been shown to 
both positively and negatively regulate Dpp signalling depending on 
context(Akiyama et al. 2008; Ramel & Hill 2012; Belenkaya et al. 2004). What is 
clear is that Dpp migration is dependent on Dally, an extracellular heparan 
sulphate protein that is homologous to the vertebrate Glypicans. GFP-Dally cannot 
migrate across the Dally null regions of the imaginal disk (Belenkaya et al. 2004). It 
is also clear that Dpp signalling is dependent on endocytosis, and that inhibiting 




phosphorylation (Belenkaya et al. 2004; Entchev et al. 2000; Akiyama et al. 2008). 
However there remains a debate as to the precise mechanism of Dpp migration, 
and consequently also of Dally action.  
 The two most popular models are receptor-mediated transcytosis (RMT) 
and restricted extracellular diffusion (RED)(Schwank et al. 2011). In RMT, the 
receptors are endocytosised and re-secreted on the other side of the cell. Thus 
endocytosis is used to ferry the ligand across cells and establish the Dpp gradient. 
There is evidence to support this. Dpp diffusion in the wing disk is dependent on 
the presence of Thickveins (the Drosophila homologue bmpr1) and GFP-Dpp 
diffusion is blocked in temperature sensitive Dynamin mutants at non-permissive 
temperatures (Entchev et al. 2000). However opponents of RED point out that Dpp 
gradients form and spread very rapidly. Which means that endocytosis and re-
secretion would have to occur within minutes. Furthermore, even when 
transcytosis has been observed an extracellular pool of Dpp is always also present. 
They argue that passive diffusion would establish a gradient with a rapidity that 
better fits the observed speeds of  Dpp migration (Schwank et al. 2011; Kicheva & 
González-Gaitán 2008). In RED the endocytosis targets both the ligand and 
receptors necessary to both smad phosphorylation (which in this model is 
confined to endocytosis these vesicles) and for ligand/receptor degradation, which 
in turn lowers the available pool for gradient formation. Of course both models are 
not mutually exclusive.  
 It remains to be investigated whether endocytosis is important in gradient 
formation in bmp signalling in zebrafish, or even in vertebrates. However, 




(Di Guglielmo et al. 2003; Mitchell et al. 2004),  Endocytosis of BMP has been 
observed in the multiple cell lines (C2C12, 293T, and COS7) with different 
endocytotic vesicles having distinct SMAD phosphorylating activities (Hartung et 
al. 2006; Akiyama et al. 2008). Additionally, heparin sulphate proteins like Dally 
have been shown to restrict bmp gradients, and when heparin sulphate groups are 
digested by artificially expressing heparitinase I mRNA in Xenopus bmp expression 
becomes ubiquitous (Ohkawara et al. 2002). 
 Another level of control of the signal gradient is on the formation of the 
bmp receptor complex. The bmp pseudo-receptor bambi (also known as radar in 
zebrafish) can also bind to type 1 bmp receptors, as bambi has no phosphorylating 
activity and any receptor complexes it forms are inactive(Ramel & Hill 2012). This 
makes Bambi a classical antagonist of bmp signalling. An example of this is the 
action of bambi during zebrafish gastrulation, where it promotes the dorsal cell 
fate (Gosse & Baier 2009).  
 Once the r-smads are phosphorylated they can be regulated intracellularly 
by inhibitory smads (i-smads; smads 6/7). The inhibitors smad 6 and 7 repress 
bmp signalling via a number of mechanisms. Both smad6 and smad 7 compete with 
R-smads by binding directly to type 1 bmp receptors (Imamura et al. 1997; 
Hayashi et al. 1997). Additionally, smad7 recruits E3 ubiquitin ligases to the 
receptor complex, thereby upregulating their degradation (Kavsak et al. 2000), 
while smad6 competes with the R-smads for binding to smad4 (Hata et al. 1998). 
They are both expressed in zebrafish during gastrulation and presumably 
antagonise bmp signalling, though this remains to be confirmed (Hammerschmidt 





Modulators  Homologue                    Type  Effect 
knypek Glypican 4 Heparan sulphate proteoglycan Positive 
chordin   Secreted BMP binding protein Negative 
Twisted   Secreted BMP/Chd binding protein Positive/negative 
Tolloid   Protease Positive 
bambia   BMP pseudo-receptor Negative 
bambib   BMP pseudo-receptor Negative 
       
Dally Glypican Heparan sulphate proteoglycan Positive/negative 
Dally-like Glypican Heparan sulphate proteoglycan Positive/negative 
Pentagone smoc-1     Positive/negative 
Sog Schnurri Brinker 
Chordin 
Schnurri None 
Secreted BMP binding protein Transcription factor Transcription factor 
Negative Positive Negative 
_______________________________________________________________________________________________________________________________________________________________________________________________ 
 The last known level of control occurs at the DNA binding level. Certain 
transcription factors block the binding of smad trimers to their target sequences, 
most notably Brinker in Drosophila, which is known to block all Dpp activity in the 






Table 3.1.2 Known modulators of bmp signalling 




3.1.4 bmp gradients in zebrafish development: dorsoventral patterning of the zebrafish embryo and eye 
 
 While bmp gradients are utilised in multiple separate processes in zebrafish 
development, the best studied system in zebrafish is the dorsoventral gradient 
formation over the course of gastrulation. Beginning 4 hpf at the sphere stage of 
development, it takes zebrafish embryos approximately 6 hours to progress 
through gastrulation into neurulation (Kimmel et al. 1995).  
 The main function of gastrulation is to establish the three germ layers 
(ectoderm, endoderm and mesoderm) and through cell migration rearrange them 
to establish the main body plan of the embryo (reviewed in Lepage & Bruce 2010). 
There are four main movements involved in zebrafish gastrulation. The first to 
begin is epiboly, as the embryo proliferates the cells migrate towards the vegetal 
pole, eventually completely covering the yolk cell. By 6 hpf the other three main 
movements have begun. The lateral cells begin to migrate dorsally towards the 
midline of the embryo in a process called convergence, narrowing the embryo 
dorsoventrally but extending its anterior posterior axis. The lip cells begin to 
migrate upwards along the yolk cell of the embryo in a process called involution. 
This allows the mesodermal and endodermal cells to migrate along the entire axis 
of the zebrafish embryo. Lastly dorsal cells migrate upwards in extension, this 
movement extends the anterior posterior axis (reviewed in Solnica-Krezel & 






 During this process bmp is known to perform two roles. The first identified 
through mutagenic screens was its role in specifying ventral identity in the dorsal 
ventral axis. Several 
degrees of dorsalisation,  typically an expansion of dorsal / anterior structures (e.g. 
an expanded notochord) at the expense of the ventral /posterior structures (e.g. a 
reduced postnatal anal tail) 
observed were the 
bmp2b and bmp7 respectively.
 
 
Fig 3.1.2 zebrafish gastrulation
The diagram depicts both cell identitythat specifies the ventral fate of zebrafish embryos.Figure constructed from information in Solmica V = ventral  D= Dorsal  AP= animal pole VP= Vegital pole DCL= Deep cell layer ECL=layer YSL=yolk syncytial layer
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bmp pathway mutants were identified which showed varying 
(Mullins et al. 1996). The most severe phenotype 
swirl and snailhouse mutants, later identified as mutations in 
 
 





 the p-smad gradients 
Fig 3.2.16.   
 Enveloping cell 
 
  
 It was initially assumed that the bmp
screens  were representative of incremental changes in the level of bm
Fig 3.1.3  The Kishimoto scale of zebrafish dorsalisationThe diagram showing both the key morphological and morphogen differences detailed in Kishimoto et al. 1997.  
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(Mullins et al. 1996). This was confirmed when Kishimoto et al. (1997) 
demonstrated that not only could bmp2b nulls be rescued with bmp2b mRNA, each 
of the less severe dorsalisation phenotypes could be recapitulated with different 
dosages of bmp2b mRNA (swirl mutants ; Kishimoto et al. 1997). At high doses 
swirl embryos could be made to exhibit ventralised phenotypes, even emulating 
the complete ventralisation observed in Chordin null embryos. From this data they 
proposed a scale of phenotypes which would encapsulate the various levels of 
smad activation (Fig.  3.1.2; Kishimoto et al. 1997). This scale was used to 
successfully identify many genes involved in regulating the dorsal ventral fate via 
the bmp pathway. Examples include the smad5 (Hild et al. 1999) , Bambi (Delot et 
al. 1999) and Alk8 (Bauer et al. 2001). 
  Later work confirmed the existence of a p-smad gradient originating from 
the dorsal side of the gastrulating embryo. This gradient is primarily mediated by 
bmp2b, as bmp2b initiates the expression of both bmp4 and bmp7 in the 
gastrulating embryo (Ramel & Hill 2012; Kondo 2007). If bmp2b is knocked out, no 
smad phosphorylation occurs (von der Hardt et al. 2007).   
 To specify the ventral identity bmp signalling must down regulate dorsal 
genes and  upregulate the ventral genes. One critical downstream target is eve1. It 
is initially expressed in response to bmp signalling during the late blastula stage in 
the ventral mesodermal progenitor cells. Later it is expressed in the somites of the 
post anal tail (Pyati et al. 2005) and this expression is dependent upon continued 
bmp expression (Pyati et al. 2005). A zebrafish ventral homeobox transcription 
factor, eve1 specifies ventral identity, which has been demonstrated by eve1 




et al. 1995), while those that are injected with eve1 targeting morpholinos are 
dorsalised, though only if co-injected with morpholinos targeting vent , vox or ved, 
as eve1 acts cooperatively with these factors (Seebald & Szeto 2011). 
 Another well characterised ventral target gene is gata2. Originally 
identified in Xenopus as a downstream target of xbmp-4 (Maeno et al. 1996), Gata2 
has since been shown to be a key player in establishing ventral identity in Xenopus. 
Inhibiting gata2 activity by expressing a dominant negative gata2 protein results 
in severely dorsalised Xenopus embryos(Sykes et al. 1998). In zebrafish it is 
expressed ventrally by segmentation  (10-13 somites; Vuilleumier et al. 2010) and 
while the precise modulators of expression remain unknown, it is inhibited by I-
smad6, demonstrating that it is the downstream target of the canonical bmp 
cascade (Oren et al. 2005). 
 Two examples of dorsally expressed genes that are down regulated by bmp 
signalling are otx2 and runx3 (runt like transcription factor). runx3 is known to be 
a downstream component of tgf-beta and bmp signalling where it acts as a cofactor 
for the smads. In zebrafish development it is expressed in the early embryo at the 
mid blastula stage, but  it is heavily up-regulated with the onset of neurulation 
(Cohen 2009). In situ hybridisation experiments have shown that its expression is 
confined to anterior neural tissue (the trigeminal ganglions, the dorsal neural tube, 
Rohon–Beard sensory neurons and neural crest cells; Kataoka et al. 2000). Which 
makes it an ideal marker of dorsally-anterior identity.  
 Otx2 is a homeobox transcription factor that is involved in specifying both 
the development of the vertebrate brain and the initial establishment of the eye 




been shown to be crucial for normal eye development in Xenopus (Zuber et al. 
2003), humans (Ragge et al. 2005) and mice (Martinez-Morales et al. 2001). In 
zebrafish otx2 has a closely related paralogue otx1a which has a similar expression 
pattern. This accounts for the fact that knocking down otx2 with MOs results in 
only minor ocular defects. However double knockdowns (both with MOs and 
genetic knockouts) show both coloboma and undifferentiated RPE (Lane & Lister 
2012; Bharathan, 2014). In zebrafish, otx2 is under repression from bmp 
signalling. This is demonstrated by Nikaido et al.  who showed that beads coated in 
bmp4 suppressed otx2 expression. This was further confirmed by the fact that cells 
expressing constitutively active bmpr1a (CA-BRIA) had lower levels of otx2 
expression (Nikaido et al. 1999). 
  
 The other known function of the p-smad gradient formed during 
gastrulation is to control the convergence movement of the lateral cells during 
epiboly. The lateral cells migrate down the bmp gradient towards the dorsal side of 
the embryo (von der Hardt et al. 2007). This is a completely separate function to 
the dorsal ventral axis specificity as it doesn't affect the expression of either dorsal 
or ventral markers. However the phenotype is remarkably similar to the C2 and C3 
bmp pathway mutants (Topczewski et al. 2001). Loss of lateral convergence leads 
to a reduction in the anterior posterior axis manifesting in a reduced post anal tail 
(Sepich et al. 2000). In fact the knypek mutant was initially identified as a bmp 
interactor because it displays a classic C2 phenotype. Although further 
investigation showed lateral cell fate was unaffected, and transplanted cells 




spatial position in the embryo (Topczewski et al. 2001). This similarity is due to 
the fact that convergence is disrupted in classical bmp mutations and is a 
significant contributor to the phenotype of mildly dorsalised embryos. 
 
 bmp signalling is also a key component of zebrafish eye development. 
Initially bmp is involved in the establishment of the eye field by antagonising 
anteriorly expressed eye genes like otx2 and rx3 (Bielen & Houart 2012) which is 
why embryos that have been ventralised have reduced eyes or the eye field is 
completely absent (Schulte-Merker et al. 1997; Kishimoto et al. 1997; Branam et al. 
2010). However, once the eyefield has been established, a new bmp gradient 
begins to form within the RPE. This pattern is clearly bmp dependent and 
treatment with the improved bmp inhibitor LDN 193189 leads to ablation of tbx5 
(which is the earliest marker of the dorsal cell fate) expression, but not in rx3 (the 
earliest marker of the optic cup) expression. Bmp2b, bmp4 and gdf-6 have all been 
shown to be expressed within the zebrafish RPE (Kruse-Bend et al. 2012). 
Additionally, up regulating bmp signalling by expressing a constitutively active 
type 1 bmp receptor in the eye (rx3:caBMPR1a) suppresses the expression of the 
ventral marker gene vax2, while suppressing bmp expression in the eye by 
expressing i-smad7 (rx3:smad7).  This inhibits the dorsally expressed genes (for 
example tbx5 and Bambi ;French et al. 2009) but  it does not lead to expansion of 
ventrally expressed genes (for example vax2 ;French et al. 2009). Both bmp2b and 
gdf-6 knockdowns have been shown to have independent ventralising activity. 
When either is knockdown using MOs, the zebrafish retina loses its dorsal identity. 




loss of the dorsal retinal markers tbx5, tbx2b, and efnb2 (Gosse & Baier 2009; 
French et al. 2009; Kruse-Bend et al. 2012). While bmp4 depletion does not have 
an observable effect on the zebrafish retina, overexpression of bmp4 does lead to 





 3.1.5 smoc-1 is linked BMP signalling 
 
In Xenopus, xsmoc-1 has been shown to act as an antagonist of BMP 
signalling. Both xsmoc1 depletion by morpholino oligonucleotide injection and 
overexpression by xsmoc1 mRNA injection show the characteristic phenotype of a 
bmp antagonist. Even more compellingly,  xsmoc1 overexpression can be rescued if 
the embryos are injected with a constitutively active bmp receptor. When xsmoc1 
is only depleted unilaterally, the Xenopus develops unilateral anophthalmia on the 
side of the injection (Thomas et al. 2009).   
 
 The most well studied model of bmp signalling gradients is the Drosophila 
wing imaginal disc. Decapentaplegic (Dpp) is the Drosophila homologue of the 
Bmps. In this system the Drosophila homologue of smoc-1, Pentagone (Pent), was 
identified bioinformatically as a sequence suppressed by Dpp. Pentagone acts as an 
antagonist of Dpp signalling by controlling the rate of Dpp endocytosis 
(Vuilleumier et al. 2010). The abnormal gradient in Pentagone mutants can be 




gradient pattern formation is endocytosis-dependent. If this were not the case, the 
mad signal would get weaker but the shape of the gradient would remain 
unchanged. A study by Vuilleumier et al. indicates that Pentagone acts through an 
interaction with Dally (Vuilleumier et al. 2010), and as has previously been 
discussed in 3.1.3 Dally is already known to regulate endocytosis of bmp receptor 
complexes (Akiyama et al. 2008).  
 Vuilleumier et al. showed that Pentagone expression was down regulated 
by Dpp. This mutual antagonism suggested that they operated in a feedback loop, 
each suppressing the activity of the other. Later this was confirmed by 
Hamaratoglu et al. (2011). In wild type Drosophila imaginal disc, the p-Mad 
gradient will remain constant with the growth of the disc. This is called scaling. 
However, in Pentagone mutants the width of the p-smad gradient remains 
unchanged even as the wing disk triples in size over the course of its development 
(Hamaratoglu et al. 2011) which demonstrates the function of the Pentagone/Dpp 
feedback loop is to control the shape of the p-MAD gradient. It would allow the 
Dpp gradients to scale with the growing organism and make the gradients much 
less susceptible to alteration in external conditions than wild type flies 
(Hamaratoglu et al. 2011). 
 A defect in BMP signalling is a plausible for OAS in humans. BMP has been 
long been known to be a central player in vertebrate eye development, and 
mutations in BMP4 have been shown to cause both anophthalmia and limb defects 






3.1.6 The current evidence for a link between smoc1 and bmp signalling in zebrafish 
 
 Published work on zsmoc1  is very limited. In situ hybridisation has shown 
that smoc1 expressed in the ventral RPE of the developing eye (Abouzeid et al. 
2011). Abouzied et al. also reported that MO depletion of zsmoc1 lead to an 
increased incidence in coloboma, both of which are consistent with a function 
regulating the bmp gradient which establishes dorsal retinal identity in the 
zebrafish eye. 
 Pilot work conducted during the Masters project preceding this thesis 
strongly implicated zsmoc1 function in bmp signalling (David Sexton 2010). Initial 
work showed that zsmoc1 morphants had the classical moderately dorsalised 
phenotypes (Fig. 3.1.3 A, B, C and D; Fig. 3.1.2). A link with the bmp pathway was 
confirmed by coinjection with bmpr1a which rescued the dorsalisation of zsmoc1 
morphants (Fig. 3.1.3 E), and that this involved a canonical BMP signalling as 
whole mount immunohistochemistry showed p-smad phosphorylation was 
dramatically upregulated in zsmoc1 morphants. 
 The bmpr1a rescue strongly suggests the morphant phenotype is not due to 
off-targeted effects. Yet, no rescue was achieved using zsmoc1 mRNA during the 
project.  Without an mRNA rescue off-target effects cannot be ruled out 
conclusively (Skromne & Prince 2008). 
_____________________________________________________________________________________________________________________________________________ 
 
Fig 3.1.4 Anteroposterior and dorsoventral patterning in zebrafish embryos requires zsmoc1.   
One day after smoc1dorsalised embryo showing embryonic length, almost complete loss of tail and bvisible neural structures.  tail (C) A phenotypically normal fish. dorsoventral patterning while control injected depletion up regulates pp-smad is upregulated in smoc1MOa injected embryos after 4 hpf. zsmoc1aMO can rescue the immunohistochemistically shows p (David Sexton 2010)
128 
aMO injection embryos show bmp dorsalisation phenotype 
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3.2.1 Characterising zebrafish smoc1 (zsmoc1) morphant phenotype 
 
 To validate the MOs I had designed to target zsmoc1, it was important to 
compare the induced phenotype to that of previous reports in the literature. This 
was particularly relevant for the translation blocking MO that I had designed to the 
newly identified exon 1 (chapter 2.2.5). Both of my zsmoc1 targeting MOs (one 
blocking translation and the other splicing) were individually co-injected with a 
p53 blocking MO to rule out off target effects caused by the triggering of the p53 
response. Even with the co-injection of p53, the same characteristic spectrum of 
bmp phenotypes was observed. Indeed the new translation blocking MO 
(zsmoc1tMO) are more dorsalised than those injected with the splice blocking MO 
(zsmoc1cMO). Only 12% of zsmoc1tMO morphants were phenotypically normal 
compared to 43% zsmoc1cMO (Fig. 3.2.1 A; B). Additionally 18% of embryos 
injected with the smoc1tMO showed the more severe C4 phenotype. 
 To further establish if the cells were indeed dorsalised, a quantitative 
RTPCR assay (qPCR) was established using the relative expression of bmp 
downstream targets. For validation purposes it was necessary to produce positive 





Fig. 3.2.1 New zsmoc1morpholinos induce the characteristic dorsalisation phenotypes previously reported in the media. Even when cowith p53 targeting MO 
(A) The new trans targeting MO zsmoc1tMO shows the same range of dorsalisation previously reported.Injection of splice morpholino zsmoc1cMO recapitulates the spectrum of phenotypes previously reported even with the coinjectionmirrors the defects seen in the 














 The previously published bmp2b MO was chosen for use as a positive 
control for dorsalisation (Lele et al. 2001). In our hands it recapitulated the 
severely dorsalised phenotype previously reported at all dosages tried (Fig. 3.2.1 
C). Confirming it is a suitable control for the qPCR assay.  bmp2b  mRNA was 
selected as the positive control for ventralisation as it had previously been shown 
to induce highly ventralised embryos (Kishimoto et al. 1997). The mRNA showed a 
strong dose-response, with higher concentrations of mRNA leading to more 
strongly ventralised phenotypes (V3,V4) (Fig. 3.2.1 D). Confirming bmp2b mRNA 
is a valid positive control for ventralisation. 
 
(Lele et al. 2001) 3.2.2  Developing a quantitative RTPCR assay to assess dorsalisation and ventralisation in morphant zebrafish embryos 
 
 To assess dorsalisation and ventralisation, we selected several downstream 
targets of bmp. Two sets of genes were chosen. One of neural markers comprised 
of both otx2 and runx3 which are normally expressed in the dorsal region of the 
early embryo (Navaneetha Krishnan Bharathan, 2014; Kataoka et al. 2000; 
Vuilleumier et al. 2010).  The other set of genes are markers of normal ventral 
ectoderm. eve1 and gata2 expressed are in the ventral ectoderm of the neurulating 
zebrafish embryo (Seebald & Szeto 2011, p.1; Oren et al. 2005, p.2; Vuilleumier et 
al. 2010).  
 
Fig. 3.2.2 Down-regulation of bmp signalling in reduction in the expression of ventral ectoderm markers and a of smoc1 and neural markers at 14hpf but not at 9hpf.
 (A) Schematic representation of the predicted response of neural and ventral ectoderm genes when bmp signalling has been down regulated (bmp2b morphants do not show the predicted pattern of neural markers and ventral ectoderm expression predicted for an ablation of bmp signalling at 9 hpfexpression pattern is entirely consistent with the one predicted markers is increased while the expression of ventral ectoderm markers is reduced. zsmoc1 is up regulated at 14 hpf i
 (B; D; F) Gene expression levels were calculated using the comparative Ct method and normalised to efla. (C; E) Is relative foldsamples were analysed in triplicateparametric students ttest * p<0.05  ** p<0.001 *** p<0.001
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 If the C and V phenotypes are indeed indicative of dorsalisation then we 
predicted that an up regulation of bmp signalling should result in a down 
regulation of the neural marker genes and a corresponding up regulation of the 
ventral ectoderm genes (Fig. 3.2.1 A).To test this, bmp2b signalling was down 
regulated in zebrafish embryos by injecting with bmp2b MO. The embryos were 
collected at 9hpf and 14hpf. The mRNA was extracted and transcribed to cDNA. 
The releative levels of expression of the marker genes was quantified with qPCR. 
At  9 hpf  both ventral and neural markers were down regulated (Fig. 3.2.2 B; C). 
However, by 14hpf the predicted pattern of marker gene expression was observed 
(Fig. 3.2.2 A; D; E). The dorasally expressed neural markers were upregulated 
while the ventrally expressed ectoderm markers were downregulated. This 
confirms that bmp2b morphants are actually dorsalised.  As the markers only 
followed the predicted pattern at 14 hpf, it was decided that for future 
dorsoventralisation assays every qPCRs would be conducted on this time point. 
 To confirm that the marker genes also showed the predicted expression 
patterns for ventralised embryos the reciprical experiment was  performed. bmp2b 
expression was upregulated through the injection of bmp2b mRNA  into zebrafish 
embryos (Fig 3.2.3. B; C).  This led to a down reglation of otx2 and runx 3 and 
upregulation of eve1 and gata2, which is the expected gene expression pattern of 
ventralised embryos, confirming that these markers can distinguish between both 
dorsalised and ventralised embryos. 
 
 
       
 
Fig. 3.2.3 Upregulatingupregulation of ventral ectoderm markers and a corresponding downand neural markers at 14hpf. 
(A) Schematic representation of the predicted response of neural and ventral ectoderm genes when bmp signalling has been up regulated (Injection of bmp2b mRNA leads to a down regulation of neural markers and a corresponding up regulation of ventral ectoderm genes predicted for an up regulation of bmp signalexpression leads to a corresponding down regulation in zsmoc1 expressiomanner.   (B; D) Gene expression levels were calculated using the comparative Ct method and normalised to (C: E) Is the relative fold  expression in relation to zebra fish injected with 2000pg of antisense mRNA.   Samples were analysed in triplicateparametric students ttest * p<0.05  ** p<0.001 *** p<0.001 
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 Additionally zsmoc1 expression is dependent on to the level of bmp activity. 
In bmp2b morphants zsmoc1 expression is upregulated (Fig 3.2.2 F), conversly the 
injection of bmp2b mRNA leads to a dose dependant reduction of zsmoc1 levels 
(Fig. 3.2.3 D; E). This expression pattern is strongly indicatve of a feedback loop 




3.2.3  The effect of zsmoc-1 depletion  on ventral ectoderm markers and dorsal neural markers 
 
 Although zsmoc1 morphants were scored as having the C2 –C4 phenotypes, 
they do not show any increased expression of the dorsalisation markers.  They also 
failed to show a typical expression pattern of a bmp antagonist, as zsmoc1tMO 
showed a universal reduction in the expression of both dorsalisation and 
ventralisation markers (Fig. 3.2.4 A; B).  This indicates that the zsmoc1 phenotype 
is not the result of “typical” dorsalisation. To rule out off target effects, the results 
were replicated with the splice targeting MO zsmoc1scMO (Fig. 3.2.4 C; D), 







Fig 3.2.4 The neural and ventral ectoderm marker genes are universally down regulated in  14 hpf zsmoc1 
(A) Embryos injected with the translation blocking zsmoc1 targeting MO zsmoc1treduced levels of both neural and ventral ectoderm markers. This change was recapitulated in both otx2 and runx3 for embryos injected with smoc1scMOboth down regulated in embryos injected with either smoc1tMo and smoc1differences are not statistically significant. (A; B) Results are the meanvalues were calculated using a type 2 parametric students ttest * p<0.05  ** p<0.001 *** p<0.001 (C; D) Results are the meana type 2 parametric students ttest * p<0.05  ** p<0.001 *** p<0.001(A; C) Gene expression levels were quantified using the comparative CT method and normalised to elfa. (B; D) Show the relative fold levels of expression of A:C relative to embryos injected with 100 μM of Control MO  
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3.2.4 The effect of zsmoc1 mRNA injection on ventral ectoderm markers and dorsal neural markers 
 
  
 Injection of zsmoc1 mRNA did not significantly alter the expression of the 
dorsalisation marker genes (Fig. 3.2.6). However, the injection of hSMOC1 mRNA 
did have an effect. hSMOC1 injection ventralised the zebrafish embryos. The neural 
marker genes were significantly down regulated, while the ventral ectoderm 
markers were up regulated (Fig. 3.2.7 B). Which indicates that hSMOC-1 is acting 
as a BMP agonist. Phenotypically embryos injected with hSMOC1 mRNA show 
significantly greater defects than those injected with bmp2b RNA. Epiboly is 
arrested at 10 hpf and the majority of the embryos die before completing 
neurulation (Fig. 3.2.7 A). 
  
 Since the zsmoc1 mRNA did not appear to be biologically active* we went 
on to use the hSMOC1 mRNA to attempt to rescue the zsmoc1 morphant.  
 
*It should be noted that it later transpired that zsmoc1 mRNA lacked both exons 14 
and 15 which provides a plausible explanation for the absence of a biological 













Fig. 3.2.5  zsmoc1does not significantly alter embryo patterning.  
(A) Injection of zsmoc1no increase in zebrafish mortality. Embryo survival was scored between 8 hpf (40% epiboly) and 14 hpf (neurulation) (B)  qPCR was used on cDNA from 14 hpf (10embryos showed no statistically significant change in the expression levels of neural and ventral ectoderm markers and ventral ectoderm marker genes. (C) qPCR was used to quantify the bmp  reporter id1 and the  FGF reporter 
dusp6. All qPCR was normalized to and quantified using expression was compared to embryos injected with an equivalent  quantity of control mRNA (1000pg of antisense hSMOC1.)   
results are derived from 3 technical replicates (mean ± s.e.m)
dead 
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3.2.5  hSMOC1 mRNA injection partially rescues zsmoc1MO injection 
 
 It remained possible that the universal down-regulation of both the neural 
and ventral ectoderm markers was attributable to off target effects. To test this 
hypothesis, hSMOC1 mRNA was co-injected with zsmoc1tMO to see if this could 
rescue the down-regulation of the marker genes.  
 Co-injection of hSMOC1 mRNA results in partial rescue of zsmoc1 
morphants. Embryos injected with 50pg of hSMOC1 mRNA show no statistically 
significant reduction in levels of otx2, eve1 and gata2 (Fig. 3.2.7 A and B). Eve1 
shows dosage response with 10pg of hSMOC1 mRNA increasing its expressions 
towards wild type levels (Fig. 3.2.7 A and B) demonstrating that the knockdown 
of the dorsal-ventral marker genes (otx2, eve1 an gata2) caused by zsmoc1tMO 

































































Fig. 3.2.7 Injection of hSMOC1 
Coinjection of 50 pg of hSMOC1gata2 expression caused by the injection of zsmoc1tMO. 
Relative expression levels
embryos injected with 50 ng/ Results are the aggregate of 3 biological replicates each with 3 technical replicatesP values were calculated using 2 ***=p<0.0001  
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 mRNA can partially rescue zsmoc1 morphants
 mRNA results in a partial rescue of the reductions in Runx3 levels remained unaffected.  
 (2-(ΔΔcT)) normalized to elfa. (B) Relative fold expression relative to 
μl antisense hSMOC1 mRNA and 100 M of control 











otx2 eve1 and (A) 
MO.  
 (mean =± s.e.m). 
 
3.2.6 Morpholino knockdown of gives similar results to knockdown
 
 
 Morpholino knockdown of type2 bmp receptor genes resulted in a similar 
pattern of dorsal-ventral gene disruption to 
3.2.8). bmpr2a knockdown caused only mild 
significantly down regulated. While
otx2 and runx3 in a similar patter to that seen in 
Fig. 3.2.8). The type 2 bmp 
dorsoventral patterning
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zsmoc1 morphants 
misregulation with only 
 bmpr2b knockdown results in reduced
zsmoc1 morphants 
receptors display a degree of redundancy
, as shown by coinjection of 25μM of 
Fig. 3.2.8 bmpr2amorpholinos to control dorsoventral patterning. 
 Injection of bmpr2a MO only down regulates bmpr2b MO results reduction in eve1, otx2 expression. When codown-regulation is enhancedeach marker more severely downregulated when compared single MO injection.expression calculatedcomparative CT method and normalized to expression relative to embryos equivalent  dosage of MO expression. Results are the aggregate 3 technical replicatess.e.m). P values were calculated using  2  tailed type 2 parametric ttests. *=p<0.05 **=p<0.001 
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3.2.7 hSMOC1 mRNA does not rescue either bmp2b mRNA induced ventralisa-tion or bmp2b MO induced dorsalisation phenotypes 
 
 In an attempt to establish a direct interaction between hSMOC1 and bmp 
signalling Co-injections of hSMOC1 mRNA and either bmp2b MO or bmp2b mRNA 
were performed (Fig. 3.2.9; Fig. 3.2.10). However, neither sets of injections  
showed rescue. Nor did they display any synergistic enhancement of the 
expression ventralisation and dorsalisation markers. With coinjection hSMOC1 
mRNA and bmp2b mRNA leading to the same degree of ventralisation as is 
observed in control embryos injected with either hSMOC1 mRNA or bmp2b mRNA 
alone (Fig. 3.2.9). While coinjection of bmp2b MO with hSMOC1 mRNA also failed 
to rescue bmp2b morphants (Fig. 3.2.10). These results do not rule out an 
interaction however as rescue experiments are often difficult to perform (Skromne 











Fig. 3.2.9 co-injection expression of neural and ventral ectoderm markers  Co-injection of bmp2b result in significant differences in the relative expression of dorsalisation markers agenes assayed by qPCR. been normalized to elfa




of hSMOC1 mRNA with bmp2b mRNA does not alter the  
mRNA with hSMOC1 mRNA into zebrafish embryos does not 
(A) Relative expression, the delta Square CT  after values have  (B) Relative fold expression relative to the  Delta square CT 



































































Fig 3.2.10 The injection of  Co-injection of hSMOC1significant differences in the relative expression of dorsalisation markers and genes assayed by qPCR. (A) Relative expression, the delta Square CT  after values have been normalized to 
Relative fold expression relative to The results are averaged from 2 biological replicates each having 3 technical replicatess.e.m). 
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3.2.7 Optimising automated live imaging protocol for early 
 
 For the initial attempts at live 
embedded with their chorions in 2% low melting point agarose when they reached 
the sphere stage of development (4 hpf 
brightfield microscopy every 30 min.  Under these conditio
apparently normally and spontaneously align horizontally. Which would enable 
the observation of eye development but from only one angle. By 20 hpf  the 
embryos had begun to move, though the movement was not significant.
_____________________________________________________________________________________________
 
 Our aim was to record transgenic fluorescent reporter signalling in real
time in the developing eye. To test how the zebrafish embryos responded 
excitation a transgenic zebrafish line carrying a gfp tagged version of the 
ubiquitously expressed histone variant 
2001) was used. Under UV illumination the embryos were found to move 
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zebrafish embryos
embryo imaging zebrafish embryos were 
; Fig. 3.2.11). Embryos




Fig 3.2.11 Zebrafish embryos embedded in 2% agarose survived overnight incubation if embedded with  Embryos were mounted in 2% low melting point agarose and imaged seven times (the plane of focus varied but 30 µm) every 30 minutes. The free movement afforded to them within chorions lead to limited control of embryo orientation. By 8 hpf every embryo lay plane. At 20 hpf embryos started to movewithin the chorion, but  movement was minimal.  
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 To immobilise the embryos they
directly in the low melting point agarose. However, this almost invariably leads to 







(Fig. 3.2.13).  
_____________________________________________________________________________________





 and embedded 
 
fourteen images  GFP filter) and 
 lead 
 This made clear  
 
 
 To address the problem of movement the
embedded later in development (upon the completion of gastrulation ; 10
using methyl cellulose at a concentration of 0.8% and anestheti
Without their chorion zebrafish embryos are extremely vulnerable to
pressure. To combat this embryos were loaded into the viewing chamber on a 
minimal amount of methyl cellose. This  allowed the presence of air spaces around 
the media within the viewing chamber, reducing the pressure. The methyl cellose 
drop was held in place by surface tension
disruption in development and allowed the embryos to develop overnight 












 (Fig. 6.3.1) . These steps minimized the 
Fig 3.2.13 Incubation of embryos in 2% low melting point agarose was invariably lethal if they were dechorionated at the sphere stage of development. 
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3.2.8 The effect of zsmoc1 depletion on the developing zebrafish eye 
 
 To investigate the effect of zsmoc1 knockdown on the establishment of the 
eye field, a rx3:gfp reporter line (Rembold et al. 2006) was used in conjunction 
with injection of zsmoc1tMO. The dosage of zsmoc1tMO was titrated to minimise 
the severe dorsalised C2-C4 phenotype reported in Fig. 3.2.1 A and in an attempt 
to recapitulate the phenotype reported in Abouzeid et al. (2011), which was 
microphthalmia and an associated coloboma. rx3 is the earliest known marker of 
the eye field and use of the rx3:gfp reporter enables direct observations of the 
zebrafish eye field using fluorescent microscopy. rx3 is expressed throughout the 
developing eye up to 30 hpf by which time most of the major morphogenic events 
of eye development have been completed (Fig. 1.2.1). Real time image capture 
under UV light allows the accurate measurement of the size of the eye field 
throughout development. 
 The results shown are from biological replicates, specifically two 
independent sets of injections but under identical conditions. The analysis showed 
that the eye field is expanded in zsmoc1 morphants, with both of the measured 
axes (a & b; Fig. 3.2.14 A i. and ii.) being  significantly extended. Overall there was 
no evidence of microphthalmia or coloboma at later stages (Fig. 3.2.14 A vi.). The 
optic cup was larger at 18 hpf in one experiment (Fig. 3.2.14 A i.) but this was not 
replicated in the bright field measurements in Fig. 3.2.15 A i. . All other 





 To control for any global effect on embryo size caused by morpholino 
injection or inconsistent orientation of embryos, the entire cross-sectional area of 
the embryo (area d; Fig. 3.2.14 B ii. and iii.) was measured along with the width 
of the embryo head (axis e; Fig. 3.2.14 B i. and iii.).  There was no significant 
difference in the length of axis e between control and zsmoc1tMO injected 
embryos, indicating that the embryos were well orientated. There was a slight 
reduction in the total cross-sectional area of the embryos treated with zsmoc1tMO 
at both 18 and 22 hpf, which may be indicative of a minor misalignment in the 
anterior posterior axis or may be related to zsmoc1tMO and represent a milder 
form of the anterior posterior shortening observed in C2 - C4 embryos. Such a 
reduction cannot account for the results obtained for the optic cup at 18 and 22 
hpf as they result in a smaller proportional optic cup size for both a smaller 
embryo or poorly aligned embryo, confirming that zsmoc1tMO does not induce 
microphthalmia. 
 zsmoc1tMO injections also appeared to have little effect on rx3 expression. 
There may be a slight up-regulation of rx3 at 14 hpf in zsmoc1 morphants although 
the differences are only statistically significant for the mean pixel intensity (Fig. 
3.2.14 A iv.). At all other time points there is no statistically significant difference 
in pixel intensity of zsmoc1tMO and control MO injected zebrafish (Fig. 3.2.14 A 










Fig 3.2.14 The size of the optic cup is unaffected in zsmoc1 morphants in rx3:gfp reporter lines.  
(A)(i)(ii) The eye field is enlarged at 14 and 18 hpf in both axis a and b, However area c remains unaffected (A)(iii). (A)(iv) zsmoc1 depletion leads to a slight up regulation of rx3:gfp expression at 14 hpf. (B) Zsmoc1tMO treated  show a reduction in embryo size estimated by area d (B)(ii) of the embryo at both 18 and 22 hpf.  This reduction was not replicated in embryo size estimate by measuring axis e (B)(i).    




Fig 3.2.14b The size of thelines.  Example axis are illustrated in n=number of embryos  
 
 optic cup is unaffected in zsmoc1 morphants in 










 BMP signalling in the developing zebrafish eye  
 
 To visualise the bmp activity gradient formed within the developing eye, we 
used live imaging of BRE (Bmp response element):gfp transgenic embryos (Collery 
& Link 2011) injected with control or zsmoc1 morpholinos. The embryos were 
assessed at 22 hpf, which was one hour after the BRE:gfp gradient became visible 
(data not shown). zsmoc1 morphants show a small but significant decrease in the 
size of axis g (Bright field; Fig. 3.2.15 A). However, this difference was not 
observed in the rx3:gfp embryos indicating that the result is spurious and that the 
eye field is not reduced by  zsmoc1 depletion (Fig. 3.2.15 A i., ii.  and B iii ). 
 As with the rx3:gfp embryos, zsmoc1tmo treatment results in smaller 
embryos. However, the differences are only statistically significant at 18 hpf (Fig. 
.2.15 B ii.) and since they are also present in the measurements of axis e (Fig. 
3.2.15 B i.) this may be a product of embryo misalignment. 
 While there was no difference in eye size there was a significant difference 
in the gradient of BRE activity. zsmoc1 depletion made no significant difference in 
the absolute size of the BRE activity gradient, either in terms of the width (axis a 
and b ; Fig. 3.2.15 A iii. and vi.) or the cross-sectional area ( area c ; Fig. 3.2.15 A 
iv. and vi.). However zsmoc1 morphants had a higher ratio of BRE fluorescence to 
eye size, suggesting that in zsmoc1 morphants the dorsoventral gradient extends 
through a greater volume of the eye field.  








Fig 3.2.15 Upregulation of  bmp signalling in the dorsal RPE of zsmoc1 morphants.   (A)The effect of zsmoc1 depletion on the optic cup development. A(i.)(ii) With the exception of axis g at 22 hpf the overall size of the eye field is not significantly different between zsmoc1 and control morphants. A(iii)(iv) The size of the bmp gradient remains unaffected by zsmoc1 depletion. However the total ratio of the eyefield taken up by BRE expression is greater in zsmoc1 morphants. (A)(v) The expression of the bmp reporter BRE:gfp is increased in zsmoc1 morphants. (B) At 18 hpf zsmoc1 morphants display a significantly reduced size, as measured by area d and axis e. 
 Example axis of interest and regions of interest are illustrated in A(vi; gfp) B(iii; brightfield) for more details consult 6.3.1.4. n=number of embryos. * All data presented as mean (± s.e.m) and the p-values were calculated using a type 3 non parametric ttest.  
 
 
   
Fig 3.2.15b Upregulation of  
 
 Example axis of interest and regions of interest are illustrated in more details consult 6.3.1.4 
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Most notably, zsmoc1 morphants displayed a significant up regulation in 
BRE activity. The mean pixel intensity in zsmoc1 morphants is 2.5 times that of 
embryos injected with control MO (Fig. 3.2.15 A v. and vi.; p= 1.6 x 10-6 ). The 
mode intensity is twice that of wild type embryos (Fig. 3.2.15 A v. and vi.; p= 2.9 x 
10-5 ) demonstrating that zsmoc1 acts as a bmp antagonist influencing the dorsal 
ventral gradient in the optic cup. 
  3.2.10 zsmoc1 morphants exhibit and a laterally expanded dorsoventral p-smad gradient at 60% epiboly(6hpf) 
 
 To determine whether zsmoc1 directly affects the shape of the dorsal 
ventral bmp gradient of gastrulating zebrafish embryos whole mount immuno-
histochemistry was performed against p-smad(1/5/8). The embryos were fixed at 
60% epiboly because this is the time point where the epibolic defects of zsmoc1 
morphants become apparent (David Sexton 2010).  The p-smad gradient was 
visualised with horseradish peroxidase (HrP) staining before being quantified 
using Optical Projection Tomography (OPT).  
 The 3d projection of the zebrafish gastrulating  embryos was optically 
sectioned in 2 planes. To produce the quantitative measure of gradient size and 
identity the region of interest was defined as the part of the gradient which had an 
signal intensity of greater than 200. The gradient was then analysed with two 





region of interest and the mean pixel intensity was measured within the region of 
interest. 
  The lateral section allowed the measurement of the  Anterior pole (AP) 
gradient. Which is the gradient that controls the dorsoventral patterning of the 
developing zebrafish (Solnica-Krezel & Sepich 2012). The analyses of the lateral 
sections showed there was no statistically significant difference in the size of the 
AP gradient in zsmoc1 morphants. (Fig. 3.2.16 A and B).  
 The embryos were also section along the AP axis as this allowed the 
visualisation of the lateral p-smad gradient. It is this part of the p-smad gradient 
that controls the dorsal migration of lateral mesoderm during convergence of the 
gastrulating zebrafish embryo (von der Hardt et al. 2007). The AP sections showed 
that the size of the lateral gradient was significantly expanded in zsmoc1 
morphants (Fig.   3.2.16 C and D). Which is consistent with an antagonistic 
function of zsmoc-1. 
 
 
Fig 3.2.16 zsmoc1 constrains the sagittal p 
OPT imaging was used to produce threewas visualised using anti(A) Images illustrating the optical sectioningreconstruction of the HRP staining of the embryo from a vegetal view. The second column depicts an example of a lateral optical section representative embryo. unaffected by zsmoc1 depletion.(C) Images illustrating the VPreconstructions of embryosagittal plane. (D) While the intensity of the gradient is not significantly different in smoc1 morphants the gradient is significantly larger in zsmoc1 morphants.Images were initially constructed and optically sectioned using analysed in Fiji 
 V= Ventral D= Dorsal 
 The axes of the optical section is denoted by the yellow dashes.
 Results displayed as the mean± s.e.m. Statistical significance was calculated using a nonparametric twotailed students t-test.  *=p<0.05 **=p<0.001. 159 
 
-smad gradient of zebrafish at 60% epiboly
-dimensional scans of whole mount immuno. The p-p-smad 1/5/8 and HR staining.  of the whole mount immunos. The first, column shows a 3
(B) The gradient lateral p -AP sectioning of the zebrafish embryos. The first columns from the lateral plane. The second column defects optical sections taken in the 
 Biotronics V4.0 then exported as Tiff files and 
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3.3  Discussion 
 
 
3.3.1 zsmoc-1, an antagonist of BMP signalling? 
 
 When I started this work the prevailing model was  that  smoc-1 acted as a 
simple antagonist of  bmp signalling. This model is largely based on one paper, 
Thomas et al. (2009) which demonstrated that in Xenopus embryos xsmoc1 
morphants display the ventralised phenotype characteristic of a bmp antagonist 
and that xsmoc1 overexpression resulted in reduced smad phosphorylation. They 
also showed that the ventralisation was bmp-dependent by showing that it was 
possible to rescue xsmoc1 morphants with the expression of constitutively active 
type one bmp receptor. 
 Yet the results presented in this chapter have demonstrated that this is not 
a complete picture, at least not in zebrafish. While multiple lines of evidence all 
implicate zsmoc1 in bmp signalling the results are largely contradictory with some 
pointing to bmp acting as a classical antagonist (Fig. 3.1.4 F; Fig. 3.2.15; Fig. 
3.2.16) while others point to an agonistic function (Fig. 3.2.6).  
 The evidence that zsmoc-1 acts as an antagonist of bmp signalling is 
threefold. 1). Zsmoc1  morphants have universally up-regulated smad 
phosphorylation at the sphere stage of embryonic development (David Sexton 




epiboly (Fig. 3.2.16 C and D) and 3). Lower doses of zsmoc1tMO result in an up 
regulation of bmp signalling within the optic cup, as shown by the increase in the 
intensity of the BRE:gfp signal (Fig. 3.2.15 A v. and vi.).  
 However overexpression of hSMOC1 led to a ventralised phenotype. The 
neural markers were down regulated while the ventral ectoderm markers were 
upregulated(Fig. 3.2.5 A and B).  Which is the pattern you would expect from a 
bmp agonist and indeed this was the pattern of gene expression observed with the 
injection of  bmp2b mRNA (Fig. 3.2.3 A; B and C).  
 
 One of the most unexpected results was the use of RT PCR to demonstrate 
that the zsmoc1 morphant phenotype observed in the preliminary work before this 
project was not standard dorsalisation. Instead of showing up regulation of the 
neural marker genes and concurrent down-regulation of ventral ectoderm marker 
genes one would expect in dorsalised embryos, the zsmoc1 morphants showed 
universally down regulated gene expression (Fig. 3.2.4 A and B) which 
conclusively show that the zsmoc1 morphants are not dorsalised. This still raises 
the question as to why the morphants display the C2-C4 phenotype (Fig. 3.2.1)?  
 One explanation is that the embryonic defects are the result of a general 
failure of differentiation of the zebrafish embryo. Thus resulting in poorly 
differentiated tissues that fails to recapitulate the expression patterns of ventral 
and neural ectoderm. This model is supported by the phenotype of OAS patients. 
Both of the key defects in OAS (anophthalmia and syndactyly) are theorised to be 
due to failure of differentiation (Verma & Fitzpatrick 2007; Tonkin 2009). A large 




microphthalmia are expressed exclusively in the RPE during eye development, 
leading Verma & Fitzpatrick to propose that anophthalmia/ microphthalmia is 
caused by the failure of retinal to differentiation. Resulting in the failure of learners 
induction and the eventual regression of the eye field (Verma & Fitzpatrick 2007). 
Syndactyly is known to be due to failure of differentiation. More specifically 
incomplete differentiation of the digital rays (Peter D. Burge 2009; Tonkin 2009). 
 An alternative explanation is that zsmoc-1 is involved in controlling the 
shape of the bmp gradient that regulates dorsal migration of the lateral mesoderm 
in convergence. This has already been observed in knypek mutants. Knypek is a 
zebrafish homolog of Glypican 4(GPC4). Knypek null embryos display C2 
phenotypes but the embryos aren't dorsalised. Instead the defects are attributable 
to the inability of knypek null cells to migrate along the lateral component of the 
dorsal ventral p-smad gradient (Topczewski et al. 2001; Kondo 2007). This is 
supported by the whole mount immuno OPTs which show no defect in the animal 
pole bmp  gradient (Fig. 3.2.16). This is the part of the dorsoventral gradient 
which determines the identity of the mesoderm, i.e. whether it differentiates 
neural or ventral mesoderm in the zebrafish embryo, and is the part which would 
alter the expression of the dorsal ventral markers. This is in contrast to the lateral 
gradient, which is both expanded and extended dorsally. The lateral component of 
the dorsoventral gradient controls the migration of the lateral mesoderm, but not 
the eventual cell fate of the mesoderm (Topczewski et al. 2001; von der Hardt et al. 
2007). This accounts for the observation that defects in zsmoc1 morphants only 
become observable at 50% epiboly (David Sexton 2010), which is when 




known function of Pentagone (the Drosophila homologue of smoc1), which has 
been shown to be dependent on a direct interaction with Dally (the Drosophila 
orthologue of the knypek; Vuilleumier et al. 2010). 
 The final possibility is that the results of Thomas et al. (2009) were 
fundamentally flawed. Given the current controversies surrounding the use of 
morpholinos in zebrafish, namely the surprisingly poor correlation between 
morphant phenotypes and those of genetic knockouts(Kok F. et al. 2014), it is 
worth reassessing the results reported by Thomas et al. Unfortunately there has 
been relatively  little work on assessing the extent of the problem in xenopus, with 
most of the prevailing assumptions derived from the results obtained in zebrafish 
(Eisen & Smith 2008: Wang,   et al. 2015.). Given the standards of the time the 
work was conducted with the necessary controls. The paper did target multiple 
morpholinos to the same gene, however given the results in zebrafish this cannot 
be considered definitive. Fortunately Thomas et al. conducted multiple other 
experiments that did not rely on morpholino data. Most notably the injection of 
xsmoc1 mRNA into xenopus embryos resulted in the upregulation of ventral 
markers and xsmoc1 mRNA can block the dorsalisation produced by the direct 
injection of bmp2 protien (Thomas et al. 2009). Both these experiments provide 
strong support for an antagonistic function of smoc-1 and cannot be accounted for 







3.3.2 A model for the feedback between zsmoc-1 and bmp signalling 
 
 It is clear that zsmoc-1 neither acts exclusively as an bmp antagonist or 
agonist. It is entirely possible that the action of zsmoc-1  is context dependent, as is 
the case for Schnurri (Dai et al. 2000; Arora et al. 1995). However, a more 
parsimonious explanation is that zsmoc-1 acts to control the shape of the gradient. 
This is why we have proposed that the function of zsmoc1 is conserved to 
Drosophila and that zsmoc-1 acts on the bmp gradient in much the same way that 
Pentagone has been shown to act on the Dpp gradient (Vuilleumier et al. 2010; 
Hamaratoglu et al. 2011).  
 
 Like Pentagone, zsmoc1 is repressed by its own downstream target. bmp2b 
overexpression results in the repression of zsmoc1 expression, and this repression 
is dosage dependent (Fig. 3.2.3).  While bmp2b morphants  have higher levels of 
zsmoc1 expression than the embryos injected with control MO (Fig. 3.2.2). 
Reciprocal repression is the characteristic expression pattern of a feedback loop 
which is important in signalling cascades as it allows the generation of robust 
gradients, allowing morphogen gradients to compensate for genetic disruptions (if 
gradients are not dynamically regulated the of majority of signalling ligands would 
have monoallelic disorders. as any single null mutation would result in a 
significantly reduced pool of available ligand) and environmental changes (e.g. 




modified dynamically during development and impart properties such as 
scalability to the gradient (Hamaratoglu et al. 2011). 
 
 Under our proposed model, zsmoc1 acts in a feedback loop with bmp and 
smad1/5/8.  In this model bmp ligand leads to smad phosphorylation while 
simultaneously suppressing the expression of zsmoc1. While we have assumed that 
this suppression is mediated via p-smad, there is no direct evidence for this and it 
is equally possible that zsmoc1s action is dependent on non canonical bmp 
signalling (e.g. MAPK pathway; Verheyen 2007; Sieber et al. 2009). zsmoc-1 
promotes the migration of bmp ligand, but the precise mechanism of this remains 
to be elucidated.  In Drosophilae, however, the regulation of Dpp signaling by 
Pentagone is endocytosis dependent which was demonstrated by the rescue of the 
bmp gradient with the knockdown of Thickveins (Vuilleumier et al. 2010). 
Under RMT, the formation of the gradient is dependent on transcytosis. 
zsmoc-1 would promote transcytosis which would spread the pool of available 
ligand resulting in a broader less concentrated bmp gradient (Schwank et al. 
2011). Under the RED model, zsmoc-1 would inhibit the endocytosis of bmp. This 
endocytosis is critical as smad phosphorylation is dependent on the correct 
intracellular localisation (Schwank et al. 2011). The internalisation of bmp/bmpr 
complex is also critical to its degradation, so if zsmoc-1 acts by inhibiting  
endocytosis the available pool of ligand would be increased and extend the bmp 





In  practice this would lead to smoc-1 being expressed only at a distance 
from the source of bmp ligand.  This indeed is the expression pattern observed in 
dorsoventral retinal eye patterning, with bmp being expressed in the dorsal retina 
and zsmoc1 expression restricted to the ventral retina by the optic fissure (French 
et al. 2009; Abouzeid et al. 2011). For the dorsoventral patterning of the zebrafish 
embryo, the expression domain is less certain. While q-PCR has demonstrated that 
zsmoc1 is expressed during gastrulation, the expression levels are relatively low 
and the expression domains have not been established (Fig. 2.2.6). Given that 
zsmoc1 morphants only display perturbed gradients in the sagittal optical sections 
(Fig. 3.2.16), it is likely that zsmoc1 is only expressed laterally and is not involved 
in regulating the sagittal gradient.   
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 How does this model account for zsmoc-1 depletion acting like a bmp 
antagonist and up regulating bmp signalling (Fig. 3.1.4; Fig 3.2.15)? The RED 
model predicts that smoc-1 ablation will remove the inhibition on endocytosis, 
while the RMT model predicts that the gradient migration will be inhibited. Both 
models will result in a buildup of bmp ligand near to the source (Schwank et al. 
2011; Kicheva & González-Gaitán 2008) resulting in a localised up-regulation of p-
smad signalling but a complete ablation of distal p-smad signalling. This theory 
does account for the universal down-regulation of the dorsal and ventral marker 
genes, as it makes no clear prediction on the levels of gene expression. Under my 
model the ventral side of the embryo be ventralised and the dorsal side of the 
embryo being dorsalised (Fig. 3.3.5).  
 It is more likely that zsmoc-1 is not involved in the dorsal ventral 
patterning in gastrulation; whole mount immunos showed that zsmoc1 morphants 
only displayed defects in the lateral p-smad gradient  (Fig. 3.2.16). This gradient is 
not involved in the establishment of the dorsal ventral cell fate but is involved in 
regulating cell migration through convergence and anterior posterior extension 
(Solnica-Krezel & Sepich 2012). hSMOC1 overexpression does affect the 
dorsoventral axis because it is a ectopically  expressed, allowing it to act on the AP 
component of the gradient. This part of the p-smad gradient is involved in 
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3.3.3 zsmoc1 depletion does not result in a morphological change in eye development 
 
 Live imaging of the rx3:gfp line failed to show any reduction in the size of 
the eye field of embryos injected with  zsmoc1tMO (Fig. 3.2.16 A i. ii. and iii.). In 
fact the eye field was expanded at 18 hpf (Fig. 3.2.16 A i. and ii.). Whilst this 
expansion of rx3:gfp expression remains unexplained, it is consistent with the 
down-regulation of bmp signalling. The eye field in teleost fish is derived from the 
telencephalon, and bmp2b inhibits the expression of rx3 and prevents its 
differentiation into the eye field (Bielen & Houart 2012). A down-regulation of 
bmp2b signalling would result in an expansion of the eye field and up-regulation of 
rx3. This was observed in the increase in the mean pixel intensity of the eye field 
rx3:gfp(Fig. 3.2.16 A iv.). This would require that zsmoc-1 acts as a agonist of bmp 
signalling which is inconsistent with other results we obtained. Additionally, 
bmp2b is not the only signalling molecule involved in the establishment of the eye 
field. For example wnt signalling is required to regulate the formation of the 
telencephalon and the establishment of the eye field (Houart et al. 2002; 
Heisenberg et al. 2001). It is also possible that the expansion of the eye field is 
attributable to a delay in embryonic development caused by the injection of 
zsmoc1tMO.  
  
 By 18 hpf, zsmoc1 depletion appears to have no effect on the optic cup. 




embryos injected with zsmoc1tMO or control MO (Fig. 3.2.14 and 3.2.15). This 
situation continues to 22 hpf. There were no observed instances of coloboma 
either. Even after five days of development, both zsmoc1tMO and zsmoc1tMO 
morphants showed no enrichment of eye defects (microphthalmia/ coloboma and 
lens extrusion) when compared to control morphants. This is surprising; every 
other animal model displays eye defects when Smoc1  is down regulated. Humans 
with no functional alleles of SMOC1 develop anophthalmia/microphthalmia 
(Abouzeid et al. 2011; Rainger et al. 2011; Okada et al. 2011) and mice develop 
coloboma (Rainger et al. 2011; Okada et al. 2011).  Xenopus develop anophthalmia 
when injected with xsmoc1 targeting  MO (Thomas et al. 2009). Though it should 
be noted that the phenotype only becomes apparent upon unilateral injection of 
xsmoc1 MO into one cell of a two cell embryo. Universal down regulation of xsmoc1 
leads to gastrulation defects that arrest embryonic development before the 
establishment of the eye field (Thomas et al. 2009). Moreover in 2011 Abouzeid et 
al. reported that zsmoc1 targeting MO induced microphthalmia  and coloboma in 
zebrafish.  
 
 How can the results we obtained be reconciled with those of Abouzeid et 
al.? The best explanation is MO toxicity or off target effects. Both microphthalmia 
and coloboma are known to be common phenotypes for morpholino toxicity 
(Bedell et al. 2011). Morpholinos often trigger the tumour suppressor p53, which 
leads to apoptosis (Gerety & Wilkinson 2011). In zebrafish, up to 20% of MOs lead 
to some degree of p53 dependent toxicity (Ekker & Larson 2001) and is notable 




morpholino did knockdown of zsmoc1, they did not take steps to control for off 
target effects (Abouzeid et al. 2011). They only used one morpholino, they didn't 
co-inject with p53 MO and they didn't manage to rescue with mRNA.  
 
 In contrast, multiple morpholinos  were used to knockdown zsmoc1 
expression in this project. In total over the course of preliminary work (David 
Sexton 2010) and the work presented in this thesis, four separate morpholinos 
were used which all produced overlapping phenotypes. This is important as it 
rules out chance off target binding effects. While MOs are 25 bp long, which means 
the chances of that precise sequence occurring in the genome are very small (The 
number of combinations of a 25 bp oligo is 425 = 1.126 x 1015 so the  probability of 
a precise match at random is  1/1.126 x 1015), even a partial match may be enough 
to produce some binding and knockdown an untargeted mRNA. However the 
chances of this being the case with two independently designed MOs is negligible 
(Skromne & Prince 2008).  
 
 If the phenotype is caused by general morpholino toxicity then the odds are 
not negligible. As the majority of non-specific morpholino toxicity in zebrafish is 
mediated by the p53 pathway (Robu et al. 2007) it is possible to significantly 
reduce it by either knocking down p53 with a coinjection or by using p53 null 
zebrafish(Gerety & Wilkinson 2011; Bedell et al. 2011; Skromne & Prince 2008). 
This is why both smoc1tMO and smoc1scMO were co-injected with p53 MO. As 
these co-injections produced the same range of phenotypes observed in the 




the C2-C4 phenotype is not dependent on the p53 pathway. p53 associated toxicity 
can therefore be ruled out.  
 
The best evidence that a morpholino is specific (with the exception of 
phenocopying targeted null mutations) is that it can be rescued by artificially 
reintroducing the depleted protein and managing to fix the genetic abnormality. 
This usually takes the form of injecting artificially transcribed mRNA. If the 
morpholino is splice targeting then it will not work on a artificial mRNA which 
excludes introns. If the morpholino is translation blocking then either the target 
site needs to be re-engineered or non-homologous RNA is used. Though highly 
desirable, rescue is often unobtainable (Skromne & Prince 2008). This is due to the 
fact that rescue often results in a gain of function. Injected mRNA is often 
ubiquitously expressed and it is almost impossible to recapitulate the precise 
dosage of the introduced gene, which means that it is difficult to completely rescue 
morpholino knockdown if the gene’s function is particularly sensitive to where it is 
localised or its concentration(Skromne & Prince 2008). 
 
Initially this was the strategy which was pursued with zsmoc1, which was 
unsuccessful (Fig. 3.2.5). However, the zsmoc1 transcript was based on the 
sequence  recorded in the UNSC genome browser, which excludes both exons 14 
and 15 (Fig. 2.2.1). While these exons only account for 15 amino acids, their 
absence provides a plausible reason for both the failure of the rescue and the 
absence of an overexpression phenotype (Fig. 3.2.7 A), despite the fact that 




to partially rescue the expression of three of the four dorsal ventral marker genes 
by injecting hSMOC1 mRNA (Fig. 3.2.7), which indicates that the down-regulation 
of these dorsoventral genes is specifically due to the loss of smoc-1.  
 
 More recently the availability of more and more efficient DNA engineering 
technologies in zebrafish has allowed the generation of unprecedented numbers of 
targeted knockouts in zebrafish which has thrown into question the primacy of 
mRNA rescue for  ruling out off target effects (Blackburn et al. 2013; Chang et al. 
2013; Cade et al. 2012; Schulte-Merker & Stainier 2014).  There are reports that 
only the phenotypes of 1 in 10 of the morphants reported in the literature 
phenocopying their associated DNA null, even for those which reported rescue 
(van Impel et al. 2014; Schulte-Merker & Stainier 2014). Some of this is probably 
due to the fact that morpholino knockdown is not equivalent to a genetic knockout. 
For example translation blocking morpholinos will ablate maternally deposited 
mRNAs while genetic ablation will not. Others may be due to a combination of 
toxicology and the effect of targeted knockdowns.  
 
In some ways this is being addressed by our use of marker genes to introduce 
a quantitative rather than a qualitative measure of rescue(Fig. 3.2.2; Fig. 3.2.3; 
Fig. 3.2.4; Fig. 3.2.5; Fig. 3.2.6 and Fig. 3.2.7). However to further verify the 
results, efforts were made to utilise TALEN technology to generate zsmoc1 nulls 
zebrafish lines in order to confirm whether they mirrored our results. This work is 





 The live imaging assays of BRE:gfp revealed that zsmoc1 depletion led to 
significant increase in bmp signalling intensity in the zebrafish eye, which is 
consistent with the predictions that smoc-1 is an antagonist of the bmp signalling 
localised to the ventral retina. While there were no gross defects in eye 
development caused by MO treatment, these wouldn't necessarily be predicted in 
zebrafish. The dorsal ventral bmp  gradient of the zebrafish eye is known to be 
required for correct specification of the dorsal retina. When this gradient is ablated 
by knockdown of gdf6a with gdf6aMO it results in a variety of eye malformations 
ranging from anophthalmia through to coloboma and lens extrusion (Asai-
Coakwell et al. 2007). This is likely due to redundancy; the bmp ligands bmp2b and 
bmp4 are both known to be expressed within the eye along with gdf6a. Of the two, 
bmp2b is the more significant as the optic cups found in dorsalised bmp2b 
morphants are completely ventralised. While  bmp2b morphants are grossly 
dorsalised (C4-C5), they do initially develop normal eye fields which become 
apparent through sectioning. It is worth noting that both gdf6a and bmp2b are 
involved in earlier stages of eye development and these ocular abnormalities may 
be down to the destruction of dorsal ventral patterning during epiboly. When bmp 
expression was inhibited within the developing eye by the ectopic expression of 
smad7 (using the rx3 promoter), the eyes were largely identical by the ten somite 
stage,  though the expression of the dorsal retinal marker tbx5 was down 
regulated(French et al. 2009). 
 
 While ablation of the dorsal-ventral  bmp gradient does lead to large 




identity is up regulated, the retina is dorsalised but microphthalmia/anophthalmia 
or coloboma defects are not induced. A good example of this is coexpression of 
gdf6a and  bmpr1 within the eye, which leads to the expansion of dorsal marker 
genes but no large morphological defects (French et al. 2009).  
 zsmoc1 morphants do have increased bmp signalling activity. Based on the 
known examples of up regulated bmp signalling in the eye, this should result in a 




















3.3.4 Concluding remarks 
 
   
 Designing and validating a novel qualitative assay of dorsalisation has 
enabled the confirmation of whether the zsmoc1 morphant phenotype is truly 
dorsalised. Based on the results obtained in  (Fig. 3.2.4), it is possible to conclude 
that the embryos are not classically dorsalised by smoc1 depletion. The fact that it 
is possible to partially rescue zsmoc1 morphants using hSMOC1 mRNA, 
demonstrates that the disruption to the dorsal ventral marker genes is attributable 
to zsmoc1 depletion (Fig. 3.2.8).  However whole mount immunohistochemistry 
revealed smad signalling was significantly disrupted during gastrulation(Fig 
2.2.16). While the dorsoventral gradient was not affected by smoc1 depletion the 
mesolateral gradient was disrupted. The gradient was extended dorsoventrally. 
This disruption could plausibly inhibit the mesolateral migration of the endoderm 
disrupting epiboly. This would result in defects during neurulation and 
mesolateral thickening and apparent dorsalised phenotype observance in Fig 3.2.1 
but without the corresponding up-regulation of dorsal markers and down-
regulation of ventral markers. This is supported by the phenotype of embryos 
injected with hSMOC1 mRNA which showed both classical dorsalisation and a 
corresponding upregulation of dorsal marker genes and down-regulation of 
ventral marker genes.  Unfortunately given the scope of our results it's impossible 
to tell whether zsmoc-1 actively controls bmp signalling during neurulation 




gastrulation, and defects in the establishment of an effective body plan could 
plausibly account for the defects seen during neurulation and somitogenesis, 
Rather than acting as a simple bmp antagonist, the results all support the principle 
that zsmoc-1 action is conserved with Drosophila Pentagone, whereby zsmoc-1 
controls the shape of the bmp gradient by acting in a feedback loop with bmp 
signalling. 
 While I was unable to replicate the eye defects observed by Abouzeid et al. 
(2011)(Fig 3.2.15), my results did show that BRE activity is significantly reduced 
in the embryonic optic cup of zsmoc1 morphants. Which suggests that bmp 
signaling is inhibited by zsmoc1 in the optic cup. If this is the case then the retina 
of the zebrafish should be dorsalised in zebrafish morphants. Further work needs 
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4.1.1 Traditional genomic editing in zebrafish 
 
 While data on SMOC-1 function has been obtained using morpholino 
knockdown of zsmoc1 there is always the concern that the phenotype is due to 
non-specific off target effects and toxicity (Bedell et al. 2011;Gerety & Wilkinson 
2011). Ideally, the cleanest genomic data is achieved via induced mutation of the 
genes in question. This has historically been difficult in zebrafish (Ekker 2008). 
Traditionally it was achieved in two ways. The first and oldest is high throughput 
mutation analysis (tilling) following chemical mutagenesis. Tilling can identify 
many mutations but it relies on random chance to hit the gene of interest. So it is 
not possible to choose the desired location of your mutations and there is also the 
significant problem of getting second hits which will cause off target effects. It is 
also expensive and time-consuming (Huang et al. 2012). More recently, the 
invention of zinc finger endonucleases (ZFNs) allowed the generation of targeted 
mutations in zebrafish. First discovered in 1996, ZFNs are endonucleases (typically 
the cleavage domain of the restriction enzyme Fok1) bound to a zinc finger DNA 
binding domain, which allows the endonucleases to cleave the target site DNA and 
induce mutations via non-homologous end joining (Kim et al. 1996). ZFNs have 




et al. 2003) and the first zebrafish knockout was produced in 2008 (Ekker 2008). 
However, targeting zinc finger binding domains is not a trivial task. There is no 
simple zinc finger targeting code and the DNA binding activity is highly context 
dependent. Ramirez et al. (2008) showed that even using previously published 
zinc finger DNA binding modules, 79% of the zinc fingers they synthesised using 
context-dependent assembly (CoDA) failed to bind to target DNA. This 
demonstrates that even identical zinc finger arrays known to bind a specific 
sequence can fail to bind to exactly the same sequence when it is located in a 
different genomic region. Since ZFNs have to bind in pairs their failure rate would 
be even higher (Ramirez et al. 2008). Targeting is also highly restricted, depending 
on the synthesis method. Compatible target sites are on average found every 140-
400bp (Blackburn et al. 2013) so there are often genes which have no suitable 
target sites within them (Clark et al. 2011).  In addition ZFNs are proprietary 
technology and therefore expensive. 
 
 Due to the above limitations of ZFN technology, it was decided that a TALEN based 











4.1.2 TALEN proteins 
 
 Recently, a DNA binding protein has been characterised that binds to DNA 
with a simple repeat code. Transcription Activator-Like Effectors (TALEs) are 
proteins that are secreted by Xanthomonas bacteria into their plant hosts to 
control gene expression (Moscou & Bogdanove 2009). They have a highly 
repetitive DNA binding domain made up of multiple repeat subunits called residual 
variable dimers (RVDs; Bogdanove et al. 2010; Fig. 4.1.1 A). These are 33 amino 
acid long sequences that are identical apart from two amino acids, the 12th and 
13th. Crystallography has demonstrated that these two amino acids impart 
binding specificity to the RVD (Deng et al. 2012; Mak et al. 2012). It is the 13th 
residue that directly binds the base via the major groove and the 12th residue 
stabilises the RVD structure. Subunits have now been identified which will bind to 
each base in the genomic code (NI to A, NG to T, HD to C and NH to G) (Moscou & 
Bogdanove 2009; Cong et al. 2012; Boch et al. 2009; Miller et al. 2011). By 
stringing these subunits together, it should theoretically be possible to target any 
conceivable arrangement of base pairs.  
 As with ZFNs, (Kim et al. 1996) it has been demonstrated that you can fuse 
a TALE protein with the catalytic domain of the endonuclease (FokI) and maintain 
cutting activity (Fig. 4.1.1 C,D).  These TALEN constructs have been used to 
generate double stranded breaks in vitro and resultant mutation in vivo (Sander, 
et al. 2011; Cade et al. 2012; Cermak et al. 2011). In reality there are other 











Fig. 4.1.1 TALE and TALEN proteins, their structure and action
(A) A generic TALE, it details the main features of a TALE protein, including nuclear localisation sequences and TALE activator domain. The DNA binding domain is composed of between 8variable dimers (RVDs) which are 32Diagram shows the seven most common RVD subunits (each is named after the variation in the 12and 13th amino acid of the repeat positions, * indicates a missing residue) along with the corresponding base they recognise. Arranged from most to least frequent in nature (et al. 2009) (C) A TALEN protein: The DNA binding domain and nuclear localisation sequences have been retained from the TALE protein but the protein has been truncated andomain and a protein tag have been added.breaks in DNA. The diagram shows that both  TALEN proteins must be close enough together for the 
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 It is possible to fuse the entire FokI DNA cleavage domain with a single  
TALE backbone (Kim et al. 1996). This is rarely done as use of ZFNs showed that 
by separating the catalytic domain between two zinc finger backbones it was 
possible to both increase cleavage efficiency and dramatically reduce off target 
cutting and toxicity (Mani et al. 2005). This is because it increases on site 
specificity as both proteins must bind to induce DSB. Most TALENs are engineered 
as pairs which flank a short spacer region. When they bind to the target sequence 
they are in opposing orientations which brings the FokI domains into close 
proximity inducing DNA cleavage (Fig. 4.1.1 D).  
 The initial studies show great potential. TALENs have far fewer binding 
constraints than ZFNs with the average gene containing hundreds of potential 
target sites (on average a target site is present every 1-3bp;Kim & Kim 2014) . The 
reports of TALEN activity in zebrafish are promising. TALENs have been shown to 
have high cleavage efficiencies of between 20%–76.8% (Moore et al. 2012;Dahlem 
et al. 2012) when compared to ZFNs cleavage efficiencies of 1.1%–3.3%. While 
Chen et al. showed  that on average a given TALEN pair produces 10 times the 
deletions of equivalent  ZFN construct in zebrafish (Chen et al. 2013) with 
comparable or lower toxicity (Moore et al. 2012; Dahlem et al. 2012).  They have 
been shown to have fewer off target effects than ZFNs,  probably due to greater 
specificity. A good example of this is when Dahlem et al. targeted ryr1a-ex6  with a 
TALEN pair which showed 100% cleaved efficiency. The ryr1 target site showed no 
detectable cleavage despite the fact that the target sites only differed by 2bp 




that a single nucleotide miss match can reduce cleavage efficiency from 70-50% to 
just 2% (Zhang et al. 2011).     
 Coupled with the fact that they are open source, and so considerably 
cheaper to produce makes them a far more attractive option than ZFNs.  
 
 
4.1.3 TALEN synthesis strategies 
 
 Given that the average TALE binding domain used is between 10 and 20 
RVDs in length they are highly repetitive (Cong et al. 2012). Virtually all the amino 
acids in RVD's are identical, and even with codon degeneracy they are extremely 
repetitive DNA sequences. However artificially produced TALENs are even more 
repetitive. The reason is twofold, firstly of the known naturally occurring RVDs 
only five are generally used for gene targeting. The HD, NG and NI were clearly the 
most suitable for gene targeting, as they are the most abundant in nature, have the 
strongest binding activity in vivo and show the greatest specificity of any RVD to a 
specific base (C, A and T respectively) (Fig. 4.1.1 B; Cong et al. 2012; Moscou & 
Bogdanove 2009; Boch et al. 2009). It is this last property which is the most 
important as this means that these RVDs can be arranged in a particular order to 
perfectly correspond to the complementary base.  
 However there is no common natural RVD that has a high specificity for G 
bases. NN is common in nature, but does not show specific binding preferences 
between G or A bases. NK has a much greater specificity to G bases but is very rare 




2012; Meckler et al. 2013).  The problem may have been solved, as more recently 
the artificial TALE RVD NH has been engineered which will bind to Guanine and 
shows a much greater binding affinity to DNA than the NK subunit (Miller et al. 
2011; Cong et al. 2012). However, the binding affinity is still not as strong as the 
NN RVD and TALENs using the NN subunit show greater cleavage efficiency 
(Meckler et al. 2013). 
 
 The repetitive nature of the TALE DNA binding domain makes it impossible 
to synthesise by solid-phase DNA synthesis and challenging to clone. To address 
this, novel cloning strategies have been developed by different groups to 
synthesise custom TALE arrays. This is the second reason that TALEN proteins 
have such highly a repetitive DNA sequence. To simplify the cloning process the 
same RVD units are cloned multiple times in different positions(Cermak et al. 
2011; Sander, Cade et al. 2011; Reyon et al. 2013; Briggs et al. 2012). So for 
example the sequence of every NI subunit is identical in a TALEN whether it is the 
1st, 7th or 18th RVD in the binding domain. 
 
  The first strategy developed was Hierarchal ligation. Hierarchical ligation is 
based on traditional cloning of individual RVDs into a standard array of plasmids 
(Fig. 4.1.2 A). This strategy is labour-intensive and requires a minimum of 15 
ligation reactions to make a DNA binding domain 16 RVDs long.  The large number 
of reactions means it easy to make a cloning error which will disrupt synthesis. 
Which is why in the restriction enzyme and ligation (REAL) method a large library 




lengths between one and four RVDs long(Sander, Cade et al. 2011). However this 
still requires a library of at least 296 plasmids (Fig. 4.1.2 A). 
 Golden Gate cloning has been of great utility in TALEN synthesis. It has been 
used to streamline the hierarchical ligation strategy in the REAL method (Sander, 
Cade et al. 2011) where the final ligation reaction can be conducted 
simultaneously. However, it is most heavily used in the Voytas method (Cermak et 
al. 2011). Golden Gate cloning relies on the use of Type II restriction enzymes. 
These enzymes have a specific binding site (usually a non-palindromic six base 
pair sequence) but cut upstream of their binding site to produce five prime over 
hangs which are four base pairs long (Engler et al. 2008). This permits the 
generation of any desired sequence for the overhang in a plasmid simply by 
directing site-directed mutagenesis next to the enzymes’ binding site. The 
advantage of using this method is that it can produce ligation of multiple fragments 
without DNA scars. If the overhangs are too similar mis-ligation can occur. To 
avoid this only non palandromic overhangs are used for complex assemblies 
(Engler et al. 2009). Therefore with a type II restriction enzyme which produces 
only four base pair over hangs, it is possible to specify 12 different sites. This 
allows you to mix multiple plasmids into a single digest with a single restriction 
enzyme and ligate DNA from up to 11 plasmids.  
 
 Of course, each plasmid could also re-ligate to its parent plasmid as the 
original cut site will have complementary overhangs. Golden Gate Technology uses 
two strategies to overcome this problem. The first is to run the reaction through 
multiple cycles of ligation and digestion, typically between 10 and 20 for ligations 
 
involving over 2 fragments. This is because any reverse ligations will result in a 
plasmid which can be redigested. As the reaction continues the proportion of 
original plasmids will decrease 
increases(Cermak et al. 2011
selection. Most of the undesired plasmids can be screened out by antibiotic 








Fig. 4.1.2 The three main approaches for TALEN synthesis
(A)Hierarchal ligation: traditional cloning is used to build up unique scaffolds used in the REAL synthesis of TALENs. (B) Solid phase ligation: ICA 
(Cermak et al. 2011; Sander, Cade et al. 2011;
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as the population of correctly ligated plasmids 
; Sander, Cade et al. 2011). The second strategy is 
). Typically this is either with blue/white 
(Cermak et al. 2011; Sander, Cade et al. 2011)
______________________________________
 
  (C) Golden Gate cloning: As used in the Voytas me
 Reyon et al. 2013; Briggs et al. 2012)
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 The Voytas method uses single RVD plasmids,  so it takes three Golden Gate 
reactions to synthesise a TALEN with a DNA binding domain of over 11 RVDs 
(given that there are only 12 possible none palindromic overhangs). However by 
using tetramers and trimers Golden Gate reactions can generate full-length 
TALENs in a single reaction(Cermak et al. 2011).  
 While the Golden Gate cloning is attractive for small-scale use, it is a labour-
intensive method for producing large numbers of TALENs which  has lead to the 
development of several high throughput methods. These methods rely on solid-
phase reactions. The initial sequence of DNA is immobilised on either a streptavin 
bead (REAL Fast  Ligation-based assemble solid-phase high-throughput (FLASH; 
Reyon et al. 2012; Reyon et al. 2013)  or a DNA chip (Iterative Capped Assembly 
(ICA; Briggs et al. 2012) as the initial seed of ligation, and  the desired RVDs are 
ligated in a linear sequence(Fig. 4.1.2 C). This arrangement leads to easy 
automation; TALEN proteins can be assembled in one go without the need for 
intermediate purification or analysis. As with Golden Gate reactions there is a 
cloning limit to the number of unique non- palandromic overhangs, to sequence a 
TALEN in one reaction FLASH uses a large library of plasmids (800<) which allows 
the ligation of RVD blocks up to 4 subunits long. The large library of plasmids 
increases the time and cost of optimisation but once the system is up and running 
the platform  can produce 96 TALENs in 24 hours for less than $100 (Reyon et al. 
2012). ICA uses a more elegant solution: RVDs are ligated individually but unique 
none palandromic overhangs can be reused as small oligonucleotides can cap 




synthesised this way in just three days. However the process requires specialised 
equipment which would be a considerable investment for  most labs. 
 The Voytas method (Cermak et al. 2011) was chosen as it relies purely on 
the ligation of multiple plasmids in one reaction using Golden Gate cloning. This is 
an advantage as it avoids PCR and the resulting mutations. Once optimised, 
TALENs can be rapidly synthesised in just two weeks (Cermak et al. 2011). While 
these advantages are shared by a solid phase ligation these protocols are 
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Fig 4.2.1 The TALEN binding sites.
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infancy, so it was decided that the TALEN pairs should be designed to mimic the 
natural structure of the TALE protein (Cermak et al. 2011). Though most of these 
criteria have now been shown to have little effect on TALEN activity with the 
exception of preceding the binding site with a thiamine (Doyle et al. 2012). Every 
TALE DNA binding domain begins with a cryptic RVD which specifies thiamine and 
all but one natural TALE target site begins with a thiamine (the exception was 
found by Yu et al. in 2011 and targets a cytosine). While TALENs have been 
designed which ignore this rule and still induce targeted deletions, the cleavage 
efficiency generally seems to be greatly reduced (Sun, Ning 2013; Meckler et al. 
2013). Another critical factor to TALEN cutting efficiency is the size of the spacer 
region. Too long and the FokI domains will be separated and won't be able to 
cleave DNA. Too short and both TALENs will not be able to bind the target site 
simultaneously. To take this into account we designed TALEN binding sites that 
would have a spacer 15 - 22bp (Cermak et al. 2011). Even so this leaves an 
abundance of potential TALEN target sites. To further narrow down our selection 
the following criteria were used. 
 
No TALENs were designed against  the first two exons. 
 
Genes often have multiple initiator codons, and given the unusual 
conservation of the SMOC-1 signal peptide (Fig. 2.2.2) it was a real concern that 






No TALENs were designed against  the final exon. 
 
Any deletions in the final codon would not trigger nonsense mediated decay 
(NMD) and therefore would be unlikely to give nulls. 
 
TALENs pairs were designed to be as close to 21 RVDs as possible. 
 
Longer TALENs have longer target sites so should have greater specificity. This 
should result in fewer off target cleavages and lower toxicity. Given the limitations 
of the Voytas method of Golden Gate cloning, target sites greater than 21 bp 
require additional plasmids. So for utility any pairs longer than this were 
discarded. 
 
Target sites were screened against the zebrafish gene using UCSC genome 
browser to ensure that they were unique. 
 
Although the chances of finding a random match for a randomly generated 
sequence of 16bp is theoretically small, genomes are not randomly assembled. By 
using only unique sequences off target deletions can be avoided. 
 
The NN rather than NK RVD was used to target Guanine basis. 
 
NN has been shown to have both higher binding affinity (Meckler et al. 2013) and 





Only TALEN pairs with a high content of both HD and NN  subunits spread 
evenly in the DNA binding domain were picked. 
 
HD(T) and NN(G-C) have been classified as strong binders. TALEN pairs which 
have less of these RVDs have shown low cleavage activity. To take this into account 
TALEN pairs with a high content of HD and NN spread evenly throughout the DNA 
binding domain, were preferred (Meckler et al. 2013). 
 
TALEN pairs that targeted strongly conserved sequences in exons four and 
nine were picked. 
 
TALEN pairs produce an array of Micro deletions. It was hoped that some would be 
in frame and produce novel zsmoc1 hypomorphs in addition to zsmoc1 nulls. As 
evolutionarily conserved sequences are likely to be more functionally significant 
they were targeted over weakly conserved regions. 
 
 Multiple TALEN backbones have been generated, though variable efficacies 
have been reported in the literature about how effective different TALEN 
backbones are (reported mutation rates range from  as low as 1% to as high as 
70% (Cade et al. 2012; Dahlem et al. 2012)).  I chose to use the paired backbones 
CS2TAL3RR and CS2TAL3DD (Dahlem et al. 2012).  This was for two reasons. 
Firstly they have been shown to induce mutations at a high frequency in vivo. With 




enough to induce phenotypes in the Fo population. Secondly, these backbones have 
been engineered to minimize toxicity (Dahlem et al. 2012; Bedell et al. 2012). This 
has been achieved by  using heterodimeric FokI  domains instead of a 
homodimeric FokI. Originally this technique was pioneered in ZFNs (Miller et al. 
2007). The FokI catalytic domains were mutated at either Q486E/I499L(EI) or 
E490K/I538K(KK). This makes it impossible for ZFN proteins bearing the same 
mutations to dimerise together. However, they can bind to a FokI catalytic domain 
containing the other mutation. If five prime and three prime targeting ZFNs use the 
opposing scaffolds (either EI/KK or KK/EI) then the chance of random off target 
dimerisation is reduced by two thirds (Miller et al. 2007) as homodimers (i.e. EI/EI 
and KK/KK) are catalytically inactive. Subsequently  Doyon et al. (2011) improved 
on the principle by inducing mutations to produce another pair of heterodimeric 
FokI domains, Q486E/I499L/N496D (ELD) and E490K/I538K/H537R (KKR). This 
pair was designed not only to inhibit homodimer formation but also to promote 
heterodimer binding. Which results in increased DNA cleavage activity. This was 
demonstrated both in vitro and in human cells (Doyon et al. 2011). It was the 
Doyon FokI domains utilised in the CS2TAL3RR and CS2TAL3DD scaffolds. As 
predicted the backbones have been shown to have reduced toxicity (Dahlem et al. 








4.2.2 TALEN construction 
 
 With TALEN construction it was vital that the RVDs were correctly 
assembled. TALEN pairs in which a single base pair does not match the target site 
have a five-fold decrease in cleavage efficiency (Zhang et al. 2011). The plasmid kit 
used was the Voytas V1.0 and was obtained from Peter Hohenstein and the Hastie 
lab. Before they were used they were assessed by Sanger sequencing to confirm 
that every plasmid was correctly labeled and free of mutations. 
  Once assembled each plasmid was screened with a restriction digest to 
confirm that cleavage had occurred. Plasmids in the first round of Golden Gate 
cloning were digested with Esp3I which produced fragments of the RVDs. For the 
second round of digestions it was impossible to find good restriction sites located 
near the DNA binding domain so it was necessary to excise the entire TALEN 
construct using NotI and KpnI.  The relevant plasmids maps are located in the 
appendix (Sup. Fig. 4. and Sup. Fig. 5). 
 Each RVD was 99bp long but only contained two amino acids which varied. 
It was the six base pairs that coded these residues were the critical sequences (Fig. 
4.2.3). To identify these sequences automatically we targeted the six base pairs 
upstream. These coded for LQ residues and were unique in the RVDs. The 
chromatogram of the upstream 6bp of these were manually assessed and the order 
annotated. As artificial RVDs are highly repetitive sequencing can only be 
conducted from primers designed to flank the target region (C8F and C8R pFus 
plasmids and TalF and TalSeq for constructs). Sanger sequencing produced reads 
of up to 900 bp. Since the pfus constructs are between 750 and 1050bp long and 
 
are  sequenced in both the forward and reverse direction, it is possible to sequence 
them in their entirety. So for the initial TALEN assembly it was possible to 
ascertain the precise RVD order of the assembled plasmids. For each sequencing 







and TalSeq for constructs). The pfus constructs were short enough to sequence in 
 
 












Fig 4.2.3 Confirmation of the RVD structure after cloning using Sanger sequencing. (A) Table summarizing the forward and reverse sequences of the two variable acids in the four RVDs used in town synthesis along with the invariant sequence of two amino acids (6 bp) upstream of the variable residues. chromatograms for each of the RVDs used in the synthesis of synthetic both the forward the invariant sequence is highlighted in light blue. Chromatograms were taken in APE v4.0. 
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Fig 4.2.4 The results of the first round of Golden Gate cloning to synthesis (A) In the initial round of the cloning for 5'Tal1zsmoc1 was successful and three colonies for the FusA plasmid and three colonies for the FusB plasmid were selected for sequencing. Of the FusA clones only colony 2 was free of cloning errors. No cloning ersequencing data for colony 1 was incomplete so an error could be present in RVD eight Sequencing data for the last repeat plasmid confirming it codes an NG repeatmutations.  
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t it coded an NG repeat  
 
Fig 4.2.6 The results of the first round of Golden Gate cloning 
 (A) In the initial round, cloning of 5'Tal2zsmoc1 was successful and three FusA plasmid and three colonies for the FusB plasmid were selected for sequencing. No cloning errors were detected in FusA Golden Gate reactions though three could be fully verified as free of errors. The sequencing of colony one is incomplete and the first RVD in colony two is incorrect. NG repeat that it is free of mutations. 




forward sequencing for colony 1 failed. Of the FusB clones only colony 
(B) Sequencing data for the last repeat plasmid 
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2zsmoc1 was successful and three 
f the FusB clones both colonies 
(B) Sequencing data for the last repeat plasmid confirming  
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 Those constructs which were correctly assembled and completely 
sequenced were selected for the next round of Golden Gate reactions. In the case 
that more than one construct was fully sequenced and free of errors the colony 
which had the greatest sequencing coverage was picked. So the first TALEN pair 
was made up of 5' pFusA_2 pFusB9_2 (Fig. 4.2.4)  and 3' pFusA_1 pFusB9_2. (Fig. 
4.2.5)  While from the second synthesis plasmids pFusA_3 pFusB9_3 were picked 
for 5' construct (Fig. 4.2.6) and plasmids pFusA_3 pFusB9_2 were picked for 3' 
construct (Fig. 4.2.7). The last repeat (LR) plasmid was also sequenced for both 
constructs, ensuring  they coded for the correct RVD.  
 Once the full TALEN binding domain is synthesised it is between 1800 and 
2000 bp.  Given that each sequencing run was 800 bp at most, it is impossible to 
fully validate the entire binding domain using Sanger sequencing. However, the 
second Golden Gate reaction contains only three plasmids. Therefore it is possible 
to infer the success of the cloning reaction as long as the sequencing read covers 
the 5' end of pFusA and the reverse read crosses the LR RVD into the 3' end of  
pFusB. If the restriction digestion proves that the binding domain of the TALEN 
construct is the correct size (Fig. 4.2.3 B)   then the whole fragment is almost 
certainly intact. As the Voytas method is entirely ligation based mutations are very 
unlikely to have occurred (Cermak et al. 2011). 
 The second round of Golden Gate ligations were successful. The number of 
colonies produced was greater (Data not shown) and every colony sequenced was 







Fig. 4.2.8 The second  Golden Gate cloning reaction for the synthesis of 5'DD and 3'RRTAL1zsmoc1 





    
 
Fig. 4.2.9 The second  Golden Gate cloning reaction for the synthesis of 5'RR and 3'DDTAL2zsmoc1 




4.2.3 In vitro confirmation of TALEN endonuclease activity 
 
To rapidly determine the cleavage efficiency of our TALEN constructs a novel in 
vitro assay was developed (Fig. 4.2.10). Both constructs of the TALEN pairs were 
transcribed using the mMessage mMachine Kits (Ambion) and the RNA was 
translated using the Retic Lysate IVT™ Kit  (Ambion). All successfully translated 
proteins were then mixed along with biotinylated DNA. The DNA has either 
previously been isolated from the target exon or an unrelated exon by PCR 
amplification with biotinylated primers. 
 In a correctly assembled and active TALEN pair both constructs should bind 
to their target sites on the target DNA, bringing their FokI domains close enough 
together to induce double-stranded breaks. The presence of these lighter cleaved 






Fig. 4.2.10 Schematic of in vitro assessment of TALEN pair cleavage strategy using southern blot




-biotin and any biotinylated DNA was detected. If  
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 As TALEN proteins encoded by both pCS2Tal3DD and pCS2Tal3RR are 
tagged (by FLAG and HA tags respectively) it was possible to confirm the 
translation of both TALEN pairs by  sodium dodecyl Polyacrylamide gel 
electrophoresis sulfate (SDS PAGE) followed by Western blotting. After the retic 
lysate reaction had been separated by gel electrophoresis and transferred by 
blotting to PVDF membrane the membrane was probed with anti-HA. This showed 
that both 3'RRTal1zsmoc1 (Fig. 4.2.11 A) and 5'RRTal2zsmoc1 (Fig. 4.2.11 B) 
were both translated to produce single bands. Both of which migrated at a rate 
consistent with their predicted MW (3'RRTal1zsmoc1 103.19kDa, and 
5'RRTal1zsmoc1 118.19 kDa respectively). The membranes were then stripped 
and re-probed with anti-FLAG. Both 5'DDTal1zsmoc1 (Fig. 4.2.11 A) and 
3'DDTal2zsmoc1 (Fig. 4.2.11 B) were translated successfully, as shown by the 
single bands that have migrated in accordance with their predicted MW 
(5'DDTal1zsmoc1 117.16 kDa and 3'DDTal1zsmoc1 117.16 kDa respectively). 
  
 To facilitate greater redundancy a 5'Tal1zsmoc1 and 3'Tal1zsmoc1 were 
both constructed in parallel in the pTAL4 backbone. However, this backbone failed 
to produce a clean translation product for either the 5' or the 3' constructs. Since 
single bands were not detected by Western blot these constructs were not carried 



















Fig. 4.2.11 5'DD and 3'RRTalzsmoc1 constructs are fully translated in vitro for both Tal1 and Tal2.  




 Southern blotting was used to assess the cleavage activity of both TALEN  
pairs. Initially there was no information on which buffers are optimal for TALEN 
activity in vitro. So a selection of commercial buffers which were recommended  
for use for FokI restriction digests were used in conjunction with a mixture of 
5'DDTal1zsmoc1 and 3'RRTal1zsmoc1 (Fig. 4.2.12 A). Under these conditions 
DNA cleavage was observed in the samples that were incubated with the TALEN 
pair and the target DNA. The most pronounced TALEN activity occurred in the 
reaction using Roche buffer A. To ensure that it was the presence of both the 5' and 
3' TALENs that lead to cleavage, a further digest was performed but with 
additional control digests containing either 5' or 3' targeting proteins but not both 
(Fig. 4.2.11 B). Again cleavage was only observed in the sample treated with both 
TALENs in the pair. This confirmed that both TALENs were necessary but not 
sufficient to induce double-stranded breaks in target DNA. 
 The same protocol was repeated for 5'RR Tal2zsmoc1 and 3'DDTal2zsmoc1 






Fig. 4.2.12 Southern blot analysis of the DNA cleavage activity in vitro.
 (A) Shows the effect of different  buffer conditions(NEB buffer 3, NEB buffer 4 and Roche buffer A) on the cleavage activity of 5'DD and 3'RRTal1zsmoc1. Cleavage was detected in both NEB buffer 3 and Roche buffer A. As it was highest in buffer A, all further (B) 5'DD and 3'RRTal1zsmoc1 only cleave DNA when both incubated with the target DNA sequence. No cleavage products were detected with DNA incubated with 5'DD and 3'RRTal2zsmoc1.
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4.2.4 Assessing the endonucleic activity of TALEN pairs 1 and 2 on zsmoc1 in vivo 
 
 Once the TALEN pairs were tested in vitro it was necessary to determine 
the toxicity of TALEN coding mRNA for zebrafish. Since the aim was to generate 
the highest cleavage rate possible it was necessary to establish the highest dosage 
to obtain this, while avoiding unacceptably high mortality. The initial work was 
conducted using the 5'DD and 3'RRTal1zsmoc1 pair as this pair had been shown to 
work in vitro (Fig. 4.2.13 A and B). Zebrafish embryos were scored on a three 
point scale quantifying the number of fish which appeared phenotypically normal, 
malformed or dead at 24 hpf. All embryos injected showed acceptable levels of 
mortality and morbidity (<50%). However, there may have been an increase in 
deformed embryos when injected with 2000 ng/μl. These levels of toxicity are 
broadly consistent with those reported in the literature for use of TALEN mRNA 
and superior to those expected from the use of zinc fingers (Cade et al. 2012). As 
2000 ng/μl of TALEN mRNA was the highest concentration that could be produced, 
and the morbidity was acceptable even at this dosage, it was decided that 
wherever possible the maximum concentration of TALEN mRNA should be 






 Even the most effective TALEN pairs would be expected to produce a 
mosaic animal with a 
sequencing would be ineffective. 
(Moore et al. 2012; Cade et al. 2012)
cloned into plasmids and a large number of clon
multiple clones must be sequenced to estimate cleavage efficiency(which can be as 
Fig 4.2.13 The effect of mRNA co
 The percentage of dead and deformed embryos at a given concentration of either DD and RRTal1zsmoc1 TALEN pair 24 hpf. TALEN pairs injected at 2000 ng/
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low as 2%; Cade et al. 2012) this process can be expensive and time consuming 
when validating large numbers of TALEN pairs. However, next-generation 
sequencing presents the opportunity to process hundreds of TALEN pairs 
simultaneously.  
 It can do this because Next Generation sequencing involves using a 
semiconductor. Each chip is covered in millions of wells containing a single bead. 
As long as the DNA sample is sufficiently diluted, only a single DNA fragment will 
bind to each bead. This is then amplified to produce identical copies. Each bead 
produces a single independent read, which means an Ion Torrent chip can be used 
to produce over 80,000 independent reads equivalent to the sequence produced 
by a single colony in traditional clonal analysis(Merriman et al. 2012).  
 Next Generation sequencing is most commonly used to process a large 
number of unique reads. However, to test the TALENs cleavage efficiency we only 
wanted to capture the specific target site. To this end, two sets of primers were 
designed to flank both the target sites of both TALEN pairs (1 and 2). One of the 
disadvantages of current generations of Ion Torrent sequencing is that only 
relatively short fragments can be sequenced.  To account for this primer pairs 
were designed to be at most 100 bp apart. At least one of the flanking primers was 
designed to target intronic DNA so the samples could only be amplified from gDNA. 
gDNA was selected over cDNA because mutated transcripts of mRNA could be lost 
to nonsense-mediated decay (NMD) or alternative splicing(Lewis et al. 2003; 






 Two types of Ion Torrent primers are commonly use
primer, made up of invariant sequence flanking a 10 bp unique barcode sequence 
followed by an invariant GAT sequence. The barcode can be recogni
software which then can sort every read with the corresponding barcode. The 
invariant GAT that follows the barcode helps the software recognize each barcode 
sequence. The other type of primer is the base primer. This primer contains no 
barcode, only the target sequence and 
invariant sequence is used 
Fig 4.2.14 Isolating the target site by PCR.
 Primers were designed to flank (Teal) between the two TALEN binding sites (red). To ensure that only genomic DNA was amplified at least one primer
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Fig 4.2.15 Ion Torrent Primer sequence designed for 
 The structure of the primers engineered for Ion Torrent sequencing. The target specific base pairs are highlighted in green (forward primers) and bluehighlighted are in black.  




 (reverse primers ) while invariant sequence is 
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 the forward and reverse orientation.
 
 





 As Ion Torrent sequencing produces many orders of magnitude more 
sequencing data than traditional clonal analysis it was important to establish 
which were real sequence variants and which sequencing artifacts. To do this we 
came up with a list of several objective criteria to filter out artifacts. The first step 
was to quantify the total number of unique deletions detected. Although it is 
possible for TALEN pair injection to result in other types of mutations, by far the 
most common mutation arising from the injection of a single TALEN pair are 
deletions resulting from an error in NHEJ (Mashimo et al. 2013;Kim & Kim 2014). 
Insertions and missense mutations were considered spurious.   
 Next we further subdivided between those deletions located within the 
spacer region of the TALEN pairs targeting site and those located outside the 
TALEN binding site. Sequencing artifacts should be randomly distributed across 
the amplified region while legitimate mutations, caused by the combined activity 
of Fok1 domains, should be confined primarily to the spacer region.  
 The deletions were then screened by abundance, legitimate mutations were 
only considered for further analysis if they were present in at least 100 reads.












pair of TALEN mRNAs or antisense TALEN mRNA. 







 None of the tests would distinguish errors introduced during the PCR 
amplification of the genomic DNA; to filter these PCR artifacts each sample was 
amplified four times by PCR. Twice in the forwards direction and twice in the 
reverse. A real deletion should be present in both forward and reverse directions 
in roughly balanced ratios. Only deletions present in ratios between 1:3 - 3:1 were 
selected. Not only did this help screen out PCR artifacts (as the forward and 
reverse reads are amplified independently) but it is also a powerful tool to 
eliminate sequencing artifacts. The second test is to repeat the experiment using a 
separate barcode to act as a technical replicate. Real deletions should be present in 
both populations. 
 Initially as a pilot study for the Ion Torrent process, eight embryos were 
injected with 5'DD and  3'RRTal1zsmoc1 for Ion Torrent sequencing (Fig. 4.2.17 
A). The first sequencing run was successful, but showed no enrichment of 
deletions in 5'DD and  3'RRTal1zsmoc1 injected embryos when compared to those 
injected with antisense 3'RRTal1zsmoc1 mRNA. It was noticed that several 
sequencing artifacts were identified. Ion Torrent sequencing showed that there 
were inserted thiamine residues in the sequence, although these bases weren't 
detected in Sanger sequencing of the PCR product. To eliminate these artifacts the 
screening procedure was modified to include a reverse read, and in all future 












Fig.  4.2.17 No novel mutations were found in TALEN pairs  Ion Torrent sequencing sequencing errors sequences were assessed on a number of characteristics. Firstly whether they were deletions. If these deletions were located within the target site. If more than 100 reads(>0.005%) were identical. If the read. And if these mutations appeared in both barcoded samples. sequencing of eight embryos injected with either 800 or 2000 ng/µl of 5'DD and 3'RRTal1zsmoc1 as compared to 8 embryos injected with 2000 ng/µl of antisense control RNA. results of an  Ion Torrent sequencin20 embryos 2000 ng/µl 5'DD and 3'RRTal1zsmoc1 and 20 embryos 2000 ng/µl of antisense control RNA and the other (embryos 2000 ng/µl of antisense control RNA. separate barcodes) detected in any of the sequencing runs.
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 Since the initial experiment was unsuccessful, the injection of 5'DD and  
3'RRTal1zsmoc1 mRNA was repeated. This time the number of embryos was 
increased to 20. Additionally, 20 embryos were injected with 5'RR and  
3'DDTal2zsmoc1 and processed simultaneously despite an absence cutting activity 
in vitro (Fig. 4.2.14). Both batches of embryos were compared to 20 embryos 
injected with antisense3'RRTal1zsmoc1 mRNA (Fig. 4.2.17 B,C).    
 There was no enrichment in the deletions detected in any of the embryos 
injected with TALEN pairs, indicating that neither TALEN pair has in vivo 
endonuclease activity.  
 Of the 241 mutations identified the screening criteria managed to eliminate 
over 98% as PCR artifacts.  
 
 Although the Ion Torrent sequencing shows that neither TALEN construct 
has cleavage activity in vivo, it is a new method of assessing endonuclease activity. 
The possibility remains that the method is ineffective. To assess this traditional 
clonal analysis was performed (Fig. 4.2.18 A and B)   on the PCR product 
amplified in the first deep sequencing experiment (Fig. 4.2.17 A). The fragments 
were TA cloned into the pGMT easy plasmid and DH5 alpha E. coli were 
transformed. Of the 96 colonies picked for each sample at least 80 were 
successfully sequenced. The reads were first screened on whether they contained 
any deletions at all. Then they were screened on whether the mutations were 
present in both the forward and reverse reads for that colony. No deletions were 










Fig 4.2.18 Clonally analysis of the cleavage activity of TALEN Treatment. The target exon was amplified usingproduct was cloned into the pGMT easy vector awere picked and sequenced using representative screen capture of an alignment of zsmoc1 exon8 the sequence of 13 clones from the gDNA of embryos injected 3'RRTal1zsmoc1. (B)(C) The results of an independent injection of eight embryos with 5'DD and 3'RR performed byWitold Rybski. In this series of experiments all the steps were performed by Witold Rybski, including mRNA synthesis, and cloning. 
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 To test whether there was some unidentified effect caused by my 
handling of the mRNA or processing of the samples, Witold Rybski repeated the 
entire procedure for both TALEN pairs from transcription through to clonal 
analysis. No deletions were present in the forwards or reverse reads obtained  
(Fig. 4.2.18 C) confirming that neither TALEN has in vivo DNA cleavage activity in 
zebrafish. 
 
 To ascertain whether the failure of either TALEN pair to induce any 
deletions in vivo was caused by the failure mRNA translation SDS PAGE and 
Western blot was performed on 30 embryos injected with either 5'DD and 
3'RRTal1zsmoc1 or 5'RR and 3'DDTal2zsmoc1 against either the HA tag present 
on the RR vector or the FLAG tag present on the DD vector (Fig. 4.2.19). The 
Western blot confirmed that both TALEN constructs had been translated correctly 
as protein bands were detected at the predicted molecular weights. There was an 
unexplained band present in both the in vitro translation and the 5'RR and 
3'DDTal2zsmoc1 injected embryos which had an estimated molecular weight 













Fig.  4.2.19 Both TALEN constructs are expressed in vivo. 






4.3  Discussion 
 
 4.3.1 Neither TALEN pair produced cleavage in vitro. 
 
 The TALEN pairs synthesised showed no activity in vivo despite 5'DD and 
3'RRTal1zsmoc1 showing promising activity in vitro. While TALEN  pairs usually 
show some cleavage activity it has been estimated that one in three TALENs fail to 
show any cleavage in their target sites (Cade et al. 2012). It is puzzling that the 
TALEN pair 1 showed cleavage in vitro but not in vivo, but there are several 
possible explanations for this. The first is that the TALENs were not correctly 
assembled. However, sequencing of both TALEN pairs confirmed that they were 
assembled correctly and free of mutations (Fig.  4.2.4; Fig.  4.2.5; Fig.  4.2.6; Fig.  
4.2.7; Fig.  4.2.8; Fig.  4.2.9). A ligation based strategy was used, so spontaneous 
mutations are unlikely. 5'DD and 3'RRTal1zsmoc1 showed in vitro cutting activity 
which can only occur if they were correctly assembled (Fig.  4.2.12 A, B).  Whilst it 
cannot be ruled out that there was an undetected defect in either 5'RR or 
3'DDTal2zsmoc1, it seems unlikely given cleavage activity,  the sequencing data 
and size of the fragments produced by restriction digests.  
 The second possibility that can be ruled out is that the TALEN mRNA is 




of every TALEN construct was confirmed by western blot (Fig. 4.2.11; Fig. 
4.2.19). The molecular weights of the detected protein bands also matched those 
predicted by sequence composition further supporting that the constructs were 
assembled correctly.  
 The final possibility that has been ruled out is that the gDNA sequence of 
the target site in the zebrafish injected with TALEN mRNA, did not match the 
sequence that the TALEN pairs were designed to target. A single mismatched base 
pair within the target site has been shown to lead to a fivefold reduction in 
cleavage activity for mammalian in cell lines (Zhang et al. 2011). In live zebrafish a 
2 bp polymorphism in the epas1b.2 target site led to a decrease from cleavage 
efficiencies of 76% and 56% to 2% (Cade et al. 2012). This is conclusively ruled 
out in this case because when assessing cleavage in vivo target sites both TALEN 
pairs were either sequenced by Ion Torrent or Sanger sequencing to identify 
deletions, and the sequences matched those used to design the TALEN pairs (Fig.  
4.2.17). 
 It is therefore likely that the lack of mutations is caused by some unknown 
context dependent effect. While the TALE code is often presented as a direct RVD 
to base code it is worth noting that in nature there is no single TALE target site 
which directly corresponds to this code (Boch et al. 2009; Cong et al. 2012). 
Although TALE technology is a new technology it has already been shown that RVD 
order and composition do affect TALEN activity (Christian et al. 2012 ; Meckler et 
al. 2013).  
 DNA methylation at the target site is also known to significantly inhibit 




binding specificity to methylated cytosine, although proprietary subunits do exist 
that have specificity for methylated cytosine base pairs. The methylation status of 
the target site is currently unknown. However, it is unlikely that methylation is the 
causative factor because the target site is located in the centre of the zsmoc1 gene, 
and faraway from the known promoter regions of any known genes (Brenet et al. 
2011).  
 There are also several factors which have not been tested but are plausible 
candidates for modifying TALEN activity. These include transcriptional state, 
binding partner and DNA confirmation. 
 Another possibility is that the TALEN pair is functional in vivo but that it 
has a low cutting efficacy. In the in vitro system when the TALEN pair cuts the 
target DNA there is no possibility of repair and homologous recombination. 
However, when DNA is cleaved in vivo it is repaired. In fact, the ability of TALENs 
to induce DNA repair is vital to their efficacy (Anon 2011; Bogdanove & Voytas 
2011). Is been shown that lesions in the DNA caused by endonucleases lead to 
induction of none homologous end joining (NHEJ), which can lead to errors 
resulting in micro deletions (Gong et al. 2005). However, not all NHEJ is equally 
error prone. In fact the classical NHEJ events are remarkably good at resolving the 
kind of double-stranded DNA breaks resulting from endonuclease activity. These 
breaks all lead to compatible over hangs which require no further processing 
before they can be resolved. It has been demonstrated that most of the cuts 
induced by endonucleases are resolved without any errors (Mladenov & Iliakis 
2011). If the targeted TALEN pair cut efficiently enough, it can overwhelm the 




repair and cleavage which can only be resolved by mutation. If this is true, then it 
should be possible to induce mutations by inhibiting cNHEJ and forcing the 
organism to use a more error prone pathway. This has now been achieved in cell 
lines (Certo et al. 2012) and in rats (Hwang et al. 2013) by co-expressing a TALEN 
pair with Exonuclease 1(Exo1). Exo1 can digest the overhangs left when the 
TALENs cleave the DNA, which means they are no longer homologous, forcing the 
cell to use the alternative NHEJ pathways resulting in larger and more frequent 
deletions (Certo et al. 2012). It would be interesting to see if exo1 expression leads 
to an up-regulation in TALEN efficacy in my constructs. It would both suggest a 
possible reason for the discrepancy between the in vitro and in vivo assays and be 
a novel finding; as yet there have been no reports of exo1 co-expression in 
zebrafish to increase TALEN efficiency. 
 
 
4.3.2 Evaluating the novel assays developed to assess TALEN activity 
 
 While the in vitro cleavage assay did work in principle and cleavage was 
detected for the co-injections of 5'DD and 3'RRTal1zsmoc1. This did not translate 
into in vivo activity. It is questionable whether it is worth pursuing this strategy in 
the future as yeast reporter systems (Sun, Ning 2013) have now been developed 
which can rapidly assess TALEN cleavage activity in vivo. The results have clearly 
shown that TALEN pair’s high cleavage efficiencies in yeast are highly likely to 




zebrafish, Drosophila etc). It is likely that in vivo screens, even between distantly 
related organisms, better reflect the conditions in the desired target species.  
 The Ion Torrent approach developed holds more promise. Modern 
manufacturing processes can produce hundreds of TALEN pairs a day which 
enables their use in large-scale experiments. For example TALEN pairs have been 
produced targeting every known gene and several hundred micro RNAs in the 
human genome (Kim et al. 2013). These pairs still need to be validated to confirm 
that they induce deletions in vivo. Clonal analysis is obviously less than ideal.  Even 
if CRISPR technology completely supplants TALEN technology the need to validate 
large cohorts for deletions remains the same. The Ion Torrent sequencing 
approach has the advantage of being able to process multiple TALEN pairs 
simultaneously. Using the 96 barcodes validated by life sciences it would be easy to 
process 24 TALEN pairs simultaneously, and it is easily possible to generate 
custom barcodes as needed (10bp mean there are theoretically 410 or 1048576 
combinations, though not all sequences are usable). By using a more advanced Ion 
Torrent sequencer, such as the Ion proton there would be no need to even sacrifice 
depth.  
 Neither TALEN pair actually worked in vivo so it has not been proved that 
Ion Torrent sequencing can detect TALE induced cleavages. However, the work 
undertaken is a good first step. The criteria for filtering out PCR and sequencing 
artifacts worked well (Fig. 4.2.17).   The clonal analysis confirmed the Ion Torrent 
results (Fig. 4.2.18). Given more time it would be worth repeating the 
experiments with TALENs of known efficacy to establish if deletions are 





4.3.3 Alternatives to a TALEN based strategy 
 
 Even though the TALENs based strategy has been unsuccessful it is unlikely 
that switching to a ZFN  based strategy would be successful. Studies comparing 
ZFN activity to TALENs have consistently shown them to be inferior to TALENs. 
They have fewer target sites, (Sander et al. 2011) show more off target effects 
(Mussolino et al. 2014; Ding et al. 2013) and lower cleavage efficiencies (Cade et al. 
2012; Chen et al. 2013). Until recently ZFN and TALEN technology have been the 
only options available for forward genetics in zebrafish, but towards the end of this 
project Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR) 
technology has been making waves in the field of programmable nucleases (Hwang 
et al. 2013). CRISPRs function in a completely different way to both TALENs and 
ZFNs. The proteins form part of the adaptive immune system of bacteria and 
archaea (Jinek et al. 2012; Wiedenheft et al. 2012). When the microbe is infected 
by plasmids or phages the DNA can be incorporated into specific spacer regions of 
these organisms genome. The sequence is then transcribed and processed, forming 
short (~20bp) specialised CRISPR RNAs (crRNAs). It is these crRNAs that target 
the DNA cleavage. The nuclease is coded for by Cas proteins (typically Cas9 for 
genomic engineering) which bind to the crRNAs. These allow the Cas proteins to 
recognise the target site and induce double strand DNA breaks (Fig. 4.3.1; 
Blackburn et al. 2013).  
 
_______________________________________________________________________________________________
 Recently it became possible to engineer artificial crRNAs, which can be used 
to target the desired DNA sequence. The principal advantage of the system is its 
simplicity. Cas9 mRNA can be directly transcribed from a standard plasmid while 
the crRNA mRNA can be synthesised by ordering two overlapping PCR primers 
which can then be cloned into a
already been generated in many model organ
al. 2013; Chang et al. 2013





 guide RNA expression vector.
isms including zebrafish 
; Hruscha et al. 2013; Ota et al. 2014
Fig 4.3.1 A schematic representation of a type II CRISPR system. 
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published (publication leads to bias for successful mutations) CRISPR cleavage 
activity seems to be much higher than that of most TALEN or ZFN pairs with 
cleavage efficiencies generally in the region of 75–90% (Jao et al. 2013). This 
activity is often high enough to produce biallelic mutations with high enough 
frequency to induce F0 phenotypes. It has even been demonstrated that CRISPRs 
can produce multiple targeted deletions in both mice and zebrafish in one 
generation (Ota et al. 2014; Wang et al. 2013). Jao et al. managed to knock down 
tyr, golden, mitfa, and ddx19 along with a GFP reporter and showed that a 
combined corresponding phenotype of four of the mutants was observed in 
individual F0 fish (Jao et al. 2013). This opens the way to much faster experiments 
on combinational knockouts. In fact, the CRISPR system is well-suited to multiple 
knockouts; its modular nature allows injection of one set of CAS9 mRNA along with 
multiple short targeting RNAs. 
 There are downsides to CRISPR technology. While the PAM is 20bp long 
CRISPRs have been shown to tolerate up to 5 bp miss matches in vivo (Fu et al. 
2013), so the actual targeting domain is short (14bp). This means the chance of off 
target effects is comparatively high (Wiedenheft et al. 2012). This is compounded 
by the fact that because the nuclease is within the Cas protein it's impossible to 
separate the nuclease domain and use the CRISPRs in pairs as you can with both 
TALEN and ZFN technology. Additionally, there is a requirement that the target 
site be preceded by a protospacer adjacent motif (PAM) sequence which means 
genes have fewer acceptable target sites than a TALEN pair (Blackburn et al. 
2013). Mutations induced by CRISPR tend to be much less diverse than those 




Which means that once a mutation has been induced it cannot be re-mutated. This 
is a double-edged sword. If the aim is to produce consistent Fo phenotypes it is 
desirable. However, if you want to obtain an extensive allelic series it is 
detrimental. These problems may be being close to being resolved as recently a 
novel strategy using paired CRISPR nucleases has been reported (Ran et al. 2013). 
Ran et al. used two mutated Cas backbones (Cas9n and Cas9H840A)  that induced 
a  single strand DNA  nick though on different strands. This wouldn't normally lead 
to deletions but by using PAMs that target sites close enough together the induced 
single stranded nicks that can form double stranded breaks. They achieved 
cleavage efficiencies of greater than 80% in mice, with a 50-1500  fold reduction in 
off target cleavage (Ran et al. 2013).  
 Obviously the outlook for CRISPR technology is incredibly positive and had 














4.3.4 Concluding remarks  
 
 
 The majority of the aims of this chapter were successfully completed. The 
TALEN pair were successfully designed, constructed and validated. A novel way of 
assessing TALEN cleavage efficiency in vitro was developed and a promising new 
strategy for assessing multiple TALEN pairs was developed.  
 
 It is unfortunate that neither TALEN pair produced heritable deletions in 
the zebrafish. Every effort was taken to verify that they were correctly constructed, 
but it will probably never be established why the TALEN pairs synthesised do not 
work in vivo. A zsmoc1 null zebrafish is still highly desirable to confirm the results 
of the morpholino experiments. It is possible that CRISPR technology could be used 

























5.1 Future work 
 
 
5.1.1 Generating a zsmoc1-/- zebrafish lines 
 
 Despite the fact that every effort was made to obtain a control for off target 
effects and morpholino toxicology the availability of efficient targeted 
endonucleases has further demonstrated that most morphant phenotypes are 
often unreproducible.  A good example of this is the recent work of van Impel et al.  
on the development of the lymphatic system in zebrafish. They generated 
knockout zebrafish lines for four genes (sox18, nr2f1a and prox1a/b) all of which 
had published lymphatic morphant phenotypes. Yet every single line failed to 
phenocopy the zebrafish morphants, and none of them had a lymphatic phenotype 
(van Impel et al. 2014). Even the validity of mRNA rescue has been called into 
question. Whilst it clearly demonstrates that at least part of the phenotype is 
attributable to the absence of the rescued gene it does not rule out off target effects 
(Schulte-Merker & Stainier 2014), which is particularly troubling given the partial 
nature of the rescue of zsmoc1 morphants with hSMOC1 mRNA (Chapter 3 3.2.7).  
 With this in mind it becomes very important to confirm these results using 
reverse genetics. Targeted endonucleases too can bind to off target sites and 




appreciably less toxic than morpholinos. Even in the cases when they do generate 
off target deletions within functional genomic regions it is possible to segregate 
away off target mutations by out crossing the zebrafish line. Usually this can be 
achieved within two or three generations (Schulte-Merker & Stainier 2014).  
 The efforts made to address this issue and establish zsmoc1 knockout lines 
are detailed in chapter 4. Unfortunately these efforts were unsuccessful. Whilst 
many groups have reported successful use of TALEN pairs (Moore et al. 2012; Cade 
et al. 2012; Sander et al. 2011) it is clear that TALEN targeting is not as simple as it 
was first thought to be (Chapter 4 4.3.1). Whilst it may be possible to generate 
TALEN pairs successfully to target the zsmoc1 locus, with the availability of 
CRISPRs it is clear that technology has already moved on.  CRISPR technology 
shares almost all of the advantages of TALEN technology, and it appears to be 
superior in a number of critical ways.  
 CRISPRs have been reported to have lower failure rates and higher cleavage 
efficiencies (Jao et al. 2013; Ota et al. 2014; Wang et al. 2013). The extent of off 
target effects remain to be fully analysed. The two platforms appear to have 
comparably low toxicities.  CRISPRs often have high enough cleavage efficiencies 
to generate phenotypes in the F0 generation. When this is the case they can be used 
in the same way as MO,  even with the use of multiple CRISPRs (Jao et al. 2013). 
Coupled with the fact that CRISPRs are considerably easier to synthesise (it takes 
just one week, requires just two plasmids and it is possible to sequence the final 
construct and conclusively eliminate any mutations)  (Blackburn et al. 2013 ; Mali 
et al. 2013). It becomes obvious that CRISPR should be the preferred platform for 




 Of course a knock out line is not only useful for verifying the MO phenotype 
it would also be a valuable model system to study the action of zsmoc1, particularly 
any effects that occur later in zebrafish development. This is because both MOs and 
mRNA become less active over the course of development and are inactive by 5 dpf 
(Nasevicius & Ekker 2000; Skromne & Prince 2008).  
 
 5.1.2 Investigate whether zsmoc-1 is acting on any other signalling pathways 
  
 Whilst the link between smoc1 and BMP signalling is now well established 
there remains the question of whether zsmoc-1 interacts with any upstream 
zebrafish pathways. There are several plausible candidates, although MAPK 
signalling is the only candidate with evidence supporting a link with bmp 
signalling. Thomas et al. demonstrated that while xsmoc1 mRNA could rescue 
constitutively active xbmpr1 in animal caps they could not rescue the phenotype of 
cell lines with linker mutated (LM)-p-smad1 (Thomas et al. 2009). As LM- smad1 is 
auto-phosphorylated at a residue under the control of MAPK signalling they 
interpreted the result is demonstrating smoc1 acted via the MAPK pathway 
(Thomas et al. 2009), and went on to show that  xsmoc1 morphants displayed 
significantly increased levels of p-erk. Consistent with this model, excess Smoc-1 
has been shown to reduce Smad signalling and increased p-Erk levels in rat tissue 




 Map kinase signalling is involved with both the establishment of the dorsal 
ventral axis in zebrafish. fgf8 forms a dorsal gradient, and its overexpression 
suppresses bmp signalling leading to a dorsalised phenotype (Fürthauer et al. 
2004). Conversely inhibition of Mapk cascade by overexpressing the Mapk 
pathway phosphatase mlp3 leads to the expansion of the expression domains of 
both bmp7 and bmp2b expression ventralising embryos (Tsang et al. 2004). Fgf 
signalling also has an established role in vertebrate eye development, including the 
dorsal ventral patterning of the zebrafish retina (Adler & Canto-Soler 2007). 
 Alternatively the results in both Thomas et al. and  Dreieicher et al. can also 
be explained if smoc-1 acts via the non-canonical bmp pathway (Hu et al. 2004; 
Hartung et al. 2006), which is smad-independent and involves signalling via the 
MAPK pathway. 
 While there is no evidence for effects on either wnt and shh signalling both 
are key players in vertebrate eye development and plausible candidates for smoc-1 
action (Adler & Canto-Soler 2007). 
 The live imaging techniques developed in this thesis could easily be used to 
carry out pilot work on establishing which, if any of the signalling pathways are 
linked to z=smoc-1. Zebrafish transgenic reporter lines are available for both mapk 
(dusp6; Molina et al. 2007) wnt (Tcf/Lef; Shimizu et al. 2012) and shh signalling 
(TOP; Dorsky et al. 2002). All of which express gfp in the optic vesicle and/or 







5.1.3 Establish the protien localisation of zsmoc1 
 
 While RNA in situ hybridizations of zsmoc1 have shown that smoc1 
transcript is present in the zebrafish eye it has yet to be established whether these 
transcripts were actually translated. Several attempts were made to validate anti-
smoc1 antibodies unfortunately all showed significant non specific 
banding/staining zebrafish(data not shown). Had there been sufficient time a GFP 
tagged smoc-1 could have been engineered. Not only would a smoc1 reporter line 
allow the  dynamic visulisation of the localisation of smoc1 through development, 
it  would also provide further evidence that morpholino treatment is actually 
reducing the levels of translated protien. 
 
 
5.1.4 Investigate the link between zsmoc-1  action, bmp signalling and the glypicans 
 
 While my results support a model of the relationship between zsmoc-1 and 
bmp signalling that mirrors that of Pentagone and Dpp. more work needs to be 
done to confirm this theory. The best way to establish this would be to develop a 
model system to visualize the gradients in real-time: a system akin to the imaginal 
disk of the Drosophila wing which has been used to great effect to probe the 
mechanisms of control of Dpp signaling (Vuilleumier et al. 2010; Hamaratoglu et al. 




ideally suited to being the vertebrate systems of choice for the real-time imaging of 
signalling gradients.  
 Our work shows two potential p-smad gradients which could be further 
developed into the system. The first potential model is the ventral-dorsal p-smad 
gradient which I have demonstrated is regulated by smoc-1 (3.2.4 and 3.2.8). This 
developmental stage presents a valuable opportunity to test the prediction that 
zsmoc-1 action is dependent on the presence of at least one Glypican. This is 
because the knypek is already known to be expressed at the same time and 
involved in controlling dorsal migration in convergence(Topczewski et al. 2001). 
Coupled with the fact that both its mutant and morphant phenotypes are very 
similar to those of the zsmoc1 morphants is certainly suggestive of a link. However, 
there are obstacles to using this system. My main objection is that current 
generations of fluorescent reporter genes do not generate detectable levels of GFP 
this early in signalling development (Molina et al. 2007; Collery & Link 2011). 
 
 Perhaps a better system would be to further investigate the dorsal ventral 
psmad gradient found in the zebrafish retina. Whilst it's unclear which (if any ) of 
the six vertebrate glypicans are expressed in the zebrafish retina during dorsal 
ventral retina patterning, reporters for all the main signalling pathways show 
detectable levels of expression in the OV (Molina et al. 2007; Shimizu et al. 2012; 
Collery & Link 2011; Dorsky et al. 2002). What's more, given the severe ocular 
abnormalities of OAS the precise function of zsmoc-1 in eye development is of 
particular interest. The first step to establishing this system would be to confirm 




dorsal retina. The easiest way to establish this is with the use of situ hybridisation 
to measure the extent of the expression domains of known retinal fate marker 
genes (e.g. bambi, tbx5 and vax2; French et al. 2009). 
 Both gene knockouts and MO knockdowns would result in the universal 
down-regulation of the target gene, which in the case of zsmoc1 leads to severe 
embryonic defects which severely affect the eye field. To combat this we used 
lower doses of zsmoc1tMO. A more elegant solution would be tissue-specific 
knockouts. CRISPR technology now makes it far easier to develop transgenic 
zebrafish lines. It is not only easier to create knockouts of choice genes but also to 
rescue those knockouts with targeted insertion of an identical gene flanked by 
LoxP sites (Hwang et al. 2013; Wilkinson & Wiedenheft 2014). Any gene flanked by 
LoxP can then be knocked down in the OV by crossing the LoxP line with a tissue 
specific CRE line (e.g. In this case tg(rx3:cre)). Tissue specific up-regulation can be 
attained by using transgenic lines that ectopically express the gene of interest 
within the OV (e.g. Tg(rx3:smad7); French et al. 2009). 
 There are a number of unresolved issues in the general mechanics of 
signalling gradients formation and maintenance and smoc-1's mode of action 
 which this system could address, but to my mind the most pressing is the role of 
endocytosis/transcytosis in great formation. Currently this work is almost entirely 
based on studies conducted in Drosophila (Akiyama et al. 2008; Belenkaya et al. 
2004; Schwank et al. 2011). However, as the existence of multiple models of 
gradient formation (e.g. RET and RED) shows the situation is less than clear even 
in Drosophila, and almost no work has been done on real-time quantification of 








 By definition every Ph.D. thesis must contribute novel knowledge to its  
field of study. My Ph.D. is no exception. To finish I will summarise the main 
contributions I have made in ascertaining smoc-1's role in embryonic development 
while conducting this thesis. 
 
 
5.2.1 Corrected the zebrafish locus of the zsmoc1 
 
 The first significant result detailed in chapter 2 was the correction of the 
miss annotated zsmoc1 sequence. I not only proved that the two zsmoc1 entries 
recorded in UCSC genome browser are actually part of a single gene. I also showed 
that the zsmoc1 was missing several exons and both the 5' and 3' ends of the gene. 
I went on to isolate the signal peptide sequence through five prime RACE. Now that 
the actual sequence of zsmoc1 has been established it should be considerably 
easier for other researchers to conduct studies on zsmoc-1's function using 




5.2.2 Established novel assays of cleavage efficiencies of targeted in endonucleases  
 
 The second main contribution was in chapter 4 with the development of 
two new assays to assess cleavage efficiency of TALEN   pairs. With the advent of 
TALEN and CRISPR technology targeted endonucleases are going to become 
increasingly central to modern biology: one which allows the assessment of in 
vitro cleavage activity using southern blotting and the other using Ion Torrent 
sequencing to quantify the function in vivo. Of the two the in vivo test is potentially 
more useful. Enzymes with high in vitro cleavage activity do not seem to reflect in 
vivo activity, and since the technique was developed yeast hybrid cleavage assays 
have been shown to make more accurate predictions of in vivo cleavage activity. 
 
 
5.2.3 Provided the first functional work supporting a model where smoc-1 acts as a regulator of gradient shape 
 
 The third and my most central contribution to the field of developmental 
biology is the functional work on zsmoc-1. Not only is this the first in-depth 
investigation into the functional role of smoc-1 in zebrafish but I'm the first to 
implicate smoc-1 in the regulation of the convergence movement of the 
gastrulation zebrafish embryo through the regulation of the lateral but not  sagittal 




inconsistent with those obtained by Abouzeid et al.  I have observed an eye 
phenotype in zsmoc1 morphants (3.2.15). Though the zebrafish did not display 
microphthalmia or anophthalmia they did have significantly regulated BRE 
expression in the dorsal retina. This would likely result in defects in retinal 
patterning (Asai-Coakwell et al. 2007; Asai-Coakwell et al. 2009; French et al. 
2009), though these remain to be observed. Given the significant eye defects 
associated with  OAS a zebrafish eye phenotype increases its usefulness as a model 
for the disease. While it is nowhere near as severe  as the anophthalmia observed 
in OAS  it is worth noting that even the mouse knockouts of SMOC1 show 
comparatively mild phenotypes (Rainger et al. 2011; Okada et al. 2011). 
 
  My results support the function of smoc-1 as a regulator of bmp signalling 
and provide the first support for the function of vertebrate smoc-1 being broadly 
conserved to Drosophila. Building on the work of  Vuilleumier et al. and 
Hamaratoglu et al. on Pentagone I have proposed a model for the action of the 
smoc-1 in vertebrates that is both consistent with the results I obtained and those 
published in Xenopus (Vuilleumier et al. 2010; Hamaratoglu et al. 2011: Thomas et 
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a Chapter 6 
 
 









 All steps were performed at room temperature unless otherwise stated. 
If a commercial kit is used accordance with manufacturer instructions unless 
stated otherwise.   
 
6.1 Zebrafish husbandry 
 
 
The zebrafish husbandry techniques detailed in this section were modified from 
those found in Westerfield (2000) and Nusslein-Volhard & Dahm (2002 ) which 
can be consulted if further detail is required. 
 
6.1.1 Embryo care 
 
 
Embryos were obtained via the use of static tanks or using marbles as described 
in The Zebrafish Book (4th edition Westerfield 2000).  Unless otherwise stated 
the experiments were performed on the AB zebrafish line. Embryos were 
incubated in 90mm petri dishes (Sterilin) filled with E3 media, at a density of no 
greater than 100 embryos per dish. All embryos were maintained at 28.5°C. The 
E3 media the embryos were incubated in was replaced daily and any dead 




 E3 media 
 
E3 Media was Prepared in 2 stages following the recipes below. 
 
E3 Embryo medium 60x Stock solution (1L)   NaCl        17.2 g  KCL       0.76 g  CaCL2  + 2H20      2.9 g  MgSO4 + 7H2O     4.9 g  ddH2O       make to 1 l  stored at 4oC  E3 Embryo medium 1x Solution (6L)   60x  E3 Stock solution    100 ml  ddH20       5.9 l  Methyl Blue       2 drops  Stored at rt  
 
6.1.2 Embryo Bleaching 
 
 
 To prevent control infections all embryos that were raised beyond 5dpf 
were leakage bleached which involves sequentially immersing chorionated 
embryos (up to 2 dpf) in a series of trays using an embryo sieve. Each train is 
filled with either bleaching solution or washing solution (ddH2O or E3 medium).  





Tray     Incubation time     1    5 min    2    5 min    3    5 min    4    5 min    5    5 min    
 The embryos are then transferred into a 90 mm Petri dish and incubated 
as previously described in 6.1.1. For transgenic lines the embryos were sorted 
based on the fluorescence using a Nikon Macroscope.  H2A:gfp (Pauls et al. 
2001) and rx3:gfp embryos (Rembold et al. 2006) were screened at 1 dpf while 
BRE:gfp embryos(Collery & Link 2011) were screened at 2 dpf. Embryos that 
showed weak or no fluorescence were discarded. At 5 dpf the embryos are 
transferred to the gravity third flowing current aquatic system where they were 
raised in accordance with the relevant statutes and zebrafish best practice 
under the care of the fish room technicians. 
 













 Embryos were either dechorionated manually using a pair of 
watchmaker’s forceps and a Nikon SMZ 1000 stereomicroscope or 
dechorionated chemically using Pronase E. 
 
 For chemical Dechorionation 200 µl of Pronase E was added to a 1.5ml 
Eppendorf containing the embryos suspended in 1 ml of E3 media. The 
solutions were mixed by inversion and the tubes were incubated for 1 min, 
before being washed in E3 twice for 2 min each time. After the final wash the 
embryos were aspirated repeatedly into a plastic graduated pasture pipette. By 
this point in time almost all of the enzymatically digested chorions will have 
detached. The embryos are then decanted into a Petri dish and the few 
remaining attached chorions are removed manually with watchmaker’s forceps. 
 
Pronase E stock solution (12mg/ml)   
 Pronase E        12mg  E3media      1ml   







6.1.4 Anaesthesia and Termination 
  
Anaesthesia  
 To anesthetise embryos 1ml of Tricaine solution was added directly to 
the Petri dishes (~30ml of E3 media). For early stage zebrafish embryos 
anaesthesia is almost instantaneous. 
 If embryos were to be retained they were transferred into fresh E3 twice 
after which time they rapidly recovered and were further incubated. 
 
Termination 
 Adult zebra fish that were old or sick were culled using a standard 
Schedule 1 procedure.  Adult zebra fish were killed with an overdose of 
anesthetic by immersion in Tricaine solution for at least 10 minutes. The brain 
was then either destroyed by crushing the head or the fish were decapitated. 
 
Tricaine Solution(Anaesthesia) 
 Tricaine powder                                               400 mg  
 ddH2O                                                                    97.9 ml  
 1M Tris (pH9.0)                                                  ~2.1 ml (Adjust pH to 7) 
 
Tricaine Solution(Termination) 
 Tricaine powder                                                400 mg  
 ddH2O                                                               100 ml  
 






6.2.1 Morpholino and mRNA solutions 
 
Name Type Sequence Reference 
zsmoc1sbMO Splicing CACATAAATGAAGCGATGAGGGCAT n/a 
zsmoc1scMO Splicing ATGCATACAGTACCTGAACACACT n/a 
zsmoc1tMO Translation AAGAGCCAGATTGTGACAGTTCATC n/a 
bmp2b MO Translation CGCGGACCACGGCGACCATGATC Lele et al. 2001 
bmpr2a MO Translation TGTTATTCGGCCTTCAACTGCCATG Monteiro et al. 2008 
bmpr2b MO Translation CTGCTGCCGCTTCTGGATGGATTCA Monteiro et al. 2008 
control MO n/a CCTCTTACCTCAGTTACAATTTATA n/a 
p53 MO Translation AAGAGCCAGATTGTGACAGTTCATC Robu et al. 2007  Table 6.2.1 Details of Morpholino utilised.  
 
______________________________________________________________________________________________________________________________________________________________  
 All Morpholinos were supplied as a powder by Gene Tools (USA; Table 
6.1). Upon receipt MO stock solutions were made up at concentrations of 5mM 
in ddH2O and stored at 4oC. For use each MO was diluted to a working stock 
(concentrations varied: details in the results). Unless otherwise stated every MO 
concentration was also co-injected with a p53MO to minimize off target effects 
caused by p53 dependent morpholino toxicity (Bedell et al. 2011). Before each 
series of injections the solution was heated to 65°C for 10mins using a PCR 
machine to resuspend MO. mRNA was synthesised and stored as detailed in 






6.2.2 Needle preparation 
 
 
 The needles were pulled from the filamentless glass capillaries (Intrafil; 
dimensions: length-10 cm, diameter: outer - 1 mm; inner - 0.8 mm) using a 
Micropipette puller (Sutter Instrument, Novato CA, USA) in accordance with the 
manufacturer’s instructions. After being pulled the point of the needle is sealed.  
 Immediately before use the needle was loaded with 2-3 μls of construct 
using micro-loader pipette tips (Eppendorf, UK) and then loaded into 
Picospritzer III micro injector. To break the seal the point of the needle was 
brought into focus using a Nikon SMZ 1000 stereomicroscope. A micro-
manipulator (Intracel, Hertss, UK) was used to finely adjust the position of the 
needle and the needle was broken with watchmaker’s forceps so the needle tip 
was big enough to  penetrate the chorion without breaking, but not so thick that 
it would lead to unnecessary damage to the embryo,  ideally to produce droplets 
of volume of ~1 nl. The final bolus size was regulated by adjusting the duration 
of the injection, with pulses ranging from between 10 and 20msec. The size of 



























microinjections methods utilised. 
 micro-manipulator was used to drive the needle at an angle of 












 Microinjections were performed using a Picospritzer III micro injector 
(Intracel) in combination with a Nikon SMZ 1000 stereomicroscope as detailed 
in Bill et al. (2009). Morpholino Oligonucleotides were injected in accordance 
with the methods detailed in  Fig. 6.2.1.  MO were injected into the yolk sac 
between 1 and 8 cells, while mRNA was injected directly into the cells of 1 or 2 
cell stage embryos.  After 6-8 hpf dead embryos were removed and E3 media 





 Embryos were dechorionated (6.2.3)  then the zebrafish were  scored 
using the Kishimoto scale detailed in (Fig 3.1.3; Kishimoto et al. 1997). 
Embryos were then fixed by overnight incubation in 4% PFA (4°C) before being 













 6.3.1 Live zebrafish imaging 
 
6.3.1.1 Methyl cellose gel preparation  
Unless otherwise stated all zebrafish were embedded in 0.8 % methyl cellulose.  
 Master methyl cellose gel (3%)  E3 media                                                             250 ml   Methyl cellose powder                                    10 g         
stored at -20oC 
  
The E3 media was heated to 80oC on a heated magnetic stirrer. The methyl 
cellose was added whilst it was mixed using a magnetic stirrer. Once the methyl 
cellose was fully dissolved the heater was switched off and the solution was 
allowed to cool to room temperature under agitation. The gel was then 
aliquoted  into 50ml falcon tubes (Sterilin) and left rolling overnight. Those not 
to be used immediately were frozen (and stored for up to 1year).  
 
Working methyl cellose gel (0.8%)  methyl cellose gel (3%) (RT)                                  8.3- 33.3 ml E3 media        40.2- 15.2 ml penicillin/streptomycin     0.5 ml Tricaine Solution       1 ml  stored at 4oC 
 
6.3.1.2 Embedding embryos 
 Embryos were then 
The embryos were then embedded in methyl cellulose in bespoke viewing 
chambers specifically designed to be loaded into a Prior H101 motorised stage 
(Prior Scientific Ltd). The details of this process are laid out in 
 
 




dechorionated chemically using PronaseE (
 
Fig 6.3.1  A explanation of the embedding  of zebrafish embryos. 
(A) bud stage embryos were loaded onto an inverted viewing chamber at a density of between 8The excess E3 media was removed. The embryos were still covered with a minimal layer of E3. µl of methyl cellulose (0.8%)and the embryos were held in place by surface tension. Embryos were reorientated and aligned and damaged embryos were removed using a fine tip Pasteur pipette 3.5ml.completed viewing chamber was assembled by placing the viewing chamber on top of the inverted viewing chamber lid. Air gaps in this chamber ensure the zebrafish embryos are not damaged by increases in pressure in the
methyl cellulose. The embryos were 






-15 embryos. (B) 
(C) A drop of ~500  was added 







6.3.1.3 live embryo imaging  
 
 All live embryo microscopy was conducted on a Nikon AZ100 
macroscope (Nikon UK Ltd) in conjunction with a Lumen 200 Pro light source 
(Prior Scientific Instruments). As the system was used primarily to image 
reporter lines of zebrafish all images were taken on a Photometrics Coolsnap 
HQ2 camera   (Photometrics Ltd) with Nickon GFP filter cubes. The camera was 
moved between embryos using an automised Prior H101 motorised stage (Prior 
Scientific Ltd). The embryos were maintained overnight in an environmental 
chamber (Solent Scientific) to provide a consistent environment (28.5°C).  
 
6.3.1.4 Image capture and analysis  
 
 The images were captured using IVision (BioVision Technologies) before 
being analysed using Fiji (Schindelin et al. 2012). The size of the developing 
optic field was measured along the axis that bisected at right angles. For details 
on precisely how these axis were drawn consult Fig 6.3.2.  The cross-sectional 
area of eyefield was calculated by manually drawing a region of interest around 
the optic field and the number of pixels within the region of interest (ROI) was 
measured. This was converted into  µm2. To control the poorly orientated 
embryos or global effects of morpholino treatment the width of the embryo was 
measured as described in Fig. 6.3.2 and the total cross-sectional area of the 
 
embryo was measured in the same way as that of the eye. Only in this case the 
perimeter of the embryo (excluding the yolk cell) was traced as
 For fluorescent signal quantification
zebrafish optic field (tg(rx3:gfp)) or the area fluorescence  (tg(BRE:gfp)). The 
intensity of signalling was measured by reporting both the mean pixel intensity 
and modal pixel intensity within the ROI. In the case of the (tg(BRE:gfp) the 
extent of the GFP gradient was also measured by measuring the width of the 
widest part of the gradient and then measuring the axis at right angles to this 
original measurement.
____________________________________________________________________________________________
Fig. 6.3.2  A diagrammatic explanation of the axes used to measure eye field size in live imaging experiments  The first measurement axis is taken by measuring the width of diameter of the embryo’s yolk cell (at a 90° angle from axis (this angle. The width of the embryo was esyolk cell behind the head  The blue dashed line represents axis while the red dashed line represents the part of the axis that was measured.
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 a ROI was drawn around the 
 
the eye field along the d1). The second axis is taken by bisecting the optic field t). Axis t is measured at the maximum width of the optic field along timated by measuring along the diameter of the (d2). 
 
Appendix 






6.3.2 Gradient quantification with OPT 
 
 
 The embryos were stained by whole mount immuno as detailed in 6.5.5.  
Ten embryo of the stained embryos were prepared for Optical Projection 
Tomography (OPT). The fixed samples were pre-cleaned in PBS, before two 
further washes in ddH2O. The embryos were then individually embedded in 1% 
low melting point agarose and dehydrated overnight in Methanol before 
transferring to BABB (1 part Benzyl Alcohol/2 part Benzyl Benzoate). Each 
sample was then scanned using the original prototype OPT scanner ( Leica 
MZFLIII with a Retiga EX camera and a 0.5x objective lens; Sharpe et al. 2002), 
using the brightfield channel to detect the HrP staining from the whole mount 
immunos. The raw images were then reconstructed into a 3-D model using the 
Bioptonics proprietary software suite (Bioptonics). 3-D images were 
reconstructed from the raw data using VolViewer (Jerome Avondo, JIC, 
Norwich). The images were then optically sectioned in two planes. To measure 
the lateral the embryos was bisected 30 µm above the involution zone of the 
embryo. To monitor the sagittal gradient the embryo was bisected dorsally to 
ventral.  The raw image was exported as a tiff file and analysed using Fiji 
(Schindelin et al. 2012). To objectively measure the extent of the gradient the 
images were thresholded at a pixel intensity of 200 using the Fiji colour 
segmentation tool and a region of interest was drawn around this region 
manually.  The mean pixel intensity and area of this image was recorded. The 
cross-sectional area of the gradient was initially recorded in Voxels but was 
 
later converted into µm








Fig 6.3.3 An example of gradient thresholding. 
(A) An example of an unFiji colour thresholding tool. All red pixels with an intensity of over 200 are highlighted. The ROI was drawn around all highlighted pixels. The yellow dashed line denotes the region of interest (ROI)
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2 using calibration data obtained by imaging a 1000 




















6.4 Nucleic acid 
techniques 
 
6.4.1 General methods and analysis 
 
 
 All DNA solutions were stored in TE buffer at -20oC while all RNA 
solutions were stored in ultra pure RNase free water (GIBCO). To ensure RNA 
stability RNA samples were aliquoted for single use and unless they were used 
immediately samples were stored at -80oC (in the in vitro transcribed  RNA was 
stored for up to 1 month). When is use all RNA samples were stored on ice. To 
ensure freedom from contamination all solutions were pipetted using filter 
tipped pipette tips. 
 
 To check DNA quality and sample identity samples were always 
subjected to both spectrophotometric analysis (6.4.2) and Agarose gel 
elctrophosis (6.4.3) after any major processing step. Where appropriate sample 
identity was also confirmed with Sanger sequencing (6.4.4).  





6.4.2 DNA purification 
 
 DNA was commonly purified using commercial spin column based 
purification. In this case the columns were used in accordance with the 
manufacturer's instructions. The exception being when RNase free preparations 
were prepare, in this case phenol-chloroform extraction was used. 
 
PCR purification 
 PCR reaction mixes and some restriction digests were purified using 




 Plasmids were extracted using spin column kits depending on the 
desired yield of DNA, detailed in table 6. The extractions were broadly 
performed according to manufacturer's instructions, the exception being for the 
QIAprep Maxi  kit. The two main differences from the public protocol were that 
the ultracentrifugation step of the cell lysis buffer was avoided by removing the 
precipitate by filtration rather than centrifugation and the yields were increased 
by heating the elution buffer to 65° C before use. 
 
Kit Stationary phase bacteria culture Yield Elution volume Manufacturer 
QIAprep MIni  kit 2ml ~10 µg 100 µL Qiagen 
Zyppy™ Plasmid Midiprep Kit 40ml ~50 µg p 200 µL Zymo 
QIAprep Maxi  kit 200ml ~250 µg 500 -1000µL Qiagen 





 During cloning it was sometimes necessary to separate digestions 
products using agarose gel electrophoresis. Once they were resolved the desired 
band was excised using a scalpel. The DNA fragment was then extracted from 
the agarose gel using Zymoclean™ Gel DNA Recovery Kit (Zymo) in accordance 
with the manufacturer's instructions. The DNA was eluted in 7 µl of elution 
buffer. 
 
Genomic DNA extraction 
 Genomic DNA was extracted from whole zebrafish embryos at 3 dpf 
using the Nucleon™ HT Genomic DNA Extraction Kit (GE Healthcare) in 
accordance with the manufacturer's instructions. 
 
Phenol chloroform extraction 
 Phenol chloroform extractions were performed only when the DNA 
template needed to be completely free of nucleases. The aqueous DNA solution 
(made up to 200 µl with nuclease free water and 23 µl of 3M ammonium  
acetate (Ambion))  was initially added to 400ul acidic ultrapure Phenol (Life 
technologies). The phases were mixed vigorously and separated by 
centrifugation. 400 µL of analytical grade chloroform was then added to the 
aqueous phase and again the solutions were mixed vigorously and separated by 
centrifugation. The aqueous phase was then purified by ethanol precipitation. 
 To maximise the recovery of the aqueous phase and avoid carrying over 




LockGel (5 Prime). The entirety of the extraction of a single sample was carried 
out in a single phase lock tube. After each step the tubes were spun down which 
allowed the aqueous phase to be separated from the previous extraction with 
the solid-phase. All extractions were carried out in accordance with the 
manufacturer's (5 Prime) instructions. 
 
Ethanol precipitation 
 Where appropriate DNA was returned to the aqueous phase via ethanol 
precipitation. If the manufacturer’s guidelines recommended isopropyl 
precipitation where possible ethanol precipitation was used. The solution was 
made up of 70% ethanol (using absolute ethanol) and spun at 17000 g for 10 
min using a centrifuge called to 4°C. As much of the liquid was removed from 
the pellet as possible before being replaced with 70% ethanol and spun at 
17000 g for 5 min using a centrifuge called to 4°C. If a particularly high purity of 
DNA was required then the ethanol wash was repeated. The pellets were then 











6.4.3 RNA purification 
 
In vivo purification- TRIzol extraction 
  
 Before isolating mRNA in zebrafish embryos were collected (20-30 
embryos) immediately and snap frozen using dry ice. The embryos were 
immediately immersed in 0.5 ml of TRI reagent (Sigma) in a disposable plastic 
1.5 ml mortar (Kimble Chase; PN EF24837U) and homogenised with a 
disposable plastic pestle (Kimble Chase; PN EF24837U). The solution was made 
to 1 ml by adding a further 0.5ml of TRI reagent (Sigma). The solution was then 
frozen in dry ice and stored at -20°C for up to 10 hpf. The RNA was then 
extracted in accordance with manufacturing instructions.  
 
cDNA synthesis  
 
 Immediately following extraction the mRNA was reverse transcribed. 
The majority of cDNA was synthesised using the first strand cDNA synthesis kit  
(Roche; PN: 04379012001). The exception was the cDNA synthesis preceding 
the RLM race. which was conducted using the reagent provided in the RLM race 








First Strand CDNA mix (10-20  µl) 
 Reaction buffer (x10)    1-2 µl    MgCl2 (25 mM)                2-4 µl  Deoxyribonuclides     1-2 µl   Oligo- p(dt)      1-2 µl   RNase Inhibitor     0.5-1 µl   AMV Reverse Transcriptase    0.4-0.8 µl  total mRNA*      up to 1 μg   Nuclease free H2O     made to volume  *Before adding the RNA it was incubated at 65°C for 15 min to denature any secondary structure.  
The reverse transcription reaction was incubated in a Thermo cycler (DNA engine Tetrad 2; MJ research) using the program detailed in table 6.2.    
 Step Temp Time 
Annealing 25°C 10 min 
Final extension 42°C 60 min 
Denaturation 95°C 5 min 
Hold 4°C up to overnight 
 Table 6.4.2 cDNA synthesis program  Once synthesised the cDNA was stored at -20°C. ____________________________________________________________________________________________ 
 
In vitro synthesis of capped and tailed mRNA 
 To achieve the maximum levels of in vivo translation the five prime end 
of the mRNA must be capped with a 7-mythyl guanine and tailed with a string of 
adenosines. Capped mRNA was synthesised using the SP6 and T7 mMESSAGE 






mMESSAGE mMACHINE reaction (20 µl)      
 NTP/ Cap Mix (x2)     10 µl    enzyme buffer mix (x10)    2 µl   linearised DNA template    1 µg   nuclease free water     made to 18 µl  T7/T3/SP6 enzyme mix    2 µl     All templates were made using either CS2+ or the CS2 Gateway vectors. 
Before the synthesis reaction plasmids were linearised using the protocols 
detailed in 6.6.2.1. The antisense control RNA was synthesised by linearising 
the DNA upstream of the gene and using the reverse promoter (T7 or T3) to 
initiate transcription. To maximise yield the reaction mix was incubated for two 
hours using a Thermo cycler (DNA engine Tetrad 2 ; MJ research). Notably the 
DNase step was omitted, to avoid the introduction of RNases.  
 To add the Poly(A) tail the Poly(A)  Tailing Kit (Ambion) was used. 
 
Tailing reaction (50 µl)      
 mMESSAGE mMACHINE reaction   10 µl    nuclease free water     18 µl   E-PAP buffer (x5)     10 µl   MnCl2       5 µl  ATP (10 mM)      5 µl   E-PAP enzyme mix     2 µl   
 The reaction mix was then incubated for 30 min at 37°C on a tetrad 
Thermo cycler. The RNA purified by the phenol chloroform extraction followed 
by ethanol precipitation as detailed above (6.4.2), with the exception that basic 





6.4.4 Spectrophotometric analysis 
 
 The concentration and quality of all Nucleic Acid samples was assessed 
using a NanoDrop 1000 UV-Vis Spectrophotometer (Thermo FisherScientific). 
The concentration of DNA was determined using absorbance at 260nm. The 
purity of the sample was assessed by the ratio of the 260nm absorbance  to the 
absorbance at 230 and 280nm. Only samples with a 230/260 ratio greater than 
1.5 and a 260/280 ratio of between 1.7 and 2.2 were used. 
 A low 260/280 (<1.7) value indicates a high  level of protein 
contamination (Thermo Fisher Scientific Inc. 2011). While a high 260/280 
(2.2<) indicates extremely high levels on contamination and/or low levels of 
actual nucleic acid.  A low 230/260 ratio implies  high levels of contamination, 
typically carry though from purification (Guanine salts or Phenol; Thermo 
Fisher Scientific Inc. 2011). Impure samples were either repurified or discarded. 
 
6.4.5 Gel electrophoresis 
 
 Once a samples Nucleic acid purity was confirmed  the quality of the 
nucleic acid was assessed by gel elctrophosis. All cells were used as analysed by 
gel electrophoresis and Nucleic acid gels were analysed using gel 
electrophoresis. This  confirmed both that the DNA was good quality (e.g. wasn’t 
degraded) and that the samples had the correct identity (did the fragment 





 Unless otherwise stated all gels were run in 2% agarose in 0.5 TBE (w:v).  
Once  the agarose was mixed into the TBE it was weighed and boiled until it had 
fully dissolved. The solution was weighed again and topped up ddH2O to 
replace any water loss by evaporation. To stain the DNA ethidium bromide (0.5 
μg/ml) was added to the mixture before it was left to set. The samples were mixed 
with loading dye (6x blue/orange Promega), loaded onto the gel along with either 1kb+ 
DNA ladder (Invitrogen) or the 100bp DNA ladder (Promega). These acted as reference 
standard for size migration and positive control. The gel was then run at between  60 
and 180V.  The gels were visualised with a UV transilluminator. 
 
 If the purpose of the gel was a gel extraction the same procedure was 
followed but the ethidium bromide was substituted with gel and SYBR Safe Blue 
and the bands were visualised on a blue light transilluminator (Safe Imager 2.0 
Blue Light Transilluminator; life technologies) to avoid the DNA damage associated 
with UV light.  
 
 6.4.6 Sequencing 
 
 
 Dye terminator sequencing was used to confirm the identity of  known  
nucleic acids or establish the identity of experimentally derived nucleic acids. 
The sequencing itself was carried out using a 3130/3730 Genetic Analyser 
(Applied Biosystems) by the Institute of Genetics and Molecular Medicine 




sequencher v 4.19.1 (Gene Codes)  or ApE. v 2.0 (Paradis et al. 2004). Plasmid 
maps were also constructed using ApE. 
 
*RNA samples were first reverse transcribed into cDNA and sub cloned into a 
donor plasmids before sequencing. 
 
6.4.7 Ion Torrent sequencing 
 
Library preparation 
 Samples were screened using the workflow detailed in Fig. 4.2.9. 
Embryos (8-20) were injected with either a equal mix of TALEN paired mRNA 
or control RNA at the one cell stage. Embryos were collected at 3 dpf.  The 
genomic DNA of injected embryos was isolated as described above. The overall 
strategy for the analyse the TALEN pairs has been discussed at length in 4.2.4. 
The region of zsmoc1 targeted by the TALEN pairs was amplified using the 
custom primers detailed in Fig. 4.2.15. utilising a high Fidelity Phusionflash 
PCR 6.4.8. For every TALEN pair tested eight PCR reactions were conducted. 
Four for the TALEN injected embryos and 4 for the control embryos.  As the 
library is already barcoded because of the custom primers many steps of the 
standard library prep can be omitted. However the library still needs to be 
purified. Initially the PCR mix was purified using QAIgen  PCR purification 
columns as described above.  
 As further purification is required for ion torrent sequencing Agencourt 




AMPure beads were left on a roller for 30 min to ensure they were both 
thoroughly mixed and equaliberated to room temperature. Meanwhile the PCR 
products were transferred to a 1.5 ml microcentrifuge tube and made up to 
volume of 160 µl using nuclease free H2O.  280 µl of AMPure bead suspension 
was then added to each sample and the solutions were mixed by aspiration 
before being placed on a tube rotator to incubate at room temperature for 10 
min. 
 The tubes were then spun down and placed in a magnetic rack. Once the 
beads had collected to one side the supernatant was discarded. The tubes were 
then washed three times in 1.5 ml of 80% ethanol. Each time the supernatant 
was replaced with 80% ethanol the solution was mixed by rapidly rotating the 
microcentrifuge tube 180° in the magnetic rack. This placed the magnetic beads 
on the opposite side of the tube to the magnets in the rack, which led to their 
migration through the 80% ethanol to the other side of the tube. This was 
repeated six times for each wash.  
 After the final wash the supernatant was removed and the tubes were 
again briefly centrifuged before being placed on the magnetic rack again. This 
was to allow the removal of residual ethanol. The beads were then air dried for 
5 min before being resuspended in 50 µl of TE buffer. To normalise the different 
amounts of template the samples were quantified with a Bioanalyser (Agilent). 
If the samples were too concentrated they were diluted at either a 1 in 5 or a 1 
in 20 dilution using ultrapure water. Once each sample was accurately 
quantified they were each diluted to a concentration of 20 pM. All 20 pM 




of each sample will be combined to a total volume of 600 µl). The pooled library 
of samples were then mixed well by aspirating them at least 30 times with a 




 The library was then sequenced using a Ion Personal Genome Machine 
sequencer (Life Technologies). The ion torrent sequencing was performed by 
the Institute of Genetics and Molecular Medicine (IGMM) sequencing. The 
sequencing reads were screened for mutations using nextGENe (Soft Genetics) 
before being exported and tabulated in Excel (Microsoft) using the criteria 
described in 4.2.4.  Finally to confirm the presence of TALEN induced 
mutations the number of mutations were compared to the number of mutations 
found in a control population of embryos  injected with antisense TALEN mRNA 
which have been processed according to the same criteria. A functioning TALEN 
pair should result in an enrichment of deletions relative to the control because 











6.4.8 Polymerase chain reaction PCR 
 
6.4.8.1 primer design 
 
 Before PCR can be performed targets specific primers must be designed. 
When not using PCR sequences obtained from commercial kits or those 
published in the literature custom primer sequences were designed. All 
sequences were designed using Primer3 (Untergasser et al. 2012; Koressaar & 
Remm 2007). Ideally the primers had a melting temperature (Tm) as close to 
55°C as possible though primer Tm ranged between  50-60°C. Each primer was 
designed to be as close to its partner primer as possible. No primer pairs we 
utilised with Tm's separated by more than 4°C. To help ensure efficient function 
where possible the functionality of primer pairs was simulated in silico using 
amplify 3.1(University of Wisconsin).  
  
 The oligos that were not supplied within commercial kits were obtained 
from Sigma-Aldrich. The specific sequences are detailed in Sup. Table 7, Sup. 
Table 8 and Sup. Table 9. 
 
 
6.4.8.2 DNA amplification 
  
 DNA amplification was critical for several experiments, including 




achieve this two types of PCR strategies were used. One utilised Faststart 
Amplitaq Gold enzyme (Faststart Amplitaq Gold Applied Science) while the 
other utilised FusionFlashTaq (Finnzymes Fisher scientific).  While Q PCR and 
RACE PCR we utilised purely for analysis.  
 
Faststart PCR 
 When extreme accuracy was not critical (e.g. DNA synthesis and 
experimental analysis), Faststart Amplitaq Gold enzyme was utilised. The 
enzyme was obtained premixed a 2x  custom mastermix ordered directly from 
Roche. 
 
FasttaqMaster mix (x2) 
 Faststart Amplitaq Gold                                  0.12 U/µl  Magnesium Chloride (Roche: PN)   proprietary    PCR buffer      proprietary  dNTPs       0.4 mM µl  
FasttaqMaster mix (x1; 12.5-50  µl) 




   
 Step Temp Time Cycles 
Initial Denaturation 94°C 5 min 1 
Denaturation 94°C 45 s 
25-35 Annealing 54-62°C 40 s 
Extension 72°C 15s+ (15s per kb) 
Final extension 72°C 10min 1 
Hold 4°C  up to overnight 0-1 
 Table 6.4.3 Fasttaq PCR program The dark blue denotes the cycling stage of the PCR program. Every cycle the PCR machine goes through a single denaturation step, followed by an annealing step, followed by the extensions step before returning to the denaturation step until the number of cycles has been completed. 
______________________________________________________________________________________________________________________________________________________________      
Phusionflash high fidelity PCR  
 For experiments where accuracy was critical (principally cloning and the 
amplification of target DNA for Ion Torrent sequencing) the Phusionflash Taq 
was used. It was principally obtained premade in the form of Phusionflash 2x 
Master Phusionflash (Finnzymes or Fisher Scientific) mix. So only the primers 
in the DNA template need to be added before use: 
 
Phusionflash (25-50  µl) 





 Step Temp Time Cycles 
Initial Denaturation 98°C 30 sec  1 
Denaturation 98°C 7 s 
25-30 Annealing  54-63°C 5 s 
Extension 72°C 15 s per kb 
Final extension 72°C 5 min 1 
Hold 4°C up to 10 hrs 0-1 




 All PCRs were performed using a Thermo cycler (DNA engine Tetrad 2; 
MJ research) and the PCR product was purified using the QiaQuick PCR 




 For experiments that required the accurate assessment of the relative 
levels of gene expression quantitative PCR (qPCR) was utilised, which relies on 
the fact that an idealised PCR amplification reaction will result in an exponential 
doubling of levels of target DNA. Eventually the reactions become saturated, 
however if the amount of DNA can be measured in realtime it is possible to 
estimate the absolute levels of the initial template by comparing the number of 
cycles it takes for the primers to cross a cycle threshold (Ct), which is an 




long as the same level of intensity is used for each reaction in a run it is 
inversely correlated to template concentration. While multiple methods are 
available for convenience comparative Ct method (2-ΔΔCT) was used to estimate 
the relative level of expression. This method assumes an ideal PCR reaction was 
DNA template doubles every cycle. However no PCR reaction is 100% efficient 
(Livak & Schmittgen 2001). As shorter amplicons are amplified far more 
efficiently, qPCR primers were designed to be between 100-200bp long. 
Additionally to ensure primer pairs were consistent over the concentrations of 
cDNA we were using they were tested against a concentration curve made from 
serial dilutions of cDNA. Only PCR primers with efficiencies of greater than 80% 
were used. Finally the HT7900 machine itself can recognise PCR reactions that 
do not amplify exponentially and these reactions were excluded. 
 To quantify the levels of template in realtime SYBR green DNA binding 
dye (Stragene) was used. SYBR green will form a complex with double-stranded 
DNA which will fluoresce when stimulated with blue light. SYBR green will 
fluoresce in the presence of any double-stranded DNA, not just target DNA. To 
control for this qPCR primers were designed to flank large introns so it was 
impossible to amplify genomic DNA. Additionally, results were only taken from 
wells that showed only a single peak in their melt curve which indicates only a 
single amplicon has been amplified in that well.  
 
  
 As qPCR is an extremely sensitive technique; all  PCR reactions were 




on 384 well plates (ABgene) in triplicate. To control for variations in template 
concentration between samples all results were normalised to elf-alpha. These 
genes were chosen as previously published data has shown it to be the most 
consistently expressed genes over the course of zebrafish development 
(McCurley & Callard 2008). However, to confirm that treatment wasn't altering 
the expression of the unrelated housekeeping gene beta actin was also 
measured. If beta actin results correlated with elongation factor alpha (elfa) 
then the expression levels of these housekeeping genes was assumed to be 
independent of morpholino or mRNA treatment. 
 
Brilliant  II Sybr Green Master mix (10  µl) 
 Brilliant  II Sybr Green Master mix (x2)  5 µl    Primer fw                  10 µM  Primer rv      10 µM  DNA template          cDNA       0.1    Nuclease free H2O     made to volume 
 The PCR program detailed in Table 6.4.5 was run on a ABI  Prism 
HT7900 Sequence Detection System. 
 Step Temp Time Cycles 
Initial Denaturation 95°C 10 min 1 
Denaturation 95°C 15 s 40 Annealing and Extension 60°C 1 min  Table 6.4.5 SYBR green PCR program The dark blue denotes the cycling stage of the PCR program. For further details consult  






6.4.9 RACE PCR  
 
 The five prime PCR of zsmoc1 was isolated using five prime RNA Ligase 
Mediated Rapid Amplification of cDNA Ends (RLM-RACE) which was conducted 
with the FirstChoice RLM-RACE Kit (Ambion). The principal improvement RLM-
RACE over traditional RACE is the elimination of degraded RNA. To achieve this 
10 µg of total RNA was dephosphorylated with a hour-long 37°C incubation 
with Calf Intestinal alkaline Phosphatase (CIP) which was terminated with a 
phenol chloroform extraction. This dephosphorylates degraded RNA. The cap of 
non degraded RNA was then cleaved by incubating ~300 ng of CIP treated RNA 
with Tobacco Acid Phosphatase (TAP) at 37°C for one hour, leaving one 
phosphate group on the non degraded mRNA transcripts. This phosphate group 
enables the ligation of a custom adapter sequence to the five prime end of 
undegraded mRNA transcripts which provides a known binding site for the five 
prime primers.  
 The RNA was reverse transcribed into cDNA using the reagents provided 
in the FirstChoice kit but with the conditions detailed in section 6.4.4.  The 
cDNA was then stored overnight for - 20°C.  
 The cDNA was then amplified using a series of nested PCRs using the 









 Step Temp Time Cycles 
Initial Denaturation 94°C 30 sec  1 
Denaturation 94°C 30 s 
35 Annealing  58°C 30 s 
Extension 72°C 30 s 
Final extension 72°C 7 min 1 
 Table 6.4.6 RACE PCR program The dark blue denotes the cycling stage of the PCR program. For further details consult Table 6.4.3. 
______________________________________________________________________________________________________________________________________________________________  
 After each round of PCR the product was run out on agarose gel (6.4.3). 
After the second round of PCR the bands became visible and the PCR products 
were TA cloned and sequenced (6.4.4). 
 
 All incubations and PCR reactions were performed on our Thermocycler 
(DNA engine Tetrad 2; MJ research). To avoid contamination all RACE PCR 










6.5 Protein techniques 
  6.5.1 In vitro synthesis  
 
 All in vitro protein synthesis of the TALEN constructs were performed 
using the Retic Lysate IVT™ Kit (Ambion). The mRNA template using the 
reactions was synthesised and purified using the methods detailed in 6.3.1. The 
only major modification to the manufacturer’s protocol was the omission of 
radiolabelled methionine in favor of unlabelled D-methionine. As the TALEN 
constructs are relatively large(~4 kb) the reactions were incubated at 37°C for 
2 hours in a water bath. 
 
mMESSAGE mMACHINE reaction (25 µl)      
 Nuclease free water      made to 5.75 µl  Translation mix (methionine depleted ;20x)  1.25 µl   D-methionine (50 mM )     1 µl   RNA template (0.5- 2.5 µg)      1 - 5.75 µl  Retic Lysate       17 µl       
 After synthesis the RNA was removed enzymatically with the addition of 
2.5 µl of RNase A (Ambion) and the reaction was then incubated for a further 30 






6.5.2 Western Blotting 
 
 
6.5.2.1 Cell pellet preparation 
 
 Before Western blots could commence the embryos must first be lysed to 
free the protein from constituent cells. Initially 30 embryos were collected at 4 
hpf (sphere stage) dechorionated and placed in 1.5 ml microcentrifuge tubes. 
The embryos were then washed twice in E3 media for 2 min under agitation. 
Embryos were then resuspended in 100 µl of ringers(-Ca) and the cells were 
disassociated by aspirating the embryos 15 times using a P200 Gilson’s pipette. 
The solution was incubated at room temperature for at least 5 min before the 
protease solution was added and the embryos were digested for 15 min at 30°C. 
After this 40 µl of stopping solution was added to inhibit digestions and the 
zebrafish cells were pelleted by being spun down at 3500 g for 5 min. The 
supernatant was aspirated off and the cells were resuspended in 1 ml of cell 
suspension media.  The cells were again pelted by a five-minute centrifugation 
step at 350 g. The suspension media was removed and the pellet was stored 
overnight at -20°C.  
 
Protease solution 




 Ringers (without calcium)     1M NaCl      5.8 ml 
 1M KCl      145 l 
 0.5M HEPES  (pH7)     50 l  ddH2O       43.5 ml  
  
Ringers (without calcium)     1M NaCl      5.8 ml 
 1M KCl      145 l 
 0.5M HEPES  (pH7)     50 l  ddH2O       43.5 ml  
HEPES   1M NaCl      116 ml 
 1M KCl      580 l  HEPES  (Sigma Aldrick)    23.83 g   ddH2O       81.2 ml  
 
Stopping solution (x6)   Calf serum      3 ml 
 2M CaCl2      30 l  PBS (x10)      1 ml  ddH2O       6 ml  
Syringed filtered  (0.22 M; Millipore)  





6.5.2.2 Cell lysis 
 The cell pellet was resuspended in 50 µl of lysis buffer by repetitively 
aspirating the solution with a P200 Gilson's pipette. The samples were then 
incubated on ice for 30 min before being centrifuged at 4°C at 21,000 g for 15 
min. The supernatant was then transferred to a clean eppendorf.  
 
Lysis buffer 
 RIPA buffer      925 µl  NaF       10 µl  Beta-glycosyl phosphate    25 µl  Phosphate inhibitor mix (x6 Roche)  40 µl   RIPA buffer  
 ddH2O      9.5 ml 
 Tris-HCl pH 7.5 (2M)     250 l  NaCl (5M)      300 µl 
 1% NP40 (Sigma Aldrich)    100 l 
 10% SDS      100 l Sodium deoxycholate    50 mg 
  
6.5.2.3 Protein quantification 
 
 To normalise the amount of protein loaded between samples the total 
amount of protein was measured using a Bradford assay. One microlitre of the 
sample of protein was added to 100 µl of Bradford reagent. The solution was 
mixed by aspiration and a 2 µl aliquot was taken.. The absorbance was 




(Thermo FisherScientific). The samples were blanked to a control Bradford 
solution that had only been mixed with lysis buffer. The readings were 
compared to a standard calibration curve measured by Joe Rainger using known 
concentrations of BSA. 
  
 
6.5.2.4 Western blot 
 
All Western blot samples were separated by SDS-PAGE using the 
NuPage/ XCell SureLock system (Life Technologies). Every gel was run out on a 
precast 10% Bis Tris gel (10 wells ;Life Technologies) at 180 V for ~ 90 min 
(until the initial loading dye and migrated to the bottom of the gel). Samples 
were run in reducing conditions in accordance with the manufacturer’s (Life 
Technologies) instructions.  
 
Sample prep (20 µl) 
 *Sample in lysis buffer    up to 13 µl  
 NuPAGE LDS Sample Buffer (4X)   5  µl  NuPAGE Reducing Agent (10X)   2  µl  ddH2O      made to volume  
*The western blots on in vitro translation reactions were not normalised. Instead 13 µl of the reaction was loaded into the gel.  




 Before loading the sample prep was integrated at 75°C for 10 min to 
denature proteins. To estimate the molecular weight of sample proteins the 
samples were run with the SeeBlue plus2 pre-stained standard (Life 
Technologies). 
 The proteins were then transferred to a Hybond-P PVDF membrane 
(Hybond-P; Amersham) using NuPAGE® Transfer Buffer (Life Technologies) in 
conjunction with a XCell II™ Blot Module (Life Technologies). The XCell II unit 
was run at 30 V for between 45 - 60 min; once the transfer has been completed 
the membrane is blocked in 5% powdered milk (Marvel; Premier foods) in the 
PBST for one hour. The blocking solution was replaced and the primary 
antibody was added (for details consult Sup. Table 10) and the membrane was 
incubated overnight at 4°C. The membrane was then washed in PBST (three 
times for 5 min) and then incubated with the appropriate HrP conjugated 
secondary (for details consult Sup. Table 10)  for one hour. To detect the HrP 
signal the membrane was first coated with ECL reagents (sourced from either 
ECL plus or ECL prime kits; Amershame Biosciences). The signal was visualised 
in two ways. Initially the membrane was exposed to photographic film (Kodak 
Biomax XAR Film) using a x-ray cassette to provide a physical copy. The length 
of exposure was determined empirically. Immediately afterwards the signal was 
visualised using an ImageQuant LAS. 
 If the membrane was reprobed with the second antibody the membrane 
was first stripped.  This entailed the membrane being  washed in PBS before 




Stripping of buffer  (1 L)   Glycine    15 g  SDS     1 g  Tween20    10 ml  ddH2O     900 ml    Adjust pH to 2.2 with HCL   ddH2O     made to volume   
 The embryo was incubated at room temperature for 10 to 15 min before 
being washed twice in PBS for 10 min and finally washed twice in the TBST for 5 
min. Before the membrane was ready for reprobing it was first blocked in 5% 
Marvel in the PBST as described above. 
 
 
6.5.3 In vitro digestions of DNA using TALEN pairs 
  
 The initial TALEN constructs were obtained using in vitro synthesis 
(detailed in 6.5.1). The targeted template was obtained by amplifying the target 
region of zsmoc1 from p5.1_smoc1using Fasttaq PCR; one of the PCR primers 
used in the amplification was biotinylated to tag the template DNA. The PCR was 
performed using the method detailed in 6.5.1. For information on the specific 
primers consult Sup. Table 7 and Sup. Table 9. The reaction was then 




 In vitro TALEN digestion (20 µl)   In vitro 5'TALEN reaction    2 µl  In vitro 3'TALEN reaction    2 µl  *Restriction buffer (20x)    2 µl  DNA target (5 µg)     6 - 16 µl  ddH2O       to volume   *unless otherwise stated the restriction buffer utilised was Roche buffer A.     
 The reaction was incubated at 28°C eight hours with a Thermo cycler. 
The solution to be stored at 4°C until use. 
    6.5.4 Southern Blotting 
 
 Cleave events were  visualised  with Southern blotting with the 
North2South Chemiluminescent Hybridization and Detection Kit (Thermo 
Scientific). However the methodology required substantial modifications.  Initially 
the DNA was separated using gel electrophoresis (6.4.3) on a 3% agarose gel 
(omitting DNA binding dyes). Simultaneously the positively charged nylon 
transfer membrane (GE Healthcare) was soaked in SCC buffer (4x). The 
biotinylated DNA was then transferred to a membrane with a vacuum blot. Once 
the transfer was complete the DNA was cross-linked to the membrane by baking 
it at 80°C overnight.  
 As the DNA template was already tagged the proteins pre-hybridisation 




skipped. Therefore after the DNA was cross-linked to the membrane it was 
initially equilibrated in stringency wash buffer (2X SSC/0.1% SDS)  before being 
washed three times (stringency wash buffer for 15 min each) while being rolled 
in a hybridisation oven at rt. The membrane was then blocked with a 15 min 
incubation in blocking buffer (Fisher Scientific). Streptavidin-HRP (Fisher 
Scientific) was added to the blocking buffer (at a concentration of one part 1 in 
300) and incubated with our team for a further 15 min. The membrane was 
then washed a further three times in wash buffer (x1; Fisher Scientific) for 5 
min each time. From then on the signal was detected following the 
manufacturer's instructions.  
 The southern blots were imaged in the same method described above for 
imaging Western blots. 
 
 
6.5.5 Whole mount immunohisto-chemistry 
 
6.5.5.1 Embryo collection 
 
 Embryos were collected when they reached 60% epiboly. The embryos 
were then placed in a 1.5 ml Eppendorf and fixed in freshly made 4% 
paraformaldehyde by incubating overnight while under rotated on a tube 




wash lasted 5 min). The embryos are then decanted into a Petri dish and 
manually  dechorionated.   
 The embryos were then dehydrated for long-term storage. This was 
achieved by transferring them to microcentrifuge tubes and sequentially treated 
with progressively more concentrated solutions of Methanol:PBST (25% : 75%, 
50% : 50% 75% : 25% and 100% : 0%).    At each step the tubes were mixed for 
5 min on a tube rotator.  Once the embryos were suspended in 100% methanol 
they were stored overnight at -20°C.  
 
 
6.5.5.2 Whole mount immuno methodology 
 
 The embryos were first transferred into in situ basket which allowed 
them to be used in conjunction with a 24 well plate. This simplified solution 
exchange as baskets were moved between wells. Each well contained 1.5 ml of 
the appropriate solution.  Before use the embryos were first rehydrated. This is 
achieved by sequential immersion in increasingly concentrated Methanol:PBST 
solutions (specifically 75% : 25%, 50% : 50% 25% : 75% and 0% : 100%). 
 Once the embryos were rehydrated they were treated using a modified 
version of the whole mount immuno found in von der Hardt et al. (2007). 
Initially the embryos were first blocked for one hour at rt in blocking solution 
(2%BSA, 2% DMSO, ~0.5% goat serum in PBST), immediately followed by an 




Table 10). The embryos were then subjected to 3x1hour washes in blocking 
solution followed by 3x10 min washes in PBST.  
 Horseradish peroxidase (HrP) staining of the embryos was achieved by 
incubating in biotinylated secondary antibody (in PBST) (Vector Laboratories) 
and washed 3x for 1 hour.  The biotinylated secondary antibody was pre-sorbed 
using 100 - 150 5 day old embryos. These were ground up and added to 10ml 
PBST  along with 100 µl of secondary antibody  which was then place on rollers 
and incubated at rt for 2 - 4 hours. 
 Embryos were then incubated for 2-3 hours in VECTASTAIN® ABC 
Reagent followed by 3x1 hour washes in 0.5% Hydrogen peroxidase in PBST. 
DAB substrate was added and the reaction allowed to continue until staining 
became apparent, at which point the reaction was stopped by 3x1hour washes 




6.5.6 Bioinformatic analysis 
 
6.5.5.1 signal IP 
 The translated nucleotide sequence of the five prime of SMOC-1 was 
analysed using signal IP.  The likelihood of a protein containing a signal peptide 






The S-score is based on the similarity of the amino acid sequence to known 
signal peptide. This is expressed using a Matthews Correlation Coefficient. 
 
C-score 
The C score is based on the similarity of the amino acid sequence to known 




The Y score is a combination of both the S and C scores. 
 
All scores were considered insignificant by using a D cutoff of 0.50 for the 
Matthews Correlation Coefficient of the respective scores (Petersen et al. 2011). 
 
6.5.5.1 PONDR-VLXT 
The intrinsic disorder of the isoforms of the zsmoc1 was modeled on PONDR-
VLXT. This system measures amino acids in nine residue blocks and compares 
the sequence to published  disordered and ordered protein regions. Those that 









6.6 Microbial Methods 
 
 
6.6.1 Basic microbial conditions 
 
 
 All microbial work was conducted on DH5α E. coli cells either sourced 
commercially (Sigma- Aldrich library competent cells) or from Martin Reijns, 
with the exception of Gateway destination plasmids. As the plasmids contain the 
ccdb death gene they can only be grown in strains that are resistant to the ccdb 
gene, because of this either One Shot® ccdB Survival™ (Sigma- Aldrich) or DB3 
(Reijns) E. coli were used.  
 
 All were cultured at 37°C in LB(Luria-Bertani)  broth or on LB medium. 
All bacteria were cultured with the antibiotic that corresponded to the 
resistance gene(s)( Table 2)  at a concentration high enough to maintain 
selection (Sup. table 13). For ease of use cultures were maintained in long-term 
storage; 450 µl of LB broth was taken from stationary phase cultures and mixed 
with 150 µl of 90% glycerol. The stocks were stored at -80°C in 2 ml Cryo 
tubes(screw tops; Greiner). Though all critical plasmids were also maintained as 







 The plasmids constructed were synthesised using a range of common 
cloning techniques ranging from standard restriction and ligation through to 
Goldengate cloning and finally Gateway Cloning using the methods detailed 
below. For the information on individual plasmids consult Sup. Table 11 and 
Sup. Table 12. 
  
 The majority of the cloning was completed by restriction digests 
followed by ligations. 
 
6.6.2.1 Restriction digests 
 Restriction digests were performed using enzymes obtained from either 
Roche or New England bioscience. Enzymes were incubated in the buffers 
recommended and supplied by their manufacturers. Up to 5 µg of DNA was 
incubated at 37°C for between one hour and overnight depending on the 
enzyme. To ensure that the DNA had been completely digested 2 µl of the 20 µl 
reaction  was run out on agarose gels as described above (6.4.5). 
 
6.5.2.2 Ligation 
 Ligations were performed using either Quick ligase (New England 
Biosciences) or T4 DNA ligase (New England Biosciences) in the associated 






6.5.2.3 Gateway cloning 
 Gateway cloning is a proprietary cloning system developed by Life 
Technologies (Invitrogen). It was used to rapidly introduce genes to destination 
plasmids detailed in supplementary table 2. Initially the genes are amplified 
using specially designed PCR primers which along with target specific sequence 
included the attB1 and attB2 sequence on the forward and reverse primers 
respectively. The DNA fragment was then cloned into the destination vector 
using the BP clonase: 
 
BP reaction (10 µl) 
 PCR product (50-150ng)     1-7 µl   destination vector (150ng)     1  µl  TE buffer pH 8.0      made to volume  BP Clonase II enzyme (Life Technologies)   2  µl 
 
 The sample was then incubated at room temperature for 60 min before 
being terminated by adding 1  µl proteins K and incubating the reaction for 10 
min at 37°C.  Two microlitres   of the reaction was then used to transform 
bacteria (detailed in 6.5.3) and the plasmid was purified 6.3.1. Subsequently a 
donor plasmid was used to clone the gene into the destination plasmid.  This 
was done by taking advantage of the fact that the BP recombination converts 
the attP sites present in the donor plasmid into an attL site. The attL site can 
then be recombined with the attR sequences present in the destination plasmid  






LR reaction (10 µl) 
 donor plasmid (<150ng)     1-7 µl   destination vector (150ng)     1  µl  TE buffer pH 8.0      made to volume  LR Clonase II enzyme (Life Technologies)   2  µl 
 
The LR reaction was incubated and terminated in using identical conditions to 
the BP clonase detailed above.  
 
6.5.2.4 TA cloning 
  TA cloning was conducted using the pGEM-T Easy TA cloning kit 
(Promega). 
 
6.5.2.5 Goldengate cloning 
 
 The theory behind Goldengate cloning is described in 4.1.3. All the 
constituent plasmids obtained from the Voytas kit were purified using midi 
prep kits. Transformations were confirmed by Sanger sequencing. 
 
First round of Goldengate cloning during TALEN synthesis (20 µl)  




 Step Temp Time Cycles 
Restriction digests 37°C 5 min  10 to 30 Ligation 16°C 10min 
Final digests 50°C 5 min 1 
Enzyme denaturation 80°C 5 min 1 
Hold 4°C 0-1 hours 0-1 
 Table 6.5.1 TALEN synthesis  program 1 The dark blue denotes the cycling stage of the program. For further details consult Table 6.4.2. The programs run on any Tetrad Thermo cycler. 
______________________________________________________________________________________________________________________________________________________________  
 The unligated DNA was digested by incubating the samples for 60 min at 
37°C after the addition of 1 µl of both Plasmid-Safe nuclease (Epicentre 
Biotechnologies) and 10 mM ATP (Epicentre Biotechnologies). Samples were 
run through a second round of Goldengate cloning. 
 
Second round of Goldengate cloning during TALEN synthesis (20 µl)  
 pFUSA vector (150 ng)     1-2  µl  pFUSA vector (150 ng)     1-2  µl  LR-vector (150 ng)      1-2  µl   Destination vector  (75 ng)     1-2 µl  Esp3I (Fermentas)      1 µl  Quick ligase (New England Biosciences)   1 µl  T4 DNA ligase buffer (New England Biosciences)  2 µl  ddH2O        made to volume 
a 
 Step Temp Time Cycles 
Restriction digests 37°C 10 min  10 to 30 Ligation 16°C 15min 
Final digests 37°C 10 min 1 
Hold 4°C 5 min 1 






 After each incubation the desired contract was obtained by using 
reaction mix to transform competent E. coli (6.5.3) followed by purifying the 
resultant plasmids using Maxi preps (6.3.1). 
 
 
6.6.3 Transformation  
 
 
 All transformations were achieved chemically, either using 50-100 
nanograms of plasmids or 1-2 µl of reaction solutions to 50 µl of chemically 
competent cells (6.5.1.). The cells were then incubated on ice for 30 min before 
being heat shocked for 30-45 seconds at 42°C. The cells were then incubated 
again for 2 min on ice before the addition of 450 µl of SOC media. Next the cells 
were outgrown for 30- 60 min (or 0-30 min for Ampicillin) on an orbital shaker 
at 37°C. Before being spread out on pre heated (37°C) 90mm LB agar plates 
made up with the appropriate antibiotic (Sup. Table 13). For TALEN synthesis 
blue white screening was also used. In this case before plating out the 
transformation 50 µL of 0.1M IPTG (Sigma) and 50 µl  X-gal 20 mg/ml (Sigma) 
was added to the plates. The bacteria were spread and the plates were then 
incubated overnight and colonies were picked (in the case of blue white 
selection only white colonies were picked) and grown in LB broth until they had 





























Supplementary Chapter 1 
 
Defects Human Smoc1tm1a/tm1a  Mouse 
Ocular  Anophthalmia (92%) coloboma (55.6%)  Micropthalmia (8%) 
Lower limb Oligodactyly (83%) Oligosyndactyly (91.6%)  Syndactyly (37%) 
Upper limb Syntosis/ None  Syndactyly 















Supplementary Chapter 2 
 
Gene Length of intron bp 
HSMOC1 72,963 
mSmoc1 83,192 
xsmoc1 58,000 Mendaka Smoc1 74,108 Drosphilia Pentagone 3,387  














Sup. Fig 3. UNSC genome BLAT of RACE PCR product sequence. 




(B). To top it corresponds to a 339 bp ated the 10kb upstream of the zebrafish loci. The second hit 













Exon 9   GAGATTACTGCTCCTACATTGTGGATTAAGCAGCTGGTGTACAAAGAGAACAAACAAAACAGTTCGAATAGTAGGAAGTCAG  Exon 10  AGAAAGTTCCCTCTTGTGACCAGGAGAGGCAGACCGCTCAGGATGAGGCTCGTCAGAACCCGCGGGAAGCCATCTTCATTCCTGACTGCGGCCTGCAGGGCCTTTACAAGCCAGTTCAGTGCCACCAGTCTACAGGTTACTGCTGGTGTGTGCTGGTGGACACCGGGAGACCTATACCTGGAACCTCTGCAAG  Exon 11   GTATAAGAAACCAGAGTGTGATAGTGCAGCTCGCTCTCGAGATACAGAGATGGAAGATCCATTCAGAGACAGAGATCTGACAG  Exon 12  GGTGTCCAGAGGGAAAGAAAGTGGAATTCATAACAAGCCTTTTGGATGCCCTTACTACTGACATGGTGCAAGCTATCAACTCGCCAACCCCCTCTGGTGGTGGGAGG  Exon 13  TTTGTTGAGCCTGACCCAAGCCACACACTGGAGGAACGGGTGGTTCACTGGTACTTTGCCCAGCTGGATAATAACGGCAGTCACGATATCAACAAGAAGGAGATGAAGCCCTTCAAGCGTTATGTGAAGAAAAAAGCCAAACCTAAGAGGTGTGCCCGCAAGTTCACAGACTACTGCGACCTTAACAAGGACAAGACCATCTCTCTTCAAGAGCTGAAAGGATGTCTAGGAGTCAATAAGGAGGG  Exon 14   GTAGCACTACAAGCAGCAGTCAAGGGACAAGGCAAGGGACAAATTTGTTCA   Exon 15  TAGGTCTTCGGGCCTGA 
 








































           
 











 Supplementary Nucleic acid techniques 
 
Sequencing 
 Sup. Table 7.Oligos used for sequencing 
Name Sequence Description 
TalSEQ_fw_1 CGTGCTGGAGTTTTTCCAGT 
Forwards and reverse sequencing primers designed to provide coverage the TALEN protein backbones in pCS2TAL3-DD, pCS2TAL3-DD, pTal3 and pTal4(excluding the RVDs)  
  TalSEQ_fw_2 ACCGTCCCCTACTTCAGCTC 
  TalSEQ_fw_3 CTCAGCTGGAGGGTAAAACG 
  TalSEQ_fw_4 GGTGGATCAAGGAAACCAGA 
  TalSEQ_fw_5 TTGTTTGTGAGTGGTCATTTCA 
  TalSEQ_fw_6 CCAACCGGATAGGGTTCAG 
  TalSEQ_fw_7 ATCGCTTCTTGATTCGATGC 
  TalSEQ_rv_1 CTGAAGTAGGGGACGGTTTG 
  TalSEQ_rv_2 GTTGAATTTCTTGCGATTTCA 
  TalSEQ_rv_3 TGCATTTCATCTGCTTGACC 
  TalSEQ_rv_4 TTCTCCACCAATCAAAAGCTC 
  TalSEQ_rv_5 ATTGCCAAATGTTTGAACGA 
  TalSEQ_rv_6 AGCGTGCGTAGATCCACCT 
  TalSEQ_rv_7 AACGATGTCTTCGTGTGTCG 




TalSubunitChek_seq_fw TAGCTGTTTCCTGGCAGCTC Forwards and reverse sequencing primers designed to provide coverage the RVD's (pNI ,pNN ,pNG and pHD) 
  TalSubunitChek_seq_rv CACGTTAAGGGATTTTGGTCA 
   CR8_seq_fw TTGATGCCTGGCAGTTCCCT  Forwards and reverse sequencing primers designed to flank RVDs in plasmids pCS2TAL3-DD, pCS2TAL3-DD 
  CR8_seq_rv CGAACCGAACAGGCTTATGT 
   pTAL_seq_fw GGCGACGAGGTGGTCGTTGG Forwards and reverse sequencing primers designed to flank RVDs in plasmids pCS2TAL3-DD, pCS2TAL3-DD  
  pTAL_seq_rv CATCGCGCAATGCACTGAC 
   hSMOC1_seq_fw_1 ACACTGTCCCAGGACTCAGC 
Forwards and reverse sequencing primers designed to provide coverage of hSMOC1. Primers 1-9 designed by Joe Rainger.  
  hSMOC1_seq_fw_2 ATCGAGGTCGATGCAAAGAT 
  hSMOC1_seq_fw_3 GGCTGTGTTTGTCCCAGAGT 
  hSMOC1_seq_fw_4 TTGAGCCAGGGTAATTCAGG 
  hSMOC1_seq_fw_5 AGACAGAGTGCCCTGGAAGA 
  hSMOC1_seq_fw_6 GCCAGAGCCAAGAGCATAGA 
  hSMOC1_seq_fw_7 ACACCCTGGAGGAGCGAGT 
  hSMOC1_seq_fw_8 GGTCATCTCACTGCCTGAGC 
  hSMOC1_seq_fw_9 CGGACGCCTTGTCTAAAGAG 
  hSMOC1_seq_rv_0 AGCATCTTTGCATCGACCTC 
  hSMOC1_seq_rv_1 CCTGTGTGAAGGAACCATCC 
  hSMOC1_seq_rv_2 AAGAACCACTGATGGGCTTG 
  hSMOC1_seq_rv_3 ACACAGGTTGGGTCTCCATC 
  hSMOC1_seq_rv_4 GGGGATCACAATGCCCTCT 




  hSMOC1_seq_rv_6 TGGCTGAAGTACCAGTGTGC 
  hSMOC1_seq_rv_7 GCCAAGGCTACCACCTTCTT 
  hSMOC1_seq_rv_8 GCGGGCACCACTTATGTTAC 
  hSMOC1_seq_rv_9 CCAGAAACAAACCACACACG 
  hSMOC1_seq_rv_10 GGAGGGTCACGGTCACTTAT 
   m13_fw GTAAAACGACGGCCA Standard sequencing primers  used to sequence pGEM-T easy and pDONR221    m13_rv GTCATAGCTGTTTCCT 
   zsmoc1fw2 TTCAGACGGACGCAGTTATG 
Forwards and reverse sequencing primers designed to provide coverage of zsmoc1. zsmoc1fw4, zsmoc1fw4, zsmoc1fw2 and  zsmoc1rv2 used in the PCR analysis in Fig. 2.2.1.  
  zsmoc1fw3 CCAGTGTCACACCCTCACAG 
  zsmoc1fw4 TGCCAGAAGGTGAGGAGATT 
  zsmoc1fw5 AGGGCCTTTACAAGCCAGTT 
  zsmoc1rv2 ACTGGCGTTTTGTTCTGGAC 
  zsmoc1rv3 TCCTGGTCACAAGAGGGAAC 
  zsmoc1rv4 GAGCGAGCTGCACTATCACA 
  zsmoc1rv5 GGTCAGGCTCAACAAACCTC 
  zsmoc1exon13_1_rv AAGCCACACACTGGAGGAAC 
  zsmoc1exon13_2_rv TGTCCTTGTTAAGGTCGCAGT 
  zsmoc1exon13_3_rv GACTCCTAGACACCCTTTCAGC 







Name Sequence Description 
qPCR_efla_fw CTGGAGGCCAGCTCAAACAT Forward qPCR primer reference  gene amplifies efla 
   
qPCR_efla_rv ATCAAGAAGAGTAGTACCGCTAGCATTAC Reverse qPCR primer reference  gene amplifies efla 
   
qPCR_bactin_fw TGCGTCTGGATCTAGCTGG Reverse qPCR primer reference  gene amplifies bactin 
   
qPCR_bactin_rv TCCCATCTCCTGCTCGAAG Reverse qPCR primer reference  gene amplifies bactin 
   
qPCR_zsmoc1_all_fw CAGTTCAGTGCCACCAGTCT Forward qPCR primer amplifies All known zsmoc1 isoforms 
   
qPCR_zsmoc1_all_rv CTCTGTCTCTGAATGGATCTTCC Reverse qPCR primer amplifies All known zsmoc1 isoforms 
   
qPCR_zsmoc1_var1_fw TGGGAACTCATGCTGGGACA Forward qPCR primer amplifies only zsmoc1  isoform A  
   
qPCR_zsmoc1_var1_rv TGGGCTTGGAACCATCATCTTT Reverse qPCR primer amplifies  only zsmoc1 isoform A  
   
qPCR_zsmoc1_var2_fw CAGGGTCAGTAACCACCGATAAGC Forward qPCR primer amplifies only zsmoc1  isoform B  
   
qPCR_zsmoc1_var2_rv TCACCTTCTGGCACAACATGC Reverse qPCR primer amplifies  only zsmoc1 isoform B  
   
qPCR_zsmoc1_var3_fw TGGGAACTCATGCTGGGACA Forward qPCR primer amplifies only zsmoc1  isoform C  
   
qPCR_zsmoc1_var3_rv TGAGGGTGAGAAAGAAACGGAAA Reverse qPCR primer amplifies  only zsmoc1 isoform C  
   
qPCR_otx2_fw ACCCCTCCGTTGGATACC Forward qPCR primer amplifies Dorsalisation marker otx2  
   
qPCR_otx2_rv ATCCGGGTAGCGTGTTTTC Reverse qPCR primer amplifies  Dorsalisation marker otx2 




Dorsalisation marker runx3 
   
qPCR_runx3_rv GCTCACCTCCAGCTTCTCC Reverse qPCR primer amplifies  Dorsalisation marker runx3 
   
qPCR_eve1_fw TGGATCCTAACGACAAAATGCTA Forward qPCR primer amplifies Ventralisation marker eve1 
   
qPCR_eve1_rv CAGTAGTGAAATACGAGGGCATT Reverse qPCR primer amplifies  Ventralisation marker eve1 
   
qPCR_gata2_fw ATCCCGGTACCCTCCTCA Forward qPCR primer amplifies Ventralisation marker gata2 
   
qPCR_gata2_rv ACATTCACGCCCCTCTGA Reverse qPCR primer amplifies  Ventralisation marker gata2 
   
qPCR_ID1_fw AAGAAAGCCAGCAAGATGGA Forward qPCR primer amplifies Downstream bmp target id1  
   
qPCR_ID1_rv GCTTCGATGATCTGTTGACG Reverse qPCR primer amplifies  Downstream bmp target id1 
 
















Name Sequence Description 
fw_RACE_Outer GCTGATGGCGATGAATGAACACTG 5' Race primers included in RLM-RACE  kit.     fw_RACE_Inner CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG 
   rv_RACE_zsmoc1_1 CATAACTGCGTCCGTCTGAA 
 Three 3' prime nested PCR primers targeted to exon 2 of zsmoc1. 
  rv_RACE_zsmoc1_2 CAGGCTTGCCGTGACTTCT 
  rv_RACE_zsmoc1_3 GAACACGGGCTCTCTCTGTC 
   rv_RACE_bmp2b_1 CAGCTCAAGTCGCCTCTTCT Two 3' prime nested PCR primers targeted to exon 1 of bmp2b as a positive control for RACE.   
  
rv_RACE_bmp2b_2 AGCGCTCAGGTCAAAGACAG 
   hsmoc1_HindIII_fw TTTCGTCTCAAGCTTCCTAGTAGACACAGGGTGCCC PCR primer pair used amplify and Isolate hSMOC1 by introducing HindIII and BamHI sites flanking the amplicon   
  
hsmoc1_BamHI_rv TTTCGTCTCGGATCCACCGGTACGCGTAGAATCG 
   
zsmoc1fw2_Bioatin [Btn]TTCAGACGGACGCAGTTATG 
Forward biotinylated Primer used to amplify target 4 in conjunction with zsmoc1fw4 
   
zsmoc1rv4_Bioatin [Btn]GAGCGAGCTGCACTATCACA 
 Forward biotinylated Primer used to amplify target 4 in conjunction with zsmoc1fw4 
   
zsmoc1SPattb1_fw  GGGGACAAGTTTGTACAAAAAAGCAGGCTGG TTGGGACTTTTGCCAATTCT PCR primer pair used amplify and Isolate hSMOC1 by introducing attb1-2 sites HI sites flanking the amplicon for gateway cloning  
  zsmoc1SPattb2_rv  GGGGACCACTTTGTACAAGAAAGCTGGGTA TCAACCCTCCTTATTGACTCCTA 
 





Supplementary Protein Techniques 
 
Antibodies 
Antibody Host Supplier Product number Dilution Protocol 
anti-psmad 1/5/ 8 Rabbit Cell signalling D5B10 1 in 200 Wholemount 
HrP Anti-rabbit Goat Vector laboratories PK-6200(kit) 1 in 1000 Wholemount 
Anti-FLAG Mouse Cell signalling 2368  1 in 500 Western blot 
Anti-HA Rabbit Sigma H3663  1 in 500 Western blot 
Anti-mouse Rabbit Dako P0260  1 in 10000 Western blot 






















Name Details Selection Source 
pCS2+  Xenopus mRNA expression vector sense expression is controlled of SP6 prompter. The promoter contains antisense T3 and T7. The basic vector also contains a FLAG tag. 
 
Amp Addgene 
pCSDest A CS2 vector containing a gateway cassette. The FLAG tag is absent. 
 
Amp/Chlo/ccdB  Addgene 
pCSMyc A CS3 is a variant of the CS2 vector. This vector contains a gateway cassette and a Myc tag. 
 
Amp/Chlo/ccdB  Addgene 
pGEM-T easy A component of a TA cloning. The plasmid was obtained pre-linearised with dephosphorylated single base (thiamine) overhangs. 
 
Amp Promega 
pDONR221 Donor plasmids with gateway cassette. Necessary to clone into before the final destination program. 
 
Kan/Chlo/ccdB  life technologies 
pNI 1 - 10 RVD plasmid contains  the NI rvd site flanked by two BsaI sites. 
 
Tet Addgene 
pNN 1 - 10 RVD plasmid contains  the NN rvd site flanked by two BsaI sites. 
 
Tet Addgene 
pNG 1 - 10 RVD plasmid contains  the NG rvd site flanked by two BsaI sites. 
 
Tet Addgene 
pHD 1 - 10 RVD plasmid contains  the HD rvd site flanked by two BsaI sites. 
 
Tet Addgene 






pFusB6-9 Second destination plasmid for the first Goldengate reaction. Contains a LacZ gene flanked by two BsaI sites. Which in turn are flanked by two  Esp3I 
 
Spec/LacZ Addgene 
pLR-NI Last repeat plasmid contains a truncated NI RVD flanked by flanked by two  Esp3I.   
 
Spec Addgene 
pLR-NN Last repeat plasmid contains a truncated NI RVD flanked by flanked by two  Esp3I. 
 
Spec Addgene 
pLR-NG Last repeat plasmid contains a truncated NI RVD flanked by flanked by two  Esp3I. 
 
Spec Addgene 
pLR-HD Last repeat plasmid contains a truncated NI RVD flanked by flanked by two  Esp3I. 
 
Spec Addgene 
Tal4 Final destination plasmid for Goldengate cloning of TALEN synthesis. It contains a TALEN backbone . The RVD domains is replaced  with a LacZ selection cassette flanked by Esp3I sites. 
 
Amp/LacZ Addgene 
pCS2TAL3-DD Final destination plasmid for Goldengate cloning of TALEN synthesis. It contains  TALEN backbone with a modified FokI domain. The RVD domains is replaced  with a LacZ selection cassette flanked by Esp3I sites. 
 
Amp/LacZ Addgene 









Name Details Selection 
pCS2+_hSMOC1 Xenopus mRNA expression vector(CS2+)  with hSMOC1 cloned in to the Bam1 and HindIII sites. Amp pCSDest_zsmoc1 Xenopus mRNA expression vector (CS2+) with zsmoc1 cloned in to the attB1 and attB2 sites. Amp  pCSMyc_zsmoc1 Xenopus mRNA expression vector (CS3+) with zsmoc1 cloned in to the attL1 and attL2 sites. Amp pDONR221_zsmoc1 E. coli expression vector (DONR221) with zsmoc1 cloned in to the gateway cassette. Kan  5'Tal1zsmoc1_FusA Destination plasmid for the first ten RVDs of 5'DDTal1zsmoc1 Spec 
5'Tal1zsmoc1_FusB9 Destination plasmid for the second nine RVDs of 5'DDTal1zsmoc1 Spec 3'Tal1zsmoc1_FusA Destination plasmid for the first ten RVDs of 3'RRTal1zsmoc1 Spec 
3'Tal1zsmoc1_FusB7 Destination plasmid for the second seven RVDs of 3'RRTal1zsmoc1 Spec 5'Tal2zsmoc1_FusA Destination plasmid for the first ten RVDs of 5'RRTal2zsmoc1 Spec 
5'Tal2zsmoc1_FusB7 Destination plasmid for the second nine RVDs of 5'RRTal2zsmoc1 Spec 3'Tal2zsmoc1_FusA Destination plasmid for the first ten RVDs of 3'DDTal2zsmoc1 Spec 
3'Tal3zsmoc1_FusB9 Destination plasmid for the second seven RVDs of 3'DDTal2zsmoc1 Spec 5'DDTal1zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 9. The construct is cloned into  CS2TAL3-DD and FLAG tagged. 
Amp 
3'RRTal1zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 9. The construct is cloned into CS2TAL3-RR and HA tagged. 
Amp 
5'RRTal2zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 4. The construct is cloned is CS2TAL3-RR and HA tagged. 
Amp 
3'DDTal2zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 4. The construct is cloned is CS2TAL3-DD and FLAG tagged. 
Amp 
5'Tal4_Tal1zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 9. The construct is cloned is CS2TAL3-RR and FLAG tagged. 
Amp 
3'Tal4_Tal1zsmoc1 Xenopus mRNA expression vector (CS2+) containing  a complete TALEN construct targeting  zsmoc1 exon 9. The construct is cloned is TAL4 and FLAG tagged. 
Amp 
 












Sup. Table 13. Antibiotic stock solutions  
 
 
Antibiotic Stock Concentration Stock Solvent Working Concentration 
Ampicillin 5 mg/ml ddH2O 100 µg/ml Chloramphenicol 25mg/ml Ethanol 25 µg/ml 
Gentamycin 10 mg/ml ddH2O 10 µg/ml Kanamycin 50 mg/ml ddH2O 50 µg/ml Spectinomycin 50 mg/ml ddH2O 50 µg/ml Tetracycline 10 mg/ml ddH2O 10 µg/ml 
   
